id	sid	tid	token	lemma	pos
ajlm-1718	1	1	abstract	abstract	ADJ
ajlm-1718	1	2	introduction	introduction	NOUN
ajlm-1718	1	3	methods	method	NOUN
ajlm-1718	1	4	results	result	VERB
ajlm-1718	1	5	discussion	discussion	NOUN
ajlm-1718	1	6	acknowledgements	acknowledgement	NOUN
ajlm-1718	1	7	references	reference	NOUN
ajlm-1718	1	8	about	about	ADP
ajlm-1718	1	9	the	the	DET
ajlm-1718	1	10	author(s	author(s	NOUN
ajlm-1718	1	11	)	)	PUNCT
ajlm-1718	1	12	nada	nada	PROPN
ajlm-1718	1	13	a.	a.	PROPN
ajlm-1718	1	14	abdelrahim	abdelrahim	PROPN
ajlm-1718	1	15	department	department	PROPN
ajlm-1718	1	16	of	of	ADP
ajlm-1718	1	17	medical	medical	ADJ
ajlm-1718	1	18	microbiology	microbiology	NOUN
ajlm-1718	1	19	,	,	PUNCT
ajlm-1718	1	20	faculty	faculty	NOUN
ajlm-1718	1	21	of	of	ADP
ajlm-1718	1	22	medical	medical	ADJ
ajlm-1718	1	23	laboratory	laboratory	NOUN
ajlm-1718	1	24	sciences	sciences	PROPN
ajlm-1718	1	25	,	,	PUNCT
ajlm-1718	1	26	nile	nile	PROPN
ajlm-1718	1	27	university	university	PROPN
ajlm-1718	1	28	,	,	PUNCT
ajlm-1718	1	29	khartoum	khartoum	PROPN
ajlm-1718	1	30	,	,	PUNCT
ajlm-1718	1	31	sudan	sudan	PROPN
ajlm-1718	1	32	nahla	nahla	PROPN
ajlm-1718	1	33	mohamed	mohamed	PROPN
ajlm-1718	1	34	department	department	PROPN
ajlm-1718	1	35	of	of	ADP
ajlm-1718	1	36	virology	virology	NOUN
ajlm-1718	1	37	,	,	PUNCT
ajlm-1718	1	38	faculty	faculty	NOUN
ajlm-1718	1	39	of	of	ADP
ajlm-1718	1	40	clinical	clinical	ADJ
ajlm-1718	1	41	microbiology	microbiology	NOUN
ajlm-1718	1	42	,	,	PUNCT
ajlm-1718	1	43	umeå	umeå	PROPN
ajlm-1718	1	44	university	university	PROPN
ajlm-1718	1	45	,	,	PUNCT
ajlm-1718	1	46	umeå	umeå	PROPN
ajlm-1718	1	47	,	,	PUNCT
ajlm-1718	1	48	sweden	sweden	PROPN
ajlm-1718	1	49	magnus	magnus	PROPN
ajlm-1718	1	50	evander	evander	PROPN
ajlm-1718	1	51	department	department	PROPN
ajlm-1718	1	52	of	of	ADP
ajlm-1718	1	53	virology	virology	NOUN
ajlm-1718	1	54	,	,	PUNCT
ajlm-1718	1	55	faculty	faculty	NOUN
ajlm-1718	1	56	of	of	ADP
ajlm-1718	1	57	clinical	clinical	ADJ
ajlm-1718	1	58	microbiology	microbiology	NOUN
ajlm-1718	1	59	,	,	PUNCT
ajlm-1718	1	60	umeå	umeå	PROPN
ajlm-1718	1	61	university	university	PROPN
ajlm-1718	1	62	,	,	PUNCT
ajlm-1718	1	63	umeå	umeå	PROPN
ajlm-1718	1	64	,	,	PUNCT
ajlm-1718	1	65	sweden	sweden	PROPN
ajlm-1718	1	66	clas	clas	PROPN
ajlm-1718	1	67	ahlm	ahlm	PROPN
ajlm-1718	1	68	department	department	PROPN
ajlm-1718	1	69	of	of	ADP
ajlm-1718	1	70	infection	infection	NOUN
ajlm-1718	1	71	and	and	CCONJ
ajlm-1718	1	72	immunology	immunology	NOUN
ajlm-1718	1	73	,	,	PUNCT
ajlm-1718	1	74	faculty	faculty	NOUN
ajlm-1718	1	75	of	of	ADP
ajlm-1718	1	76	clinical	clinical	ADJ
ajlm-1718	1	77	microbiology	microbiology	NOUN
ajlm-1718	1	78	,	,	PUNCT
ajlm-1718	1	79	umeå	umeå	PROPN
ajlm-1718	1	80	university	university	PROPN
ajlm-1718	1	81	,	,	PUNCT
ajlm-1718	1	82	umeå	umeå	PROPN
ajlm-1718	1	83	,	,	PUNCT
ajlm-1718	1	84	sweden	sweden	PROPN
ajlm-1718	1	85	imad	imad	PROPN
ajlm-1718	1	86	m.	m.	PROPN
ajlm-1718	1	87	fadl	fadl	NOUN
ajlm-1718	1	88	-	-	PUNCT
ajlm-1718	1	89	elmula	elmula	VERB
ajlm-1718	1	90	department	department	NOUN
ajlm-1718	1	91	of	of	ADP
ajlm-1718	1	92	pathology	pathology	PROPN
ajlm-1718	1	93	and	and	CCONJ
ajlm-1718	1	94	clinical	clinical	ADJ
ajlm-1718	1	95	genetics	genetic	NOUN
ajlm-1718	1	96	,	,	PUNCT
ajlm-1718	1	97	faculty	faculty	NOUN
ajlm-1718	1	98	of	of	ADP
ajlm-1718	1	99	medicine	medicine	NOUN
ajlm-1718	1	100	,	,	PUNCT
ajlm-1718	1	101	al	al	PROPN
ajlm-1718	1	102	-	-	PUNCT
ajlm-1718	1	103	neelain	neelain	PROPN
ajlm-1718	1	104	university	university	NOUN
ajlm-1718	1	105	,	,	PUNCT
ajlm-1718	1	106	khartoum	khartoum	PROPN
ajlm-1718	1	107	,	,	PUNCT
ajlm-1718	1	108	sudan	sudan	PROPN
ajlm-1718	1	109	assafa	assafa	PROPN
ajlm-1718	1	110	academy	academy	PROPN
ajlm-1718	1	111	,	,	PUNCT
ajlm-1718	1	112	kartoum	kartoum	PROPN
ajlm-1718	1	113	,	,	PUNCT
ajlm-1718	1	114	sudan	sudan	PROPN
ajlm-1718	1	115	citation	citation	PROPN
ajlm-1718	1	116	abdelrahim	abdelrahim	PROPN
ajlm-1718	1	117	na	na	PROPN
ajlm-1718	1	118	,	,	PUNCT
ajlm-1718	1	119	mohamed	mohamed	PROPN
ajlm-1718	1	120	n	n	PROPN
ajlm-1718	1	121	,	,	PUNCT
ajlm-1718	1	122	evander	evander	PROPN
ajlm-1718	1	123	m	m	PROPN
ajlm-1718	1	124	,	,	PUNCT
ajlm-1718	1	125	ahlm	ahlm	PROPN
ajlm-1718	1	126	c	c	NOUN
ajlm-1718	1	127	,	,	PUNCT
ajlm-1718	1	128	fadl	fadl	NOUN
ajlm-1718	1	129	-	-	PUNCT
ajlm-1718	1	130	elmula	elmula	VERB
ajlm-1718	1	131	i	i	PRON
ajlm-1718	1	132	m.	m.	NOUN
ajlm-1718	1	133	human	human	ADJ
ajlm-1718	1	134	herpes	herpe	NOUN
ajlm-1718	1	135	virus	virus	NOUN
ajlm-1718	1	136	type-6	type-6	PROPN
ajlm-1718	1	137	is	be	AUX
ajlm-1718	1	138	associated	associate	VERB
ajlm-1718	1	139	with	with	ADP
ajlm-1718	1	140	central	central	ADJ
ajlm-1718	1	141	nervous	nervous	ADJ
ajlm-1718	1	142	system	system	NOUN
ajlm-1718	1	143	infections	infection	NOUN
ajlm-1718	1	144	in	in	ADP
ajlm-1718	1	145	children	child	NOUN
ajlm-1718	1	146	in	in	ADP
ajlm-1718	1	147	sudan	sudan	PROPN
ajlm-1718	1	148	.	.	PUNCT
ajlm-1718	2	1	afr	afr	PROPN
ajlm-1718	2	2	j	j	PROPN
ajlm-1718	2	3	lab	lab	PROPN
ajlm-1718	2	4	med	med	PROPN
ajlm-1718	2	5	.	.	PUNCT
ajlm-1718	3	1	2022;11(1	2022;11(1	NUM
ajlm-1718	3	2	)	)	PUNCT
ajlm-1718	3	3	,	,	PUNCT
ajlm-1718	3	4	a1718	a1718	PROPN
ajlm-1718	3	5	.	.	PUNCT
ajlm-1718	4	1	https://doi.org/10.4102/ajlm.v11i1.1718	https://doi.org/10.4102/ajlm.v11i1.1718	AUX
ajlm-1718	4	2	original	original	ADJ
ajlm-1718	4	3	research	research	NOUN
ajlm-1718	4	4	human	human	ADJ
ajlm-1718	4	5	herpes	herpe	NOUN
ajlm-1718	4	6	virus	virus	NOUN
ajlm-1718	4	7	type-6	type-6	PROPN
ajlm-1718	4	8	is	be	AUX
ajlm-1718	4	9	associated	associate	VERB
ajlm-1718	4	10	with	with	ADP
ajlm-1718	4	11	central	central	ADJ
ajlm-1718	4	12	nervous	nervous	ADJ
ajlm-1718	4	13	system	system	NOUN
ajlm-1718	4	14	infections	infection	NOUN
ajlm-1718	4	15	in	in	ADP
ajlm-1718	4	16	children	child	NOUN
ajlm-1718	4	17	in	in	ADP
ajlm-1718	4	18	sudan	sudan	PROPN
ajlm-1718	4	19	nada	nada	PROPN
ajlm-1718	4	20	a.	a.	PROPN
ajlm-1718	4	21	abdelrahim	abdelrahim	PROPN
ajlm-1718	4	22	,	,	PUNCT
ajlm-1718	4	23	nahla	nahla	PROPN
ajlm-1718	4	24	mohamed	mohamed	PROPN
ajlm-1718	4	25	,	,	PUNCT
ajlm-1718	4	26	magnus	magnus	PROPN
ajlm-1718	4	27	evander	evander	PROPN
ajlm-1718	4	28	,	,	PUNCT
ajlm-1718	4	29	clas	clas	NOUN
ajlm-1718	4	30	ahlm	ahlm	PROPN
ajlm-1718	4	31	,	,	PUNCT
ajlm-1718	4	32	imad	imad	PROPN
ajlm-1718	4	33	m.	m.	PROPN
ajlm-1718	4	34	fadl	fadl	NOUN
ajlm-1718	4	35	-	-	PUNCT
ajlm-1718	4	36	elmula	elmula	VERB
ajlm-1718	4	37	received	receive	VERB
ajlm-1718	4	38	:	:	PUNCT
ajlm-1718	4	39	29	29	NUM
ajlm-1718	4	40	aug	aug	PROPN
ajlm-1718	4	41	.	.	PROPN
ajlm-1718	4	42	2021	2021	NUM
ajlm-1718	4	43	;	;	PUNCT
ajlm-1718	4	44	accepted	accept	VERB
ajlm-1718	4	45	:	:	PUNCT
ajlm-1718	4	46	25	25	NUM
ajlm-1718	4	47	may	may	PROPN
ajlm-1718	4	48	2022	2022	NUM
ajlm-1718	4	49	;	;	PUNCT
ajlm-1718	4	50	published	publish	VERB
ajlm-1718	4	51	:	:	PUNCT
ajlm-1718	4	52	22	22	NUM
ajlm-1718	4	53	sept	sept	PROPN
ajlm-1718	4	54	.	.	PROPN
ajlm-1718	4	55	2022	2022	NUM
ajlm-1718	4	56	copyright	copyright	NOUN
ajlm-1718	4	57	:	:	PUNCT
ajlm-1718	4	58	©	©	PROPN
ajlm-1718	4	59	2022	2022	NUM
ajlm-1718	4	60	.	.	PUNCT
ajlm-1718	5	1	the	the	DET
ajlm-1718	5	2	author(s	author(s	PROPN
ajlm-1718	5	3	)	)	PUNCT
ajlm-1718	5	4	.	.	PUNCT
ajlm-1718	6	1	licensee	licensee	NOUN
ajlm-1718	6	2	:	:	PUNCT
ajlm-1718	6	3	aosis	aosis	NOUN
ajlm-1718	6	4	.	.	PUNCT
ajlm-1718	7	1	this	this	PRON
ajlm-1718	7	2	is	be	AUX
ajlm-1718	7	3	an	an	DET
ajlm-1718	7	4	open	open	ADJ
ajlm-1718	7	5	access	access	NOUN
ajlm-1718	7	6	article	article	NOUN
ajlm-1718	7	7	distributed	distribute	VERB
ajlm-1718	7	8	under	under	ADP
ajlm-1718	7	9	the	the	DET
ajlm-1718	7	10	terms	term	NOUN
ajlm-1718	7	11	of	of	ADP
ajlm-1718	7	12	the	the	DET
ajlm-1718	7	13	creative	creative	ADJ
ajlm-1718	7	14	commons	common	NOUN
ajlm-1718	7	15	attribution	attribution	NOUN
ajlm-1718	7	16	license	license	NOUN
ajlm-1718	7	17	,	,	PUNCT
ajlm-1718	7	18	which	which	PRON
ajlm-1718	7	19	permits	permit	VERB
ajlm-1718	7	20	unrestricted	unrestricted	ADJ
ajlm-1718	7	21	use	use	NOUN
ajlm-1718	7	22	,	,	PUNCT
ajlm-1718	7	23	distribution	distribution	NOUN
ajlm-1718	7	24	,	,	PUNCT
ajlm-1718	7	25	and	and	CCONJ
ajlm-1718	7	26	reproduction	reproduction	NOUN
ajlm-1718	7	27	in	in	ADP
ajlm-1718	7	28	any	any	DET
ajlm-1718	7	29	medium	medium	NOUN
ajlm-1718	7	30	,	,	PUNCT
ajlm-1718	7	31	provided	provide	VERB
ajlm-1718	7	32	the	the	DET
ajlm-1718	7	33	original	original	ADJ
ajlm-1718	7	34	work	work	NOUN
ajlm-1718	7	35	is	be	AUX
ajlm-1718	7	36	properly	properly	ADV
ajlm-1718	7	37	cited	cite	VERB
ajlm-1718	7	38	.	.	PUNCT
ajlm-1718	8	1	abstract	abstract	ADJ
ajlm-1718	8	2	background	background	NOUN
ajlm-1718	8	3	:	:	PUNCT
ajlm-1718	8	4	human	human	ADJ
ajlm-1718	8	5	herpes	herpe	NOUN
ajlm-1718	8	6	virus	virus	NOUN
ajlm-1718	8	7	type-6	type-6	PROPN
ajlm-1718	8	8	(	(	PUNCT
ajlm-1718	8	9	hhv-6	hhv-6	NOUN
ajlm-1718	8	10	)	)	PUNCT
ajlm-1718	8	11	is	be	AUX
ajlm-1718	8	12	increasingly	increasingly	ADV
ajlm-1718	8	13	recognised	recognise	VERB
ajlm-1718	8	14	as	as	ADP
ajlm-1718	8	15	a	a	DET
ajlm-1718	8	16	febrile	febrile	NOUN
ajlm-1718	8	17	agent	agent	NOUN
ajlm-1718	8	18	in	in	ADP
ajlm-1718	8	19	children	child	NOUN
ajlm-1718	8	20	.	.	PUNCT
ajlm-1718	9	1	however	however	ADV
ajlm-1718	9	2	,	,	PUNCT
ajlm-1718	9	3	less	less	ADV
ajlm-1718	9	4	is	be	AUX
ajlm-1718	9	5	known	know	VERB
ajlm-1718	9	6	in	in	ADP
ajlm-1718	9	7	sub	sub	ADJ
ajlm-1718	9	8	-	-	ADJ
ajlm-1718	9	9	saharan	saharan	ADJ
ajlm-1718	9	10	african	african	ADJ
ajlm-1718	9	11	countries	country	NOUN
ajlm-1718	9	12	,	,	PUNCT
ajlm-1718	9	13	including	include	VERB
ajlm-1718	9	14	sudan	sudan	PROPN
ajlm-1718	9	15	.	.	PUNCT
ajlm-1718	10	1	objective	objective	NOUN
ajlm-1718	10	2	:	:	PUNCT
ajlm-1718	11	1	we	we	PRON
ajlm-1718	11	2	investigated	investigate	VERB
ajlm-1718	11	3	the	the	DET
ajlm-1718	11	4	involvement	involvement	NOUN
ajlm-1718	11	5	of	of	ADP
ajlm-1718	11	6	hhv-6	hhv-6	NOUN
ajlm-1718	11	7	in	in	ADP
ajlm-1718	11	8	paediatric	paediatric	ADJ
ajlm-1718	11	9	central	central	ADJ
ajlm-1718	11	10	nervous	nervous	ADJ
ajlm-1718	11	11	system	system	NOUN
ajlm-1718	11	12	(	(	PUNCT
ajlm-1718	11	13	cns	cns	NOUN
ajlm-1718	11	14	)	)	PUNCT
ajlm-1718	11	15	infections	infection	NOUN
ajlm-1718	11	16	in	in	ADP
ajlm-1718	11	17	khartoum	khartoum	PROPN
ajlm-1718	11	18	,	,	PUNCT
ajlm-1718	11	19	sudan	sudan	PROPN
ajlm-1718	11	20	.	.	PUNCT
ajlm-1718	12	1	methods	method	NOUN
ajlm-1718	12	2	:	:	PUNCT
ajlm-1718	12	3	febrile	febrile	NOUN
ajlm-1718	12	4	patients	patient	NOUN
ajlm-1718	12	5	aged	age	VERB
ajlm-1718	12	6	up	up	ADP
ajlm-1718	12	7	to	to	PART
ajlm-1718	12	8	15	15	NUM
ajlm-1718	12	9	years	year	NOUN
ajlm-1718	12	10	with	with	ADP
ajlm-1718	12	11	suspected	suspect	VERB
ajlm-1718	12	12	cns	cns	NOUN
ajlm-1718	12	13	infections	infection	NOUN
ajlm-1718	12	14	at	at	ADP
ajlm-1718	12	15	omdurman	omdurman	ADJ
ajlm-1718	12	16	hospital	hospital	NOUN
ajlm-1718	12	17	for	for	ADP
ajlm-1718	12	18	children	child	NOUN
ajlm-1718	12	19	from	from	ADP
ajlm-1718	12	20	01	01	NUM
ajlm-1718	12	21	december	december	PROPN
ajlm-1718	12	22	2009	2009	NUM
ajlm-1718	12	23	to	to	ADP
ajlm-1718	12	24	01	01	NUM
ajlm-1718	12	25	august	august	PROPN
ajlm-1718	12	26	2010	2010	NUM
ajlm-1718	12	27	were	be	AUX
ajlm-1718	12	28	included	include	VERB
ajlm-1718	12	29	.	.	PUNCT
ajlm-1718	13	1	viral	viral	ADJ
ajlm-1718	13	2	dna	dna	PROPN
ajlm-1718	13	3	was	be	AUX
ajlm-1718	13	4	extracted	extract	VERB
ajlm-1718	13	5	from	from	ADP
ajlm-1718	13	6	leftover	leftover	ADJ
ajlm-1718	13	7	cerebrospinal	cerebrospinal	ADJ
ajlm-1718	13	8	fluid	fluid	NOUN
ajlm-1718	13	9	(	(	PUNCT
ajlm-1718	13	10	csf	csf	NOUN
ajlm-1718	13	11	)	)	PUNCT
ajlm-1718	13	12	specimens	specimen	NOUN
ajlm-1718	13	13	and	and	CCONJ
ajlm-1718	13	14	quantitatively	quantitatively	ADV
ajlm-1718	13	15	amplified	amplify	VERB
ajlm-1718	13	16	by	by	ADP
ajlm-1718	13	17	real	real	ADJ
ajlm-1718	13	18	-	-	PUNCT
ajlm-1718	13	19	time	time	NOUN
ajlm-1718	13	20	polymerase	polymerase	NOUN
ajlm-1718	13	21	chain	chain	NOUN
ajlm-1718	13	22	reaction	reaction	NOUN
ajlm-1718	13	23	(	(	PUNCT
ajlm-1718	13	24	pcr	pcr	PROPN
ajlm-1718	13	25	)	)	PUNCT
ajlm-1718	13	26	at	at	ADP
ajlm-1718	13	27	umeå	umeå	PROPN
ajlm-1718	13	28	university	university	PROPN
ajlm-1718	13	29	in	in	ADP
ajlm-1718	13	30	sweden	sweden	PROPN
ajlm-1718	13	31	.	.	PUNCT
ajlm-1718	14	1	results	result	NOUN
ajlm-1718	14	2	:	:	PUNCT
ajlm-1718	14	3	of	of	ADP
ajlm-1718	14	4	503	503	NUM
ajlm-1718	14	5	csf	csf	ADJ
ajlm-1718	14	6	specimens	specimen	NOUN
ajlm-1718	14	7	,	,	PUNCT
ajlm-1718	14	8	13	13	NUM
ajlm-1718	14	9	(	(	PUNCT
ajlm-1718	14	10	2.6	2.6	NUM
ajlm-1718	14	11	%	%	NOUN
ajlm-1718	14	12	)	)	PUNCT
ajlm-1718	14	13	were	be	AUX
ajlm-1718	14	14	positive	positive	ADJ
ajlm-1718	14	15	for	for	ADP
ajlm-1718	14	16	hhv-6	hhv-6	NOUN
ajlm-1718	14	17	(	(	PUNCT
ajlm-1718	14	18	33.0	33.0	NUM
ajlm-1718	14	19	%	%	NOUN
ajlm-1718	15	1	[	[	X
ajlm-1718	15	2	13/40	13/40	NUM
ajlm-1718	15	3	of	of	ADP
ajlm-1718	15	4	cases	case	NOUN
ajlm-1718	15	5	with	with	ADP
ajlm-1718	15	6	proven	prove	VERB
ajlm-1718	15	7	infectious	infectious	ADJ
ajlm-1718	15	8	meningitis	meningitis	NOUN
ajlm-1718	15	9	]	]	PUNCT
ajlm-1718	15	10	)	)	PUNCT
ajlm-1718	15	11	.	.	PUNCT
ajlm-1718	16	1	the	the	DET
ajlm-1718	16	2	median	median	ADJ
ajlm-1718	16	3	thermal	thermal	ADJ
ajlm-1718	16	4	cycle	cycle	NOUN
ajlm-1718	16	5	threshold	threshold	NOUN
ajlm-1718	16	6	for	for	ADP
ajlm-1718	16	7	all	all	DET
ajlm-1718	16	8	hhv-6	hhv-6	ADJ
ajlm-1718	16	9	-	-	ADJ
ajlm-1718	16	10	positive	positive	ADJ
ajlm-1718	16	11	specimens	specimen	NOUN
ajlm-1718	16	12	was	be	AUX
ajlm-1718	16	13	38	38	NUM
ajlm-1718	16	14	(	(	PUNCT
ajlm-1718	16	15	range	range	NOUN
ajlm-1718	16	16	:	:	PUNCT
ajlm-1718	16	17	31.9–40.8	31.9–40.8	NUM
ajlm-1718	16	18	)	)	PUNCT
ajlm-1718	16	19	.	.	PUNCT
ajlm-1718	17	1	the	the	DET
ajlm-1718	17	2	median	median	ADJ
ajlm-1718	17	3	number	number	NOUN
ajlm-1718	17	4	of	of	ADP
ajlm-1718	17	5	virus	virus	NOUN
ajlm-1718	17	6	copies	copy	NOUN
ajlm-1718	17	7	was	be	AUX
ajlm-1718	17	8	281.3	281.3	NUM
ajlm-1718	17	9	/	/	SYM
ajlm-1718	17	10	pcr	pcr	ADJ
ajlm-1718	17	11	run	run	NOUN
ajlm-1718	17	12	(	(	PUNCT
ajlm-1718	17	13	1	1	NUM
ajlm-1718	17	14	×	×	NOUN
ajlm-1718	17	15	105	105	NUM
ajlm-1718	17	16	copies	copy	NOUN
ajlm-1718	17	17	/	/	SYM
ajlm-1718	17	18	ml	ml	X
ajlm-1718	17	19	csf	csf	NOUN
ajlm-1718	17	20	;	;	PUNCT
ajlm-1718	17	21	range	range	NOUN
ajlm-1718	17	22	:	:	PUNCT
ajlm-1718	17	23	30–44	30–44	NUM
ajlm-1718	17	24	×	×	NOUN
ajlm-1718	17	25	103	103	NUM
ajlm-1718	17	26	copies	copy	NOUN
ajlm-1718	17	27	/	/	SYM
ajlm-1718	17	28	pcr	pcr	ADJ
ajlm-1718	17	29	run	run	NOUN
ajlm-1718	17	30	[	[	X
ajlm-1718	17	31	12	12	NUM
ajlm-1718	17	32	×	×	NOUN
ajlm-1718	17	33	103	103	NUM
ajlm-1718	17	34	–	–	PUNCT
ajlm-1718	17	35	18	18	NUM
ajlm-1718	17	36	×	×	NOUN
ajlm-1718	17	37	106	106	NUM
ajlm-1718	17	38	copies	copy	NOUN
ajlm-1718	17	39	/	/	SYM
ajlm-1718	17	40	ml	ml	X
ajlm-1718	17	41	csf	csf	NOUN
ajlm-1718	17	42	]	]	PUNCT
ajlm-1718	17	43	)	)	PUNCT
ajlm-1718	17	44	.	.	PUNCT
ajlm-1718	18	1	all	all	DET
ajlm-1718	18	2	positive	positive	ADJ
ajlm-1718	18	3	patients	patient	NOUN
ajlm-1718	18	4	presented	present	VERB
ajlm-1718	18	5	with	with	ADP
ajlm-1718	18	6	fever	fever	NOUN
ajlm-1718	18	7	and	and	CCONJ
ajlm-1718	18	8	vomiting	vomiting	NOUN
ajlm-1718	18	9	;	;	PUNCT
ajlm-1718	18	10	86.0	86.0	NUM
ajlm-1718	18	11	%	%	NOUN
ajlm-1718	18	12	had	have	VERB
ajlm-1718	18	13	seizures	seizure	NOUN
ajlm-1718	18	14	.	.	PUNCT
ajlm-1718	19	1	the	the	DET
ajlm-1718	19	2	male	male	NOUN
ajlm-1718	19	3	-	-	PUNCT
ajlm-1718	19	4	to	to	ADP
ajlm-1718	19	5	-	-	PUNCT
ajlm-1718	19	6	female	female	ADJ
ajlm-1718	19	7	ratio	ratio	NOUN
ajlm-1718	19	8	was	be	AUX
ajlm-1718	19	9	1:1	1:1	NUM
ajlm-1718	19	10	;	;	PUNCT
ajlm-1718	19	11	50.0	50.0	NUM
ajlm-1718	19	12	%	%	NOUN
ajlm-1718	19	13	were	be	AUX
ajlm-1718	19	14	toddlers	toddler	NOUN
ajlm-1718	19	15	,	,	PUNCT
ajlm-1718	19	16	42.0	42.0	NUM
ajlm-1718	19	17	%	%	NOUN
ajlm-1718	19	18	infants	infant	NOUN
ajlm-1718	19	19	and	and	CCONJ
ajlm-1718	19	20	8.0	8.0	NUM
ajlm-1718	19	21	%	%	NOUN
ajlm-1718	19	22	teenagers	teenager	NOUN
ajlm-1718	19	23	.	.	PUNCT
ajlm-1718	20	1	most	most	ADJ
ajlm-1718	20	2	(	(	PUNCT
ajlm-1718	20	3	83.0	83.0	NUM
ajlm-1718	20	4	%	%	NOUN
ajlm-1718	20	5	)	)	PUNCT
ajlm-1718	20	6	were	be	AUX
ajlm-1718	20	7	admitted	admit	VERB
ajlm-1718	20	8	in	in	ADP
ajlm-1718	20	9	the	the	DET
ajlm-1718	20	10	dry	dry	ADJ
ajlm-1718	20	11	season	season	NOUN
ajlm-1718	20	12	and	and	CCONJ
ajlm-1718	20	13	17.0	17.0	NUM
ajlm-1718	20	14	%	%	NOUN
ajlm-1718	20	15	in	in	ADP
ajlm-1718	20	16	the	the	DET
ajlm-1718	20	17	rainy	rainy	ADJ
ajlm-1718	20	18	season	season	NOUN
ajlm-1718	20	19	.	.	PUNCT
ajlm-1718	21	1	cerebrospinal	cerebrospinal	ADJ
ajlm-1718	21	2	fluid	fluid	NOUN
ajlm-1718	21	3	leukocytosis	leukocytosis	NOUN
ajlm-1718	21	4	was	be	AUX
ajlm-1718	21	5	seen	see	VERB
ajlm-1718	21	6	in	in	ADP
ajlm-1718	21	7	33.0	33.0	NUM
ajlm-1718	21	8	%	%	NOUN
ajlm-1718	21	9	,	,	PUNCT
ajlm-1718	21	10	csf	csf	ADJ
ajlm-1718	21	11	glucose	glucose	NOUN
ajlm-1718	21	12	levels	level	NOUN
ajlm-1718	21	13	were	be	AUX
ajlm-1718	21	14	normal	normal	ADJ
ajlm-1718	21	15	in	in	ADP
ajlm-1718	21	16	86.0	86.0	NUM
ajlm-1718	21	17	%	%	NOUN
ajlm-1718	21	18	and	and	CCONJ
ajlm-1718	21	19	low	low	ADJ
ajlm-1718	21	20	in	in	ADP
ajlm-1718	21	21	14.0	14.0	NUM
ajlm-1718	21	22	%	%	NOUN
ajlm-1718	21	23	,	,	PUNCT
ajlm-1718	21	24	and	and	CCONJ
ajlm-1718	21	25	csf	csf	ADJ
ajlm-1718	21	26	protein	protein	NOUN
ajlm-1718	21	27	levels	level	NOUN
ajlm-1718	21	28	were	be	AUX
ajlm-1718	21	29	low	low	ADJ
ajlm-1718	21	30	in	in	ADP
ajlm-1718	21	31	14.0	14.0	NUM
ajlm-1718	21	32	%	%	NOUN
ajlm-1718	21	33	and	and	CCONJ
ajlm-1718	21	34	high	high	ADJ
ajlm-1718	21	35	in	in	ADP
ajlm-1718	21	36	43.0	43.0	NUM
ajlm-1718	21	37	%	%	NOUN
ajlm-1718	21	38	.	.	PUNCT
ajlm-1718	22	1	conclusion	conclusion	NOUN
ajlm-1718	22	2	:	:	PUNCT
ajlm-1718	22	3	among	among	ADP
ajlm-1718	22	4	children	child	NOUN
ajlm-1718	22	5	in	in	ADP
ajlm-1718	22	6	sudan	sudan	PROPN
ajlm-1718	22	7	with	with	ADP
ajlm-1718	22	8	cns	cns	PROPN
ajlm-1718	22	9	infections	infection	NOUN
ajlm-1718	22	10	,	,	PUNCT
ajlm-1718	22	11	hhv-6	hhv-6	NOUN
ajlm-1718	22	12	is	be	AUX
ajlm-1718	22	13	common	common	ADJ
ajlm-1718	22	14	.	.	PUNCT
ajlm-1718	23	1	studies	study	NOUN
ajlm-1718	23	2	on	on	ADP
ajlm-1718	23	3	the	the	DET
ajlm-1718	23	4	existence	existence	NOUN
ajlm-1718	23	5	and	and	CCONJ
ajlm-1718	23	6	spread	spread	VERB
ajlm-1718	23	7	of	of	ADP
ajlm-1718	23	8	hhv-6	hhv-6	NOUN
ajlm-1718	23	9	chromosomal	chromosomal	ADJ
ajlm-1718	23	10	integration	integration	NOUN
ajlm-1718	23	11	in	in	ADP
ajlm-1718	23	12	this	this	DET
ajlm-1718	23	13	population	population	NOUN
ajlm-1718	23	14	are	be	AUX
ajlm-1718	23	15	needed	need	VERB
ajlm-1718	23	16	.	.	PUNCT
ajlm-1718	24	1	keywords	keyword	NOUN
ajlm-1718	24	2	:	:	PUNCT
ajlm-1718	24	3	hhv-6	hhv-6	NOUN
ajlm-1718	24	4	;	;	PUNCT
ajlm-1718	24	5	viral	viral	ADJ
ajlm-1718	24	6	neuroinfections	neuroinfection	NOUN
ajlm-1718	24	7	;	;	PUNCT
ajlm-1718	24	8	viral	viral	ADJ
ajlm-1718	24	9	meningitis	meningitis	NOUN
ajlm-1718	24	10	;	;	PUNCT
ajlm-1718	24	11	aseptic	aseptic	ADJ
ajlm-1718	24	12	meningitis	meningitis	NOUN
ajlm-1718	24	13	;	;	PUNCT
ajlm-1718	24	14	real	real	ADJ
ajlm-1718	24	15	-	-	PUNCT
ajlm-1718	24	16	time	time	NOUN
ajlm-1718	24	17	pcr	pcr	PROPN
ajlm-1718	24	18	.	.	PUNCT
ajlm-1718	25	1	introduction	introduction	NOUN
ajlm-1718	25	2	human	human	ADJ
ajlm-1718	25	3	herpes	herpe	NOUN
ajlm-1718	25	4	virus	virus	NOUN
ajlm-1718	25	5	type-6	type-6	PROPN
ajlm-1718	25	6	(	(	PUNCT
ajlm-1718	25	7	hhv-6	hhv-6	NOUN
ajlm-1718	25	8	)	)	PUNCT
ajlm-1718	25	9	is	be	AUX
ajlm-1718	25	10	a	a	DET
ajlm-1718	25	11	major	major	ADJ
ajlm-1718	25	12	cause	cause	NOUN
ajlm-1718	25	13	of	of	ADP
ajlm-1718	25	14	acute	acute	ADJ
ajlm-1718	25	15	febrile	febrile	NOUN
ajlm-1718	25	16	illnesses	illness	NOUN
ajlm-1718	25	17	in	in	ADP
ajlm-1718	25	18	young	young	ADJ
ajlm-1718	25	19	children1	children1	NOUN
ajlm-1718	25	20	where	where	SCONJ
ajlm-1718	25	21	most	most	ADJ
ajlm-1718	25	22	are	be	AUX
ajlm-1718	25	23	infected	infect	VERB
ajlm-1718	25	24	by	by	ADP
ajlm-1718	25	25	the	the	DET
ajlm-1718	25	26	age	age	NOUN
ajlm-1718	25	27	of	of	ADP
ajlm-1718	25	28	three.2	three.2	PROPN
ajlm-1718	25	29	the	the	DET
ajlm-1718	25	30	virus	virus	NOUN
ajlm-1718	25	31	remains	remain	VERB
ajlm-1718	25	32	latent	latent	NOUN
ajlm-1718	25	33	in	in	ADP
ajlm-1718	25	34	white	white	ADJ
ajlm-1718	25	35	blood	blood	NOUN
ajlm-1718	25	36	cells	cell	NOUN
ajlm-1718	25	37	(	(	PUNCT
ajlm-1718	25	38	i.e.	i.e.	X
ajlm-1718	25	39	monocytes	monocyte	NOUN
ajlm-1718	25	40	and	and	CCONJ
ajlm-1718	25	41	macrophages	macrophage	NOUN
ajlm-1718	25	42	)	)	PUNCT
ajlm-1718	25	43	following	follow	VERB
ajlm-1718	25	44	a	a	DET
ajlm-1718	25	45	primary	primary	ADJ
ajlm-1718	25	46	infection	infection	NOUN
ajlm-1718	25	47	and	and	CCONJ
ajlm-1718	25	48	persistence	persistence	NOUN
ajlm-1718	25	49	in	in	ADP
ajlm-1718	25	50	salivary	salivary	ADJ
ajlm-1718	25	51	glands.3	glands.3	PROPN
ajlm-1718	25	52	reactivation	reactivation	NOUN
ajlm-1718	25	53	of	of	ADP
ajlm-1718	25	54	hhv-6	hhv-6	NOUN
ajlm-1718	25	55	can	can	AUX
ajlm-1718	25	56	occur	occur	VERB
ajlm-1718	25	57	in	in	ADP
ajlm-1718	25	58	the	the	DET
ajlm-1718	25	59	case	case	NOUN
ajlm-1718	25	60	of	of	ADP
ajlm-1718	25	61	an	an	DET
ajlm-1718	25	62	immunosuppression	immunosuppression	NOUN
ajlm-1718	25	63	which	which	PRON
ajlm-1718	25	64	may	may	AUX
ajlm-1718	25	65	result	result	VERB
ajlm-1718	25	66	in	in	ADP
ajlm-1718	25	67	complications	complication	NOUN
ajlm-1718	25	68	affecting	affect	VERB
ajlm-1718	25	69	various	various	ADJ
ajlm-1718	25	70	systems	system	NOUN
ajlm-1718	25	71	including	include	VERB
ajlm-1718	25	72	the	the	DET
ajlm-1718	25	73	central	central	ADJ
ajlm-1718	25	74	nervous	nervous	ADJ
ajlm-1718	25	75	system	system	NOUN
ajlm-1718	25	76	(	(	PUNCT
ajlm-1718	25	77	cns).3	cns).3	X
ajlm-1718	25	78	young	young	ADJ
ajlm-1718	25	79	immunocompetent	immunocompetent	ADJ
ajlm-1718	25	80	children	child	NOUN
ajlm-1718	25	81	who	who	PRON
ajlm-1718	25	82	suffer	suffer	VERB
ajlm-1718	25	83	from	from	ADP
ajlm-1718	25	84	fever	fever	NOUN
ajlm-1718	25	85	and	and	CCONJ
ajlm-1718	25	86	seizures	seizure	NOUN
ajlm-1718	25	87	can	can	AUX
ajlm-1718	25	88	develop	develop	VERB
ajlm-1718	25	89	cns	cns	NOUN
ajlm-1718	25	90	disease	disease	NOUN
ajlm-1718	25	91	in	in	ADP
ajlm-1718	25	92	primary	primary	ADJ
ajlm-1718	25	93	hhv-6	hhv-6	ADJ
ajlm-1718	25	94	infections.4,5	infections.4,5	NOUN
ajlm-1718	25	95	in	in	ADP
ajlm-1718	25	96	this	this	DET
ajlm-1718	25	97	matter	matter	NOUN
ajlm-1718	25	98	,	,	PUNCT
ajlm-1718	25	99	several	several	ADJ
ajlm-1718	25	100	authors	author	NOUN
ajlm-1718	25	101	have	have	AUX
ajlm-1718	25	102	described	describe	VERB
ajlm-1718	25	103	the	the	DET
ajlm-1718	25	104	major	major	ADJ
ajlm-1718	25	105	role	role	NOUN
ajlm-1718	25	106	that	that	PRON
ajlm-1718	25	107	could	could	AUX
ajlm-1718	25	108	be	be	AUX
ajlm-1718	25	109	played	play	VERB
ajlm-1718	25	110	by	by	ADP
ajlm-1718	25	111	the	the	DET
ajlm-1718	25	112	virus	virus	NOUN
ajlm-1718	25	113	as	as	ADP
ajlm-1718	25	114	a	a	DET
ajlm-1718	25	115	cause	cause	NOUN
ajlm-1718	25	116	of	of	ADP
ajlm-1718	25	117	paediatric	paediatric	ADJ
ajlm-1718	25	118	neuroinfections.6,7,8,9,10,11	neuroinfections.6,7,8,9,10,11	NOUN
ajlm-1718	25	119	detecting	detect	VERB
ajlm-1718	25	120	hhv-6	hhv-6	ADJ
ajlm-1718	25	121	nucleic	nucleic	ADJ
ajlm-1718	25	122	acids	acid	NOUN
ajlm-1718	25	123	in	in	ADP
ajlm-1718	25	124	the	the	DET
ajlm-1718	25	125	cerebrospinal	cerebrospinal	ADJ
ajlm-1718	25	126	fluid	fluid	NOUN
ajlm-1718	25	127	(	(	PUNCT
ajlm-1718	25	128	csf	csf	NOUN
ajlm-1718	25	129	)	)	PUNCT
ajlm-1718	25	130	by	by	ADP
ajlm-1718	25	131	molecular	molecular	ADJ
ajlm-1718	25	132	assays	assay	NOUN
ajlm-1718	25	133	indicates	indicate	VERB
ajlm-1718	25	134	active	active	ADJ
ajlm-1718	25	135	virus	virus	NOUN
ajlm-1718	25	136	replication	replication	NOUN
ajlm-1718	25	137	,	,	PUNCT
ajlm-1718	25	138	hence	hence	ADV
ajlm-1718	25	139	cns	cns	NOUN
ajlm-1718	25	140	infection	infection	NOUN
ajlm-1718	25	141	.	.	PUNCT
ajlm-1718	26	1	this	this	DET
ajlm-1718	26	2	interpretation	interpretation	NOUN
ajlm-1718	26	3	is	be	AUX
ajlm-1718	26	4	complicated	complicate	VERB
ajlm-1718	26	5	by	by	ADP
ajlm-1718	26	6	the	the	DET
ajlm-1718	26	7	phenomenon	phenomenon	NOUN
ajlm-1718	26	8	of	of	ADP
ajlm-1718	26	9	hhv-6	hhv-6	NOUN
ajlm-1718	26	10	chromosomal	chromosomal	ADJ
ajlm-1718	26	11	integration.12,13	integration.12,13	NOUN
ajlm-1718	26	12	the	the	DET
ajlm-1718	26	13	only	only	ADJ
ajlm-1718	26	14	human	human	ADJ
ajlm-1718	26	15	herpes	herpe	NOUN
ajlm-1718	26	16	virus	virus	NOUN
ajlm-1718	26	17	that	that	PRON
ajlm-1718	26	18	is	be	AUX
ajlm-1718	26	19	found	find	VERB
ajlm-1718	26	20	integrated	integrate	VERB
ajlm-1718	26	21	in	in	ADP
ajlm-1718	26	22	the	the	DET
ajlm-1718	26	23	human	human	ADJ
ajlm-1718	26	24	genome	genome	NOUN
ajlm-1718	26	25	and	and	CCONJ
ajlm-1718	26	26	can	can	AUX
ajlm-1718	26	27	be	be	AUX
ajlm-1718	26	28	passed	pass	VERB
ajlm-1718	26	29	on	on	ADP
ajlm-1718	26	30	vertically	vertically	ADV
ajlm-1718	26	31	from	from	ADP
ajlm-1718	26	32	parent	parent	NOUN
ajlm-1718	26	33	to	to	ADP
ajlm-1718	26	34	child	child	NOUN
ajlm-1718	26	35	is	be	AUX
ajlm-1718	26	36	hhv-6.14	hhv-6.14	PROPN
ajlm-1718	26	37	this	this	PRON
ajlm-1718	26	38	occurs	occur	VERB
ajlm-1718	26	39	occasionally	occasionally	ADV
ajlm-1718	26	40	,	,	PUNCT
ajlm-1718	26	41	and	and	CCONJ
ajlm-1718	26	42	is	be	AUX
ajlm-1718	26	43	claimed	claim	VERB
ajlm-1718	26	44	to	to	PART
ajlm-1718	26	45	be	be	AUX
ajlm-1718	26	46	detected	detect	VERB
ajlm-1718	26	47	by	by	ADP
ajlm-1718	26	48	simply	simply	ADV
ajlm-1718	26	49	identifying	identify	VERB
ajlm-1718	26	50	persistently	persistently	ADV
ajlm-1718	26	51	high	high	ADJ
ajlm-1718	26	52	concentrations	concentration	NOUN
ajlm-1718	26	53	of	of	ADP
ajlm-1718	26	54	hhv-6	hhv-6	ADJ
ajlm-1718	26	55	nucleic	nucleic	ADJ
ajlm-1718	26	56	acids	acid	NOUN
ajlm-1718	26	57	in	in	ADP
ajlm-1718	26	58	blood	blood	NOUN
ajlm-1718	26	59	because	because	SCONJ
ajlm-1718	26	60	of	of	ADP
ajlm-1718	26	61	chromosomal	chromosomal	ADJ
ajlm-1718	26	62	integration	integration	NOUN
ajlm-1718	26	63	in	in	ADP
ajlm-1718	26	64	white	white	ADJ
ajlm-1718	26	65	blood	blood	NOUN
ajlm-1718	26	66	cells.12,13	cells.12,13	NOUN
ajlm-1718	26	67	in	in	ADP
ajlm-1718	26	68	contrast	contrast	NOUN
ajlm-1718	26	69	,	,	PUNCT
ajlm-1718	26	70	integrated	integrate	VERB
ajlm-1718	26	71	hhv-6	hhv-6	ADJ
ajlm-1718	26	72	dna	dna	NOUN
ajlm-1718	26	73	is	be	AUX
ajlm-1718	26	74	highly	highly	ADV
ajlm-1718	26	75	unexpected	unexpected	ADJ
ajlm-1718	26	76	in	in	ADP
ajlm-1718	26	77	normal	normal	ADJ
ajlm-1718	26	78	cell	cell	NOUN
ajlm-1718	26	79	-	-	PUNCT
ajlm-1718	26	80	free	free	ADJ
ajlm-1718	26	81	body	body	NOUN
ajlm-1718	26	82	compartments	compartment	NOUN
ajlm-1718	26	83	,	,	PUNCT
ajlm-1718	26	84	including	include	VERB
ajlm-1718	26	85	the	the	DET
ajlm-1718	26	86	csf.11,13,15	csf.11,13,15	PROPN
ajlm-1718	26	87	ward16	ward16	NOUN
ajlm-1718	26	88	stated	state	VERB
ajlm-1718	26	89	that	that	SCONJ
ajlm-1718	26	90	viral	viral	ADJ
ajlm-1718	26	91	load	load	NOUN
ajlm-1718	26	92	should	should	AUX
ajlm-1718	26	93	be	be	AUX
ajlm-1718	26	94	high	high	ADJ
ajlm-1718	26	95	to	to	PART
ajlm-1718	26	96	identify	identify	VERB
ajlm-1718	26	97	a	a	DET
ajlm-1718	26	98	condition	condition	NOUN
ajlm-1718	26	99	as	as	ADP
ajlm-1718	26	100	chromosomal	chromosomal	ADJ
ajlm-1718	26	101	integration	integration	NOUN
ajlm-1718	26	102	and	and	CCONJ
ajlm-1718	26	103	low	low	ADJ
ajlm-1718	26	104	virus	virus	NOUN
ajlm-1718	26	105	copies	copy	NOUN
ajlm-1718	26	106	would	would	AUX
ajlm-1718	26	107	indicate	indicate	VERB
ajlm-1718	26	108	an	an	DET
ajlm-1718	26	109	infection	infection	NOUN
ajlm-1718	26	110	.	.	PUNCT
ajlm-1718	27	1	normal	normal	ADJ
ajlm-1718	27	2	csf	csf	ADJ
ajlm-1718	27	3	glucose	glucose	NOUN
ajlm-1718	27	4	with	with	ADP
ajlm-1718	27	5	normal	normal	ADJ
ajlm-1718	27	6	or	or	CCONJ
ajlm-1718	27	7	elevated	elevated	ADJ
ajlm-1718	27	8	proteins	protein	NOUN
ajlm-1718	27	9	is	be	AUX
ajlm-1718	27	10	the	the	DET
ajlm-1718	27	11	usual	usual	ADJ
ajlm-1718	27	12	finding	finding	NOUN
ajlm-1718	27	13	in	in	ADP
ajlm-1718	27	14	viral	viral	ADJ
ajlm-1718	27	15	infections	infection	NOUN
ajlm-1718	27	16	of	of	ADP
ajlm-1718	27	17	the	the	DET
ajlm-1718	27	18	cns.17	cns.17	PROPN
ajlm-1718	27	19	increased	increase	VERB
ajlm-1718	27	20	numbers	number	NOUN
ajlm-1718	27	21	of	of	ADP
ajlm-1718	27	22	white	white	ADJ
ajlm-1718	27	23	blood	blood	NOUN
ajlm-1718	27	24	cells	cell	NOUN
ajlm-1718	27	25	(	(	PUNCT
ajlm-1718	27	26	˃	˃	NOUN
ajlm-1718	27	27	5	5	NUM
ajlm-1718	27	28	cell	cell	NOUN
ajlm-1718	27	29	/	/	SYM
ajlm-1718	27	30	mm3	mm3	NOUN
ajlm-1718	27	31	)	)	PUNCT
ajlm-1718	27	32	in	in	ADP
ajlm-1718	27	33	csf	csf	ADJ
ajlm-1718	27	34	indicates	indicate	VERB
ajlm-1718	27	35	inflammation	inflammation	NOUN
ajlm-1718	27	36	;	;	PUNCT
ajlm-1718	27	37	however	however	ADV
ajlm-1718	27	38	,	,	PUNCT
ajlm-1718	27	39	normal	normal	ADJ
ajlm-1718	27	40	csf	csf	ADJ
ajlm-1718	27	41	cellular	cellular	ADJ
ajlm-1718	27	42	counts	count	NOUN
ajlm-1718	27	43	in	in	ADP
ajlm-1718	27	44	patients	patient	NOUN
ajlm-1718	27	45	with	with	ADP
ajlm-1718	27	46	proven	prove	VERB
ajlm-1718	27	47	cns	cns	PROPN
ajlm-1718	27	48	infections	infection	NOUN
ajlm-1718	27	49	have	have	AUX
ajlm-1718	27	50	been	be	AUX
ajlm-1718	27	51	frequently	frequently	ADV
ajlm-1718	27	52	reported.17,18,19,20	reported.17,18,19,20	VERB
ajlm-1718	27	53	it	it	PRON
ajlm-1718	27	54	is	be	AUX
ajlm-1718	27	55	therefore	therefore	ADV
ajlm-1718	27	56	recommended	recommend	VERB
ajlm-1718	27	57	not	not	PART
ajlm-1718	27	58	to	to	PART
ajlm-1718	27	59	limit	limit	VERB
ajlm-1718	27	60	hhv-6	hhv-6	NOUN
ajlm-1718	27	61	testing	testing	NOUN
ajlm-1718	27	62	to	to	ADP
ajlm-1718	27	63	patients	patient	NOUN
ajlm-1718	27	64	with	with	ADP
ajlm-1718	27	65	increased	increase	VERB
ajlm-1718	27	66	csf	csf	ADJ
ajlm-1718	27	67	cellular	cellular	ADJ
ajlm-1718	27	68	counts.21	counts.21	NOUN
ajlm-1718	27	69	most	most	ADJ
ajlm-1718	27	70	patients	patient	NOUN
ajlm-1718	27	71	recover	recover	VERB
ajlm-1718	27	72	fully	fully	ADV
ajlm-1718	27	73	from	from	ADP
ajlm-1718	27	74	an	an	DET
ajlm-1718	27	75	hhv-6	hhv-6	ADJ
ajlm-1718	27	76	infection	infection	NOUN
ajlm-1718	27	77	,	,	PUNCT
ajlm-1718	27	78	but	but	CCONJ
ajlm-1718	27	79	rare	rare	ADJ
ajlm-1718	27	80	complications	complication	NOUN
ajlm-1718	27	81	leading	lead	VERB
ajlm-1718	27	82	to	to	ADP
ajlm-1718	27	83	neurological	neurological	ADJ
ajlm-1718	27	84	impairments	impairment	NOUN
ajlm-1718	27	85	or	or	CCONJ
ajlm-1718	27	86	death	death	NOUN
ajlm-1718	27	87	can	can	AUX
ajlm-1718	27	88	also	also	ADV
ajlm-1718	27	89	occur.22,23	occur.22,23	VERB
ajlm-1718	27	90	little	little	ADJ
ajlm-1718	27	91	is	be	AUX
ajlm-1718	27	92	known	know	VERB
ajlm-1718	27	93	on	on	ADP
ajlm-1718	27	94	hhv-6	hhv-6	NUM
ajlm-1718	27	95	infections	infection	NOUN
ajlm-1718	27	96	in	in	ADP
ajlm-1718	27	97	saharan	saharan	ADJ
ajlm-1718	27	98	and	and	CCONJ
ajlm-1718	27	99	sub	sub	ADJ
ajlm-1718	27	100	-	-	ADJ
ajlm-1718	27	101	saharan	saharan	ADJ
ajlm-1718	27	102	africa	africa	PROPN
ajlm-1718	27	103	,	,	PUNCT
ajlm-1718	27	104	and	and	CCONJ
ajlm-1718	27	105	the	the	DET
ajlm-1718	27	106	infection	infection	NOUN
ajlm-1718	27	107	has	have	AUX
ajlm-1718	27	108	never	never	ADV
ajlm-1718	27	109	been	be	AUX
ajlm-1718	27	110	investigated	investigate	VERB
ajlm-1718	27	111	in	in	ADP
ajlm-1718	27	112	sudan	sudan	PROPN
ajlm-1718	27	113	.	.	PUNCT
ajlm-1718	28	1	we	we	PRON
ajlm-1718	28	2	,	,	PUNCT
ajlm-1718	28	3	therefore	therefore	ADV
ajlm-1718	28	4	,	,	PUNCT
ajlm-1718	28	5	intended	intend	VERB
ajlm-1718	28	6	to	to	PART
ajlm-1718	28	7	identify	identify	VERB
ajlm-1718	28	8	the	the	DET
ajlm-1718	28	9	involvement	involvement	NOUN
ajlm-1718	28	10	of	of	ADP
ajlm-1718	28	11	hhv-6	hhv-6	NOUN
ajlm-1718	28	12	in	in	ADP
ajlm-1718	28	13	cns	cns	NOUN
ajlm-1718	28	14	infections	infection	NOUN
ajlm-1718	28	15	in	in	ADP
ajlm-1718	28	16	a	a	DET
ajlm-1718	28	17	large	large	ADJ
ajlm-1718	28	18	group	group	NOUN
ajlm-1718	28	19	of	of	ADP
ajlm-1718	28	20	children	child	NOUN
ajlm-1718	28	21	in	in	ADP
ajlm-1718	28	22	khartoum	khartoum	PROPN
ajlm-1718	28	23	,	,	PUNCT
ajlm-1718	28	24	sudan	sudan	PROPN
ajlm-1718	28	25	.	.	PUNCT
ajlm-1718	29	1	this	this	DET
ajlm-1718	29	2	report	report	NOUN
ajlm-1718	29	3	is	be	AUX
ajlm-1718	29	4	a	a	DET
ajlm-1718	29	5	part	part	NOUN
ajlm-1718	29	6	of	of	ADP
ajlm-1718	29	7	a	a	DET
ajlm-1718	29	8	larger	large	ADJ
ajlm-1718	29	9	study	study	NOUN
ajlm-1718	29	10	on	on	ADP
ajlm-1718	29	11	the	the	DET
ajlm-1718	29	12	microbial	microbial	ADJ
ajlm-1718	29	13	aetiologies	aetiology	NOUN
ajlm-1718	29	14	of	of	ADP
ajlm-1718	29	15	cns	cns	PROPN
ajlm-1718	29	16	infections	infection	NOUN
ajlm-1718	29	17	in	in	ADP
ajlm-1718	29	18	this	this	DET
ajlm-1718	29	19	population	population	NOUN
ajlm-1718	29	20	.	.	PUNCT
ajlm-1718	30	1	methods	method	NOUN
ajlm-1718	30	2	ethical	ethical	ADJ
ajlm-1718	30	3	considerations	consideration	NOUN
ajlm-1718	30	4	the	the	DET
ajlm-1718	30	5	ethical	ethical	ADJ
ajlm-1718	30	6	clearance	clearance	NOUN
ajlm-1718	30	7	for	for	ADP
ajlm-1718	30	8	conducting	conduct	VERB
ajlm-1718	30	9	this	this	DET
ajlm-1718	30	10	study	study	NOUN
ajlm-1718	30	11	was	be	AUX
ajlm-1718	30	12	obtained	obtain	VERB
ajlm-1718	30	13	from	from	ADP
ajlm-1718	30	14	the	the	DET
ajlm-1718	30	15	ethical	ethical	ADJ
ajlm-1718	30	16	review	review	NOUN
ajlm-1718	30	17	board	board	NOUN
ajlm-1718	30	18	of	of	ADP
ajlm-1718	30	19	the	the	DET
ajlm-1718	30	20	national	national	ADJ
ajlm-1718	30	21	center	center	NOUN
ajlm-1718	30	22	for	for	ADP
ajlm-1718	30	23	neurological	neurological	ADJ
ajlm-1718	30	24	sciences	science	NOUN
ajlm-1718	30	25	in	in	ADP
ajlm-1718	30	26	september	september	PROPN
ajlm-1718	30	27	2009	2009	NUM
ajlm-1718	30	28	.	.	PUNCT
ajlm-1718	31	1	patient	patient	ADJ
ajlm-1718	31	2	consent	consent	NOUN
ajlm-1718	31	3	was	be	AUX
ajlm-1718	31	4	determined	determine	VERB
ajlm-1718	31	5	to	to	PART
ajlm-1718	31	6	be	be	AUX
ajlm-1718	31	7	unnecessary	unnecessary	ADJ
ajlm-1718	31	8	and	and	CCONJ
ajlm-1718	31	9	was	be	AUX
ajlm-1718	31	10	waived	waive	VERB
ajlm-1718	31	11	.	.	PUNCT
ajlm-1718	32	1	patients	patient	NOUN
ajlm-1718	32	2	were	be	AUX
ajlm-1718	32	3	not	not	PART
ajlm-1718	32	4	contacted	contact	VERB
ajlm-1718	32	5	directly	directly	ADV
ajlm-1718	32	6	;	;	PUNCT
ajlm-1718	32	7	data	datum	NOUN
ajlm-1718	32	8	were	be	AUX
ajlm-1718	32	9	obtained	obtain	VERB
ajlm-1718	32	10	from	from	ADP
ajlm-1718	32	11	hospital	hospital	NOUN
ajlm-1718	32	12	files	file	NOUN
ajlm-1718	32	13	and	and	CCONJ
ajlm-1718	32	14	were	be	AUX
ajlm-1718	32	15	kept	keep	VERB
ajlm-1718	32	16	anonymous	anonymous	ADJ
ajlm-1718	32	17	at	at	ADP
ajlm-1718	32	18	all	all	DET
ajlm-1718	32	19	stages	stage	NOUN
ajlm-1718	32	20	of	of	ADP
ajlm-1718	32	21	the	the	DET
ajlm-1718	32	22	study	study	NOUN
ajlm-1718	32	23	.	.	PUNCT
ajlm-1718	33	1	excess	excess	ADJ
ajlm-1718	33	2	specimens	specimen	NOUN
ajlm-1718	33	3	were	be	AUX
ajlm-1718	33	4	obtained	obtain	VERB
ajlm-1718	33	5	from	from	ADP
ajlm-1718	33	6	the	the	DET
ajlm-1718	33	7	hospitals	hospital	NOUN
ajlm-1718	33	8	main	main	ADJ
ajlm-1718	33	9	laboratory	laboratory	NOUN
ajlm-1718	33	10	after	after	ADV
ajlm-1718	33	11	all	all	ADV
ajlm-1718	33	12	officially	officially	ADV
ajlm-1718	33	13	requested	request	VERB
ajlm-1718	33	14	tests	test	NOUN
ajlm-1718	33	15	were	be	AUX
ajlm-1718	33	16	applied	apply	VERB
ajlm-1718	33	17	.	.	PUNCT
ajlm-1718	34	1	permission	permission	NOUN
ajlm-1718	34	2	to	to	PART
ajlm-1718	34	3	collect	collect	VERB
ajlm-1718	34	4	data	datum	NOUN
ajlm-1718	34	5	and	and	CCONJ
ajlm-1718	34	6	specimens	specimen	NOUN
ajlm-1718	34	7	was	be	AUX
ajlm-1718	34	8	granted	grant	VERB
ajlm-1718	34	9	from	from	ADP
ajlm-1718	34	10	hospital	hospital	NOUN
ajlm-1718	34	11	authorities	authority	NOUN
ajlm-1718	34	12	verbally	verbally	ADV
ajlm-1718	34	13	(	(	PUNCT
ajlm-1718	34	14	from	from	ADP
ajlm-1718	34	15	hospital	hospital	NOUN
ajlm-1718	34	16	general	general	ADJ
ajlm-1718	34	17	director	director	NOUN
ajlm-1718	34	18	;	;	PUNCT
ajlm-1718	34	19	authors	author	NOUN
ajlm-1718	34	20	’	’	PART
ajlm-1718	34	21	attestation	attestation	NOUN
ajlm-1718	34	22	on	on	ADP
ajlm-1718	34	23	file	file	NOUN
ajlm-1718	34	24	)	)	PUNCT
ajlm-1718	34	25	and	and	CCONJ
ajlm-1718	34	26	in	in	ADP
ajlm-1718	34	27	writing	writing	NOUN
ajlm-1718	34	28	(	(	PUNCT
ajlm-1718	34	29	from	from	ADP
ajlm-1718	34	30	laboratories	laboratory	NOUN
ajlm-1718	34	31	administration	administration	NOUN
ajlm-1718	34	32	,	,	PUNCT
ajlm-1718	34	33	federal	federal	PROPN
ajlm-1718	34	34	ministry	ministry	PROPN
ajlm-1718	34	35	of	of	ADP
ajlm-1718	34	36	health	health	PROPN
ajlm-1718	34	37	)	)	PUNCT
ajlm-1718	34	38	.	.	PUNCT
ajlm-1718	35	1	study	study	NOUN
ajlm-1718	35	2	materials	material	NOUN
ajlm-1718	35	3	a	a	DET
ajlm-1718	35	4	total	total	NOUN
ajlm-1718	35	5	of	of	ADP
ajlm-1718	35	6	503	503	NUM
ajlm-1718	35	7	csf	csf	ADJ
ajlm-1718	35	8	specimens	specimen	NOUN
ajlm-1718	35	9	were	be	AUX
ajlm-1718	35	10	obtained	obtain	VERB
ajlm-1718	35	11	from	from	ADP
ajlm-1718	35	12	febrile	febrile	NOUN
ajlm-1718	35	13	(	(	PUNCT
ajlm-1718	35	14	˃	˃	NOUN
ajlm-1718	35	15	37	37	NUM
ajlm-1718	35	16	°	°	NOUN
ajlm-1718	35	17	c	c	NOUN
ajlm-1718	35	18	)	)	PUNCT
ajlm-1718	35	19	meningitis	meningitis	NOUN
ajlm-1718	35	20	-	-	PUNCT
ajlm-1718	35	21	suspected	suspect	VERB
ajlm-1718	35	22	attendees	attendee	NOUN
ajlm-1718	35	23	of	of	ADP
ajlm-1718	35	24	the	the	DET
ajlm-1718	35	25	omdurman	omdurman	ADJ
ajlm-1718	35	26	hospital	hospital	NOUN
ajlm-1718	35	27	for	for	ADP
ajlm-1718	35	28	children	child	NOUN
ajlm-1718	35	29	in	in	ADP
ajlm-1718	35	30	khartoum	khartoum	PROPN
ajlm-1718	35	31	,	,	PUNCT
ajlm-1718	35	32	sudan	sudan	PROPN
ajlm-1718	35	33	.	.	PUNCT
ajlm-1718	36	1	patients	patient	NOUN
ajlm-1718	36	2	aged	age	VERB
ajlm-1718	36	3	0	0	NUM
ajlm-1718	36	4	to	to	ADP
ajlm-1718	36	5	15	15	NUM
ajlm-1718	36	6	years	year	NOUN
ajlm-1718	36	7	who	who	PRON
ajlm-1718	36	8	were	be	AUX
ajlm-1718	36	9	admitted	admit	VERB
ajlm-1718	36	10	between	between	ADP
ajlm-1718	36	11	01	01	NUM
ajlm-1718	36	12	december	december	PROPN
ajlm-1718	36	13	2009	2009	NUM
ajlm-1718	36	14	and	and	CCONJ
ajlm-1718	36	15	01	01	NUM
ajlm-1718	36	16	august	august	PROPN
ajlm-1718	36	17	2010	2010	NUM
ajlm-1718	36	18	were	be	AUX
ajlm-1718	36	19	included	include	VERB
ajlm-1718	36	20	.	.	PUNCT
ajlm-1718	37	1	clinical	clinical	ADJ
ajlm-1718	37	2	and	and	CCONJ
ajlm-1718	37	3	demographic	demographic	ADJ
ajlm-1718	37	4	data	datum	NOUN
ajlm-1718	37	5	were	be	AUX
ajlm-1718	37	6	obtained	obtain	VERB
ajlm-1718	37	7	from	from	ADP
ajlm-1718	37	8	hospital	hospital	NOUN
ajlm-1718	37	9	records	record	NOUN
ajlm-1718	37	10	retrospectively	retrospectively	ADV
ajlm-1718	37	11	.	.	PUNCT
ajlm-1718	38	1	routine	routine	ADJ
ajlm-1718	38	2	csf	csf	ADJ
ajlm-1718	38	3	analyses	analysis	NOUN
ajlm-1718	38	4	were	be	AUX
ajlm-1718	38	5	performed	perform	VERB
ajlm-1718	38	6	at	at	ADP
ajlm-1718	38	7	the	the	DET
ajlm-1718	38	8	microbiology	microbiology	NOUN
ajlm-1718	38	9	laboratory	laboratory	NOUN
ajlm-1718	38	10	of	of	ADP
ajlm-1718	38	11	omdurman	omdurman	ADJ
ajlm-1718	38	12	hospital	hospital	NOUN
ajlm-1718	38	13	.	.	PUNCT
ajlm-1718	39	1	an	an	DET
ajlm-1718	39	2	aliquot	aliquot	NOUN
ajlm-1718	39	3	of	of	ADP
ajlm-1718	39	4	csf	csf	NOUN
ajlm-1718	39	5	was	be	AUX
ajlm-1718	39	6	frozen	freeze	VERB
ajlm-1718	39	7	at	at	ADP
ajlm-1718	39	8	−80	−80	PROPN
ajlm-1718	39	9	°	°	ADP
ajlm-1718	39	10	c	c	NOUN
ajlm-1718	39	11	for	for	ADP
ajlm-1718	39	12	further	further	ADJ
ajlm-1718	39	13	analysis	analysis	NOUN
ajlm-1718	39	14	for	for	ADP
ajlm-1718	39	15	hhv-6	hhv-6	NOUN
ajlm-1718	39	16	dna	dna	NOUN
ajlm-1718	39	17	at	at	ADP
ajlm-1718	39	18	the	the	DET
ajlm-1718	39	19	department	department	NOUN
ajlm-1718	39	20	of	of	ADP
ajlm-1718	39	21	clinical	clinical	ADJ
ajlm-1718	39	22	microbiology	microbiology	NOUN
ajlm-1718	39	23	,	,	PUNCT
ajlm-1718	39	24	umeå	umeå	PROPN
ajlm-1718	39	25	university	university	PROPN
ajlm-1718	39	26	,	,	PUNCT
ajlm-1718	39	27	umeå	umeå	PROPN
ajlm-1718	39	28	,	,	PUNCT
ajlm-1718	39	29	sweden	sweden	PROPN
ajlm-1718	39	30	.	.	PUNCT
ajlm-1718	40	1	human	human	ADJ
ajlm-1718	40	2	herpes	herpe	NOUN
ajlm-1718	40	3	virus	virus	NOUN
ajlm-1718	40	4	type-6	type-6	PROPN
ajlm-1718	40	5	dna	dna	PROPN
ajlm-1718	40	6	was	be	AUX
ajlm-1718	40	7	extracted	extract	VERB
ajlm-1718	40	8	then	then	ADV
ajlm-1718	40	9	quantitatively	quantitatively	ADV
ajlm-1718	40	10	amplified	amplify	VERB
ajlm-1718	40	11	by	by	ADP
ajlm-1718	40	12	real	real	ADJ
ajlm-1718	40	13	-	-	PUNCT
ajlm-1718	40	14	time	time	NOUN
ajlm-1718	40	15	polymerase	polymerase	NOUN
ajlm-1718	40	16	chain	chain	NOUN
ajlm-1718	40	17	reaction	reaction	NOUN
ajlm-1718	40	18	(	(	PUNCT
ajlm-1718	40	19	pcr	pcr	NOUN
ajlm-1718	40	20	)	)	PUNCT
ajlm-1718	40	21	using	use	VERB
ajlm-1718	40	22	taqman	taqman	NOUN
ajlm-1718	40	23	®	®	NOUN
ajlm-1718	40	24	(	(	PUNCT
ajlm-1718	40	25	eurogentec	eurogentec	ADJ
ajlm-1718	40	26	®	®	NOUN
ajlm-1718	40	27	,	,	PUNCT
ajlm-1718	40	28	seraing	seraing	NOUN
ajlm-1718	40	29	,	,	PUNCT
ajlm-1718	40	30	liège	liège	PROPN
ajlm-1718	40	31	,	,	PUNCT
ajlm-1718	40	32	belgium	belgium	NOUN
ajlm-1718	40	33	)	)	PUNCT
ajlm-1718	40	34	method	method	NOUN
ajlm-1718	40	35	.	.	PUNCT
ajlm-1718	41	1	viral	viral	ADJ
ajlm-1718	41	2	dna	dna	PROPN
ajlm-1718	41	3	extraction	extraction	NOUN
ajlm-1718	41	4	the	the	DET
ajlm-1718	41	5	qiaamp	qiaamp	NOUN
ajlm-1718	41	6	ultrasens	ultrasens	PROPN
ajlm-1718	41	7	virus	virus	PROPN
ajlm-1718	41	8	technology	technology	NOUN
ajlm-1718	41	9	kit	kit	NOUN
ajlm-1718	41	10	(	(	PUNCT
ajlm-1718	41	11	qiagen	qiagen	PROPN
ajlm-1718	41	12	®	®	PROPN
ajlm-1718	41	13	,	,	PUNCT
ajlm-1718	41	14	hilden	hilden	PROPN
ajlm-1718	41	15	,	,	PUNCT
ajlm-1718	41	16	germany	germany	PROPN
ajlm-1718	41	17	)	)	PUNCT
ajlm-1718	41	18	was	be	AUX
ajlm-1718	41	19	used	use	VERB
ajlm-1718	41	20	for	for	ADP
ajlm-1718	41	21	viral	viral	ADJ
ajlm-1718	41	22	dna	dna	NOUN
ajlm-1718	41	23	extraction	extraction	NOUN
ajlm-1718	41	24	in	in	ADP
ajlm-1718	41	25	csf	csf	PROPN
ajlm-1718	41	26	.	.	PROPN
ajlm-1718	42	1	one	one	NUM
ajlm-1718	42	2	ml	ml	NOUN
ajlm-1718	42	3	specimen	speciman	NOUN
ajlm-1718	42	4	was	be	AUX
ajlm-1718	42	5	used	use	VERB
ajlm-1718	42	6	to	to	PART
ajlm-1718	42	7	concentrate	concentrate	VERB
ajlm-1718	42	8	viral	viral	ADJ
ajlm-1718	42	9	dna	dna	NOUN
ajlm-1718	42	10	:	:	PUNCT
ajlm-1718	42	11	buffer	buffer	NOUN
ajlm-1718	42	12	ac	ac	PROPN
ajlm-1718	43	1	(	(	PUNCT
ajlm-1718	43	2	qiagen	qiagen	PROPN
ajlm-1718	43	3	®	®	PROPN
ajlm-1718	43	4	,	,	PUNCT
ajlm-1718	43	5	hilden	hilden	PROPN
ajlm-1718	43	6	,	,	PUNCT
ajlm-1718	43	7	germany	germany	PROPN
ajlm-1718	43	8	)	)	PUNCT
ajlm-1718	43	9	was	be	AUX
ajlm-1718	43	10	added	add	VERB
ajlm-1718	43	11	,	,	PUNCT
ajlm-1718	43	12	shortly	shortly	ADV
ajlm-1718	43	13	incubated	incubate	VERB
ajlm-1718	43	14	,	,	PUNCT
ajlm-1718	43	15	then	then	ADV
ajlm-1718	43	16	sediment	sediment	NOUN
ajlm-1718	43	17	by	by	ADP
ajlm-1718	43	18	low	low	ADJ
ajlm-1718	43	19	g	g	NOUN
ajlm-1718	43	20	-	-	PUNCT
ajlm-1718	43	21	force	force	NOUN
ajlm-1718	43	22	(	(	PUNCT
ajlm-1718	43	23	i.e.	i.e.	X
ajlm-1718	43	24	1000–1200	1000–1200	NUM
ajlm-1718	43	25	×	×	NOUN
ajlm-1718	43	26	g	g	NOUN
ajlm-1718	43	27	)	)	PUNCT
ajlm-1718	43	28	centrifugation	centrifugation	NOUN
ajlm-1718	43	29	(	(	PUNCT
ajlm-1718	43	30	eppindorf	eppindorf	VERB
ajlm-1718	43	31	centrifuge	centrifuge	NOUN
ajlm-1718	43	32	5415d	5415d	PROPN
ajlm-1718	43	33	®	®	PROPN
ajlm-1718	43	34	,	,	PUNCT
ajlm-1718	43	35	hamburg	hamburg	PROPN
ajlm-1718	43	36	,	,	PUNCT
ajlm-1718	43	37	germany	germany	PROPN
ajlm-1718	43	38	)	)	PUNCT
ajlm-1718	43	39	to	to	PART
ajlm-1718	43	40	pellet	pellet	VERB
ajlm-1718	43	41	nucleic	nucleic	ADJ
ajlm-1718	43	42	acid	acid	NOUN
ajlm-1718	43	43	complexes	complex	NOUN
ajlm-1718	43	44	.	.	PUNCT
ajlm-1718	44	1	the	the	DET
ajlm-1718	44	2	supernatant	supernatant	NOUN
ajlm-1718	44	3	was	be	AUX
ajlm-1718	44	4	discarded	discard	VERB
ajlm-1718	44	5	;	;	PUNCT
ajlm-1718	44	6	the	the	DET
ajlm-1718	44	7	pellet	pellet	NOUN
ajlm-1718	44	8	was	be	AUX
ajlm-1718	44	9	re	re	VERB
ajlm-1718	44	10	-	-	VERB
ajlm-1718	44	11	suspended	suspend	VERB
ajlm-1718	44	12	in	in	ADP
ajlm-1718	44	13	buffer	buffer	NOUN
ajlm-1718	44	14	ar	ar	PROPN
ajlm-1718	44	15	(	(	PUNCT
ajlm-1718	44	16	qiagen	qiagen	PROPN
ajlm-1718	44	17	®	®	PROPN
ajlm-1718	44	18	,	,	PUNCT
ajlm-1718	44	19	hilden	hilden	PROPN
ajlm-1718	44	20	,	,	PUNCT
ajlm-1718	44	21	germany	germany	PROPN
ajlm-1718	44	22	)	)	PUNCT
ajlm-1718	44	23	and	and	CCONJ
ajlm-1718	44	24	proteinase	proteinase	PROPN
ajlm-1718	44	25	k	k	PROPN
ajlm-1718	44	26	and	and	CCONJ
ajlm-1718	44	27	incubated	incubate	VERB
ajlm-1718	44	28	for	for	ADP
ajlm-1718	44	29	10	10	NUM
ajlm-1718	44	30	min	min	NOUN
ajlm-1718	44	31	at	at	ADP
ajlm-1718	44	32	40	40	NUM
ajlm-1718	44	33	°	°	NOUN
ajlm-1718	44	34	c	c	NOUN
ajlm-1718	44	35	.	.	PUNCT
ajlm-1718	45	1	binding	bind	VERB
ajlm-1718	45	2	conditions	condition	NOUN
ajlm-1718	45	3	were	be	AUX
ajlm-1718	45	4	adjusted	adjust	VERB
ajlm-1718	45	5	by	by	ADP
ajlm-1718	45	6	adding	add	VERB
ajlm-1718	45	7	buffer	buffer	NOUN
ajlm-1718	45	8	ab	ab	PROPN
ajlm-1718	45	9	(	(	PUNCT
ajlm-1718	45	10	qiagen	qiagen	PROPN
ajlm-1718	45	11	®	®	PROPN
ajlm-1718	45	12	,	,	PUNCT
ajlm-1718	45	13	hilden	hilden	PROPN
ajlm-1718	45	14	,	,	PUNCT
ajlm-1718	45	15	germany	germany	PROPN
ajlm-1718	45	16	)	)	PUNCT
ajlm-1718	45	17	;	;	PUNCT
ajlm-1718	45	18	the	the	DET
ajlm-1718	45	19	lysate	lysate	NOUN
ajlm-1718	45	20	was	be	AUX
ajlm-1718	45	21	applied	apply	VERB
ajlm-1718	45	22	to	to	ADP
ajlm-1718	45	23	the	the	DET
ajlm-1718	45	24	silica	silica	NOUN
ajlm-1718	45	25	gel	gel	NOUN
ajlm-1718	45	26	membrane	membrane	NOUN
ajlm-1718	45	27	spin	spin	NOUN
ajlm-1718	45	28	column	column	NOUN
ajlm-1718	45	29	.	.	PUNCT
ajlm-1718	46	1	during	during	ADP
ajlm-1718	46	2	brief	brief	ADJ
ajlm-1718	46	3	centrifugation	centrifugation	NOUN
ajlm-1718	46	4	(	(	PUNCT
ajlm-1718	46	5	i.e.	i.e.	X
ajlm-1718	46	6	3000–5000	3000–5000	NUM
ajlm-1718	46	7	×	×	NOUN
ajlm-1718	46	8	g	g	NOUN
ajlm-1718	46	9	)	)	PUNCT
ajlm-1718	46	10	,	,	PUNCT
ajlm-1718	46	11	dna	dna	PROPN
ajlm-1718	46	12	selectively	selectively	ADV
ajlm-1718	46	13	binds	bind	VERB
ajlm-1718	46	14	to	to	ADP
ajlm-1718	46	15	the	the	DET
ajlm-1718	46	16	membrane	membrane	NOUN
ajlm-1718	46	17	.	.	PUNCT
ajlm-1718	47	1	remaining	remain	VERB
ajlm-1718	47	2	contaminants	contaminant	NOUN
ajlm-1718	47	3	and	and	CCONJ
ajlm-1718	47	4	enzyme	enzyme	NOUN
ajlm-1718	47	5	inhibitors	inhibitor	NOUN
ajlm-1718	47	6	were	be	AUX
ajlm-1718	47	7	removed	remove	VERB
ajlm-1718	47	8	by	by	ADP
ajlm-1718	47	9	centrifugation	centrifugation	NOUN
ajlm-1718	47	10	(	(	PUNCT
ajlm-1718	47	11	i.e.	i.e.	X
ajlm-1718	47	12	3000–5000	3000–5000	NUM
ajlm-1718	47	13	×	×	NOUN
ajlm-1718	47	14	g	g	NOUN
ajlm-1718	47	15	)	)	PUNCT
ajlm-1718	47	16	in	in	ADP
ajlm-1718	47	17	two	two	NUM
ajlm-1718	47	18	wash	wash	NOUN
ajlm-1718	47	19	steps	step	NOUN
ajlm-1718	47	20	using	use	VERB
ajlm-1718	47	21	buffer	buffer	NOUN
ajlm-1718	47	22	aw1	aw1	VERB
ajlm-1718	47	23	then	then	ADV
ajlm-1718	47	24	buffer	buffer	VERB
ajlm-1718	47	25	aw2	aw2	PROPN
ajlm-1718	47	26	.	.	PUNCT
ajlm-1718	48	1	pure	pure	ADJ
ajlm-1718	48	2	viral	viral	ADJ
ajlm-1718	48	3	nucleic	nucleic	ADJ
ajlm-1718	48	4	acids	acid	NOUN
ajlm-1718	48	5	were	be	AUX
ajlm-1718	48	6	eluted	elute	VERB
ajlm-1718	48	7	in	in	ADP
ajlm-1718	48	8	30	30	NUM
ajlm-1718	48	9	µl	µl	ADP
ajlm-1718	48	10	low	low	ADJ
ajlm-1718	48	11	-	-	PUNCT
ajlm-1718	48	12	salt	salt	NOUN
ajlm-1718	48	13	buffer	buffer	NOUN
ajlm-1718	48	14	ave	ave	NOUN
ajlm-1718	48	15	(	(	PUNCT
ajlm-1718	48	16	qiagen	qiagen	PROPN
ajlm-1718	48	17	®	®	PROPN
ajlm-1718	48	18	,	,	PUNCT
ajlm-1718	48	19	hilden	hilden	PROPN
ajlm-1718	48	20	,	,	PUNCT
ajlm-1718	48	21	germany	germany	PROPN
ajlm-1718	48	22	)	)	PUNCT
ajlm-1718	48	23	twice	twice	ADV
ajlm-1718	48	24	.	.	PUNCT
ajlm-1718	49	1	each	each	DET
ajlm-1718	49	2	elute	elute	NOUN
ajlm-1718	49	3	(	(	PUNCT
ajlm-1718	49	4	60	60	NUM
ajlm-1718	49	5	µl	µl	NOUN
ajlm-1718	49	6	)	)	PUNCT
ajlm-1718	49	7	was	be	AUX
ajlm-1718	49	8	divided	divide	VERB
ajlm-1718	49	9	into	into	ADP
ajlm-1718	49	10	two	two	NUM
ajlm-1718	49	11	aliquots	aliquot	NOUN
ajlm-1718	49	12	(	(	PUNCT
ajlm-1718	49	13	30	30	NUM
ajlm-1718	49	14	µl	µl	ADP
ajlm-1718	49	15	each	each	PRON
ajlm-1718	49	16	)	)	PUNCT
ajlm-1718	49	17	and	and	CCONJ
ajlm-1718	49	18	preserved	preserve	VERB
ajlm-1718	49	19	at	at	ADP
ajlm-1718	49	20	−80	−80	PROPN
ajlm-1718	49	21	°	°	ADP
ajlm-1718	49	22	c	c	PROPN
ajlm-1718	49	23	.	.	PUNCT
ajlm-1718	50	1	taqman	taqman	NOUN
ajlm-1718	50	2	®	®	NOUN
ajlm-1718	50	3	real	real	ADJ
ajlm-1718	50	4	-	-	PUNCT
ajlm-1718	50	5	time	time	NOUN
ajlm-1718	50	6	polymerase	polymerase	NOUN
ajlm-1718	50	7	chain	chain	NOUN
ajlm-1718	50	8	reaction	reaction	NOUN
ajlm-1718	50	9	viral	viral	ADJ
ajlm-1718	50	10	gdna	gdna	NOUN
ajlm-1718	50	11	amplification	amplification	NOUN
ajlm-1718	50	12	and	and	CCONJ
ajlm-1718	50	13	detection	detection	NOUN
ajlm-1718	50	14	was	be	AUX
ajlm-1718	50	15	performed	perform	VERB
ajlm-1718	50	16	by	by	ADP
ajlm-1718	50	17	real	real	ADJ
ajlm-1718	50	18	-	-	PUNCT
ajlm-1718	50	19	time	time	NOUN
ajlm-1718	50	20	analysis	analysis	NOUN
ajlm-1718	50	21	using	use	VERB
ajlm-1718	50	22	the	the	DET
ajlm-1718	50	23	applied	apply	VERB
ajlm-1718	50	24	biosystems	biosystem	NOUN
ajlm-1718	50	25	®	®	NOUN
ajlm-1718	50	26	7900ht	7900ht	VERB
ajlm-1718	50	27	fast	fast	ADJ
ajlm-1718	50	28	real	real	ADJ
ajlm-1718	50	29	-	-	PUNCT
ajlm-1718	50	30	time	time	NOUN
ajlm-1718	50	31	pcr	pcr	NOUN
ajlm-1718	50	32	system	system	NOUN
ajlm-1718	50	33	(	(	PUNCT
ajlm-1718	50	34	foster	foster	ADJ
ajlm-1718	50	35	city	city	NOUN
ajlm-1718	50	36	,	,	PUNCT
ajlm-1718	50	37	california	california	PROPN
ajlm-1718	50	38	,	,	PUNCT
ajlm-1718	50	39	united	united	PROPN
ajlm-1718	50	40	states	states	PROPN
ajlm-1718	50	41	)	)	PUNCT
ajlm-1718	50	42	and	and	CCONJ
ajlm-1718	50	43	the	the	DET
ajlm-1718	50	44	taqman	taqman	NOUN
ajlm-1718	50	45	®	®	NOUN
ajlm-1718	50	46	(	(	PUNCT
ajlm-1718	50	47	eurogentec	eurogentec	ADJ
ajlm-1718	50	48	®	®	NOUN
ajlm-1718	50	49	,	,	PUNCT
ajlm-1718	50	50	seraing	seraing	NOUN
ajlm-1718	50	51	,	,	PUNCT
ajlm-1718	50	52	liège	liège	PROPN
ajlm-1718	50	53	,	,	PUNCT
ajlm-1718	50	54	belgium	belgium	NOUN
ajlm-1718	50	55	)	)	PUNCT
ajlm-1718	50	56	probe	probe	NOUN
ajlm-1718	50	57	(	(	PUNCT
ajlm-1718	50	58	reporter	reporter	NOUN
ajlm-1718	50	59	dye	dye	NOUN
ajlm-1718	50	60	famtm	famtm	PROPN
ajlm-1718	50	61	on	on	ADP
ajlm-1718	50	62	5	5	NUM
ajlm-1718	50	63	´	´	NOUN
ajlm-1718	50	64	end	end	NOUN
ajlm-1718	50	65	and	and	CCONJ
ajlm-1718	50	66	quencher	quencher	NOUN
ajlm-1718	50	67	dye	dye	NOUN
ajlm-1718	50	68	tamratm	tamratm	NOUN
ajlm-1718	50	69	on	on	ADP
ajlm-1718	50	70	3	3	NUM
ajlm-1718	50	71	´	´	NOUN
ajlm-1718	50	72	end	end	NOUN
ajlm-1718	50	73	)	)	PUNCT
ajlm-1718	50	74	.	.	PUNCT
ajlm-1718	51	1	the	the	DET
ajlm-1718	51	2	lower	low	ADJ
ajlm-1718	51	3	assay	assay	NOUN
ajlm-1718	51	4	detection	detection	NOUN
ajlm-1718	51	5	limit	limit	NOUN
ajlm-1718	51	6	is	be	AUX
ajlm-1718	51	7	one	one	NUM
ajlm-1718	51	8	virus	virus	NOUN
ajlm-1718	51	9	copy	copy	VERB
ajlm-1718	51	10	per	per	ADP
ajlm-1718	51	11	ml	ml	ADP
ajlm-1718	51	12	specimen	speciman	NOUN
ajlm-1718	51	13	.	.	PUNCT
ajlm-1718	52	1	forward	forward	ADV
ajlm-1718	52	2	and	and	CCONJ
ajlm-1718	52	3	reverse	reverse	VERB
ajlm-1718	52	4	primers	primer	NOUN
ajlm-1718	52	5	(	(	PUNCT
ajlm-1718	52	6	figure	figure	NOUN
ajlm-1718	52	7	1	1	NUM
ajlm-1718	52	8	)	)	PUNCT
ajlm-1718	52	9	and	and	CCONJ
ajlm-1718	52	10	probes	probe	NOUN
ajlm-1718	52	11	(	(	PUNCT
ajlm-1718	52	12	dna	dna	PROPN
ajlm-1718	52	13	technology	technology	PROPN
ajlm-1718	52	14	®	®	PROPN
ajlm-1718	52	15	,	,	PUNCT
ajlm-1718	52	16	aarhus	aarhus	PROPN
ajlm-1718	52	17	,	,	PUNCT
ajlm-1718	52	18	denmark	denmark	PROPN
ajlm-1718	52	19	)	)	PUNCT
ajlm-1718	52	20	were	be	AUX
ajlm-1718	52	21	diluted	dilute	VERB
ajlm-1718	52	22	to	to	PART
ajlm-1718	52	23	reach	reach	VERB
ajlm-1718	52	24	final	final	ADJ
ajlm-1718	52	25	working	working	NOUN
ajlm-1718	52	26	concentration	concentration	NOUN
ajlm-1718	52	27	of	of	ADP
ajlm-1718	52	28	25	25	NUM
ajlm-1718	52	29	µm	µm	NOUN
ajlm-1718	52	30	(	(	PUNCT
ajlm-1718	52	31	standardised	standardised	ADJ
ajlm-1718	52	32	concentration	concentration	NOUN
ajlm-1718	52	33	by	by	ADP
ajlm-1718	52	34	umeå	umeå	PROPN
ajlm-1718	52	35	university	university	NOUN
ajlm-1718	52	36	hospital	hospital	NOUN
ajlm-1718	52	37	)	)	PUNCT
ajlm-1718	52	38	.	.	PUNCT
ajlm-1718	53	1	commercially	commercially	ADV
ajlm-1718	53	2	provided	provide	VERB
ajlm-1718	53	3	oligonucleotide	oligonucleotide	NOUN
ajlm-1718	53	4	products	product	NOUN
ajlm-1718	53	5	were	be	AUX
ajlm-1718	53	6	diluted	dilute	VERB
ajlm-1718	53	7	to	to	ADP
ajlm-1718	53	8	the	the	DET
ajlm-1718	53	9	suitable	suitable	ADJ
ajlm-1718	53	10	working	work	VERB
ajlm-1718	53	11	solution	solution	NOUN
ajlm-1718	53	12	and	and	CCONJ
ajlm-1718	53	13	the	the	DET
ajlm-1718	53	14	recommendation	recommendation	NOUN
ajlm-1718	53	15	of	of	ADP
ajlm-1718	53	16	quantitect	quantitect	ADJ
ajlm-1718	53	17	®	®	NOUN
ajlm-1718	53	18	(	(	PUNCT
ajlm-1718	53	19	qiagen	qiagen	PROPN
ajlm-1718	53	20	®	®	PROPN
ajlm-1718	53	21	,	,	PUNCT
ajlm-1718	53	22	hilden	hilden	PROPN
ajlm-1718	53	23	,	,	PUNCT
ajlm-1718	53	24	germany	germany	PROPN
ajlm-1718	53	25	)	)	PUNCT
ajlm-1718	53	26	q	q	PROPN
ajlm-1718	53	27	pcr	pcr	ADJ
ajlm-1718	53	28	protocol	protocol	NOUN
ajlm-1718	53	29	was	be	AUX
ajlm-1718	53	30	followed	follow	VERB
ajlm-1718	53	31	.	.	PUNCT
ajlm-1718	54	1	a	a	DET
ajlm-1718	54	2	pcr	pcr	PROPN
ajlm-1718	54	3	master	master	NOUN
ajlm-1718	54	4	mix	mix	NOUN
ajlm-1718	54	5	solution	solution	NOUN
ajlm-1718	54	6	was	be	AUX
ajlm-1718	54	7	prepared	prepare	VERB
ajlm-1718	54	8	for	for	ADP
ajlm-1718	54	9	harry	harry	PROPN
ajlm-1718	54	10	(	(	PUNCT
ajlm-1718	54	11	hhv-6	hhv-6	NOUN
ajlm-1718	54	12	)	)	PUNCT
ajlm-1718	54	13	primers	primer	NOUN
ajlm-1718	54	14	(	(	PUNCT
ajlm-1718	54	15	figure	figure	NOUN
ajlm-1718	54	16	1	1	NUM
ajlm-1718	54	17	)	)	PUNCT
ajlm-1718	54	18	as	as	ADP
ajlm-1718	54	19	follow	follow	VERB
ajlm-1718	54	20	:	:	PUNCT
ajlm-1718	54	21	volumes	volume	NOUN
ajlm-1718	54	22	of	of	ADP
ajlm-1718	54	23	12.5	12.5	NUM
ajlm-1718	54	24	µl	µl	NOUN
ajlm-1718	54	25	of	of	ADP
ajlm-1718	54	26	2	2	NUM
ajlm-1718	54	27	×	×	NOUN
ajlm-1718	54	28	quantitecttm	quantitecttm	NOUN
ajlm-1718	54	29	probe	probe	VERB
ajlm-1718	54	30	pcr	pcr	NOUN
ajlm-1718	54	31	master	master	NOUN
ajlm-1718	54	32	mix	mix	NOUN
ajlm-1718	54	33	(	(	PUNCT
ajlm-1718	54	34	qiagen	qiagen	PROPN
ajlm-1718	54	35	®	®	PROPN
ajlm-1718	54	36	,	,	PUNCT
ajlm-1718	54	37	hilden	hilden	PROPN
ajlm-1718	54	38	,	,	PUNCT
ajlm-1718	54	39	germany	germany	PROPN
ajlm-1718	54	40	)	)	PUNCT
ajlm-1718	54	41	,	,	PUNCT
ajlm-1718	54	42	1.0	1.0	NUM
ajlm-1718	54	43	µl	µl	AUX
ajlm-1718	54	44	forward	forward	ADJ
ajlm-1718	54	45	primer	primer	NOUN
ajlm-1718	54	46	(	(	PUNCT
ajlm-1718	54	47	final	final	ADJ
ajlm-1718	54	48	concentration	concentration	NOUN
ajlm-1718	54	49	25	25	NUM
ajlm-1718	54	50	µm	µm	NOUN
ajlm-1718	54	51	)	)	PUNCT
ajlm-1718	54	52	,	,	PUNCT
ajlm-1718	54	53	1.0	1.0	NUM
ajlm-1718	54	54	µl	µl	ADP
ajlm-1718	54	55	reverse	reverse	ADJ
ajlm-1718	54	56	primer	primer	NOUN
ajlm-1718	54	57	(	(	PUNCT
ajlm-1718	54	58	final	final	ADJ
ajlm-1718	54	59	concentration	concentration	NOUN
ajlm-1718	54	60	25	25	NUM
ajlm-1718	54	61	µm	µm	NOUN
ajlm-1718	54	62	)	)	PUNCT
ajlm-1718	54	63	,	,	PUNCT
ajlm-1718	54	64	0.8	0.8	NUM
ajlm-1718	54	65	µl	µl	ADP
ajlm-1718	54	66	probe	probe	NOUN
ajlm-1718	54	67	(	(	PUNCT
ajlm-1718	54	68	final	final	ADJ
ajlm-1718	54	69	concentration	concentration	NOUN
ajlm-1718	54	70	20	20	NUM
ajlm-1718	54	71	µm	µm	NOUN
ajlm-1718	54	72	)	)	PUNCT
ajlm-1718	54	73	and	and	CCONJ
ajlm-1718	54	74	7.2	7.2	NUM
ajlm-1718	54	75	µl	µl	ADP
ajlm-1718	54	76	rnase	rnase	NOUN
ajlm-1718	54	77	-	-	PUNCT
ajlm-1718	54	78	free	free	ADJ
ajlm-1718	54	79	water	water	NOUN
ajlm-1718	54	80	(	(	PUNCT
ajlm-1718	54	81	ambion	ambion	PROPN
ajlm-1718	54	82	®	®	PROPN
ajlm-1718	54	83	,	,	PUNCT
ajlm-1718	54	84	waltham	waltham	PROPN
ajlm-1718	54	85	,	,	PUNCT
ajlm-1718	54	86	massachusetts	massachusetts	PROPN
ajlm-1718	54	87	,	,	PUNCT
ajlm-1718	54	88	united	united	PROPN
ajlm-1718	54	89	states	states	PROPN
ajlm-1718	54	90	)	)	PUNCT
ajlm-1718	54	91	were	be	AUX
ajlm-1718	54	92	added	add	VERB
ajlm-1718	54	93	into	into	ADP
ajlm-1718	54	94	2.5	2.5	NUM
ajlm-1718	54	95	µl	µl	ADP
ajlm-1718	54	96	template	template	NOUN
ajlm-1718	54	97	gdna	gdna	ADV
ajlm-1718	54	98	to	to	PART
ajlm-1718	54	99	complete	complete	VERB
ajlm-1718	54	100	a	a	DET
ajlm-1718	54	101	total	total	ADJ
ajlm-1718	54	102	reaction	reaction	NOUN
ajlm-1718	54	103	volume	volume	NOUN
ajlm-1718	54	104	of	of	ADP
ajlm-1718	54	105	25.0	25.0	NUM
ajlm-1718	54	106	µl	µl	NOUN
ajlm-1718	54	107	per	per	ADP
ajlm-1718	54	108	single	single	ADJ
ajlm-1718	54	109	pcr	pcr	ADJ
ajlm-1718	54	110	reaction	reaction	NOUN
ajlm-1718	54	111	.	.	PUNCT
ajlm-1718	55	1	the	the	DET
ajlm-1718	55	2	mixture	mixture	NOUN
ajlm-1718	55	3	was	be	AUX
ajlm-1718	55	4	pulse	pulse	NOUN
ajlm-1718	55	5	-	-	PUNCT
ajlm-1718	55	6	vortexed	vortexe	VERB
ajlm-1718	55	7	(	(	PUNCT
ajlm-1718	55	8	vortex	vortex	NOUN
ajlm-1718	55	9	-	-	PUNCT
ajlm-1718	55	10	genie	genie	NOUN
ajlm-1718	55	11	pulse	pulse	NOUN
ajlm-1718	55	12	®	®	PROPN
ajlm-1718	55	13	,	,	PUNCT
ajlm-1718	55	14	bohemia	bohemia	NOUN
ajlm-1718	55	15	,	,	PUNCT
ajlm-1718	55	16	new	new	PROPN
ajlm-1718	55	17	york	york	PROPN
ajlm-1718	55	18	,	,	PUNCT
ajlm-1718	55	19	united	united	PROPN
ajlm-1718	55	20	states	states	PROPN
ajlm-1718	55	21	)	)	PUNCT
ajlm-1718	55	22	and	and	CCONJ
ajlm-1718	55	23	centrifuged	centrifuge	VERB
ajlm-1718	55	24	briefly	briefly	ADV
ajlm-1718	55	25	(	(	PUNCT
ajlm-1718	55	26	i.e.	i.e.	X
ajlm-1718	55	27	3000	3000	NUM
ajlm-1718	55	28	×	×	NOUN
ajlm-1718	55	29	g	g	NOUN
ajlm-1718	55	30	)	)	PUNCT
ajlm-1718	55	31	.	.	PUNCT
ajlm-1718	56	1	then	then	ADV
ajlm-1718	56	2	,	,	PUNCT
ajlm-1718	56	3	22.5	22.5	NUM
ajlm-1718	56	4	µl	µl	ADP
ajlm-1718	56	5	single	single	ADJ
ajlm-1718	56	6	reaction	reaction	NOUN
ajlm-1718	56	7	mix	mix	NOUN
ajlm-1718	56	8	was	be	AUX
ajlm-1718	56	9	transferred	transfer	VERB
ajlm-1718	56	10	into	into	ADP
ajlm-1718	56	11	a	a	DET
ajlm-1718	56	12	well	well	NOUN
ajlm-1718	56	13	of	of	ADP
ajlm-1718	56	14	a	a	DET
ajlm-1718	56	15	microamptm	microamptm	ADJ
ajlm-1718	56	16	optical	optical	ADJ
ajlm-1718	56	17	96	96	NUM
ajlm-1718	56	18	-	-	PUNCT
ajlm-1718	56	19	well	well	NOUN
ajlm-1718	56	20	reaction	reaction	NOUN
ajlm-1718	56	21	plate	plate	NOUN
ajlm-1718	56	22	(	(	PUNCT
ajlm-1718	56	23	applied	apply	VERB
ajlm-1718	56	24	biosystems	biosystem	NOUN
ajlm-1718	56	25	®	®	PROPN
ajlm-1718	56	26	,	,	PUNCT
ajlm-1718	56	27	foster	foster	ADJ
ajlm-1718	56	28	city	city	PROPN
ajlm-1718	56	29	,	,	PUNCT
ajlm-1718	56	30	california	california	PROPN
ajlm-1718	56	31	,	,	PUNCT
ajlm-1718	56	32	united	united	PROPN
ajlm-1718	56	33	states	states	PROPN
ajlm-1718	56	34	)	)	PUNCT
ajlm-1718	56	35	to	to	PART
ajlm-1718	56	36	which	which	PRON
ajlm-1718	56	37	2.5	2.5	NUM
ajlm-1718	56	38	µl	µl	ADP
ajlm-1718	56	39	template	template	NOUN
ajlm-1718	56	40	gdna	gdna	ADV
ajlm-1718	56	41	was	be	AUX
ajlm-1718	56	42	added	add	VERB
ajlm-1718	56	43	to	to	PART
ajlm-1718	56	44	reach	reach	VERB
ajlm-1718	56	45	total	total	ADJ
ajlm-1718	56	46	volume	volume	NOUN
ajlm-1718	56	47	of	of	ADP
ajlm-1718	56	48	25.0	25.0	NUM
ajlm-1718	56	49	µl	µl	NOUN
ajlm-1718	56	50	per	per	ADP
ajlm-1718	56	51	one	one	NUM
ajlm-1718	56	52	reaction	reaction	NOUN
ajlm-1718	56	53	.	.	PUNCT
ajlm-1718	57	1	figure	figure	NOUN
ajlm-1718	57	2	1	1	NUM
ajlm-1718	57	3	:	:	PUNCT
ajlm-1718	57	4	specifications	specification	NOUN
ajlm-1718	57	5	of	of	ADP
ajlm-1718	57	6	human	human	ADJ
ajlm-1718	57	7	herpes	herpe	NOUN
ajlm-1718	57	8	virus	virus	NOUN
ajlm-1718	57	9	type	type	VERB
ajlm-1718	57	10	6	6	NUM
ajlm-1718	57	11	primers	primer	NOUN
ajlm-1718	57	12	and	and	CCONJ
ajlm-1718	57	13	probe	probe	VERB
ajlm-1718	57	14	in	in	ADP
ajlm-1718	57	15	khartoum	khartoum	PROPN
ajlm-1718	57	16	,	,	PUNCT
ajlm-1718	57	17	sudan	sudan	PROPN
ajlm-1718	57	18	,	,	PUNCT
ajlm-1718	57	19	december	december	PROPN
ajlm-1718	57	20	2009	2009	NUM
ajlm-1718	57	21	–	–	PUNCT
ajlm-1718	57	22	august	august	PROPN
ajlm-1718	57	23	2010	2010	NUM
ajlm-1718	57	24	.	.	PUNCT
ajlm-1718	58	1	the	the	DET
ajlm-1718	58	2	pcr	pcr	ADJ
ajlm-1718	58	3	plates	plate	NOUN
ajlm-1718	58	4	were	be	AUX
ajlm-1718	58	5	covered	cover	VERB
ajlm-1718	58	6	by	by	ADP
ajlm-1718	58	7	microamptm	microamptm	ADJ
ajlm-1718	58	8	optical	optical	ADJ
ajlm-1718	58	9	adhesive	adhesive	ADJ
ajlm-1718	58	10	film	film	NOUN
ajlm-1718	58	11	(	(	PUNCT
ajlm-1718	58	12	applied	apply	VERB
ajlm-1718	58	13	biosystems	biosystem	NOUN
ajlm-1718	58	14	®	®	PROPN
ajlm-1718	58	15	)	)	PUNCT
ajlm-1718	58	16	,	,	PUNCT
ajlm-1718	58	17	concentrated	concentrate	VERB
ajlm-1718	58	18	at	at	ADP
ajlm-1718	58	19	the	the	DET
ajlm-1718	58	20	bottom	bottom	NOUN
ajlm-1718	58	21	of	of	ADP
ajlm-1718	58	22	the	the	DET
ajlm-1718	58	23	plate	plate	NOUN
ajlm-1718	58	24	wells	well	NOUN
ajlm-1718	58	25	by	by	ADP
ajlm-1718	58	26	spinning	spin	VERB
ajlm-1718	58	27	at	at	ADP
ajlm-1718	58	28	low	low	ADJ
ajlm-1718	58	29	speed	speed	NOUN
ajlm-1718	58	30	in	in	ADP
ajlm-1718	58	31	a	a	DET
ajlm-1718	58	32	cold	cold	ADJ
ajlm-1718	58	33	centrifuge	centrifuge	NOUN
ajlm-1718	58	34	(	(	PUNCT
ajlm-1718	58	35	i.e.	i.e.	X
ajlm-1718	58	36	1200	1200	NUM
ajlm-1718	58	37	×	×	NOUN
ajlm-1718	58	38	g	g	NOUN
ajlm-1718	58	39	)	)	PUNCT
ajlm-1718	58	40	using	use	VERB
ajlm-1718	58	41	allegratm	allegratm	PROPN
ajlm-1718	58	42	x-12r	x-12r	PUNCT
ajlm-1718	58	43	centrifuge	centrifuge	PROPN
ajlm-1718	58	44	(	(	PUNCT
ajlm-1718	58	45	beckman	beckman	PROPN
ajlm-1718	58	46	coulter	coulter	PROPN
ajlm-1718	58	47	®	®	PROPN
ajlm-1718	58	48	,	,	PUNCT
ajlm-1718	58	49	brea	brea	PROPN
ajlm-1718	58	50	,	,	PUNCT
ajlm-1718	58	51	california	california	PROPN
ajlm-1718	58	52	,	,	PUNCT
ajlm-1718	58	53	united	united	PROPN
ajlm-1718	58	54	states	states	PROPN
ajlm-1718	58	55	)	)	PUNCT
ajlm-1718	58	56	.	.	PUNCT
ajlm-1718	59	1	each	each	DET
ajlm-1718	59	2	pcr	pcr	ADJ
ajlm-1718	59	3	reaction	reaction	NOUN
ajlm-1718	59	4	plate	plate	NOUN
ajlm-1718	59	5	was	be	AUX
ajlm-1718	59	6	designed	design	VERB
ajlm-1718	59	7	for	for	ADP
ajlm-1718	59	8	carrying	carry	VERB
ajlm-1718	59	9	eight	eight	NUM
ajlm-1718	59	10	standard	standard	ADJ
ajlm-1718	59	11	dilutions	dilution	NOUN
ajlm-1718	59	12	,	,	PUNCT
ajlm-1718	59	13	one	one	NUM
ajlm-1718	59	14	negative	negative	ADJ
ajlm-1718	59	15	reverse	reverse	ADJ
ajlm-1718	59	16	transcriptase	transcriptase	NOUN
ajlm-1718	59	17	preparation	preparation	NOUN
ajlm-1718	59	18	,	,	PUNCT
ajlm-1718	59	19	one	one	NUM
ajlm-1718	59	20	non	non	ADJ
ajlm-1718	59	21	-	-	ADJ
ajlm-1718	59	22	template	template	ADJ
ajlm-1718	59	23	control	control	NOUN
ajlm-1718	59	24	containing	contain	VERB
ajlm-1718	59	25	ddh2o	ddh2o	NOUN
ajlm-1718	59	26	and	and	CCONJ
ajlm-1718	59	27	duplicates	duplicate	NOUN
ajlm-1718	59	28	or	or	CCONJ
ajlm-1718	59	29	triplicates	triplicate	NOUN
ajlm-1718	59	30	of	of	ADP
ajlm-1718	59	31	each	each	DET
ajlm-1718	59	32	experimental	experimental	ADJ
ajlm-1718	59	33	dna	dna	PROPN
ajlm-1718	59	34	template	template	NOUN
ajlm-1718	59	35	.	.	PUNCT
ajlm-1718	60	1	the	the	DET
ajlm-1718	60	2	standard	standard	NOUN
ajlm-1718	60	3	used	use	VERB
ajlm-1718	60	4	for	for	ADP
ajlm-1718	60	5	pcr	pcr	NOUN
ajlm-1718	60	6	had	have	VERB
ajlm-1718	60	7	5	5	NUM
ajlm-1718	60	8	×	×	NOUN
ajlm-1718	60	9	106	106	NUM
ajlm-1718	60	10	(	(	PUNCT
ajlm-1718	60	11	5e6	5e6	NUM
ajlm-1718	60	12	)	)	PUNCT
ajlm-1718	60	13	virus	virus	NOUN
ajlm-1718	60	14	copies	copy	NOUN
ajlm-1718	60	15	(	(	PUNCT
ajlm-1718	60	16	obtained	obtain	VERB
ajlm-1718	60	17	from	from	ADP
ajlm-1718	60	18	the	the	DET
ajlm-1718	60	19	virology	virology	NOUN
ajlm-1718	60	20	department	department	NOUN
ajlm-1718	60	21	,	,	PUNCT
ajlm-1718	60	22	umeå	umeå	PROPN
ajlm-1718	60	23	university	university	NOUN
ajlm-1718	60	24	hospital	hospital	NOUN
ajlm-1718	60	25	)	)	PUNCT
ajlm-1718	60	26	.	.	PUNCT
ajlm-1718	61	1	the	the	DET
ajlm-1718	61	2	first	first	ADJ
ajlm-1718	61	3	standard	standard	ADJ
ajlm-1718	61	4	preparation	preparation	NOUN
ajlm-1718	61	5	was	be	AUX
ajlm-1718	61	6	used	use	VERB
ajlm-1718	61	7	without	without	ADP
ajlm-1718	61	8	dilution	dilution	NOUN
ajlm-1718	61	9	,	,	PUNCT
ajlm-1718	61	10	having	have	VERB
ajlm-1718	61	11	a	a	DET
ajlm-1718	61	12	concentration	concentration	NOUN
ajlm-1718	61	13	of	of	ADP
ajlm-1718	61	14	5e6	5e6	NUM
ajlm-1718	61	15	copies	copy	NOUN
ajlm-1718	61	16	,	,	PUNCT
ajlm-1718	61	17	followed	follow	VERB
ajlm-1718	61	18	by	by	ADP
ajlm-1718	61	19	1/10	1/10	NUM
ajlm-1718	61	20	serial	serial	ADJ
ajlm-1718	61	21	dilutions	dilution	NOUN
ajlm-1718	61	22	for	for	ADP
ajlm-1718	61	23	the	the	DET
ajlm-1718	61	24	subsequent	subsequent	ADJ
ajlm-1718	61	25	seven	seven	NUM
ajlm-1718	61	26	preparations	preparation	NOUN
ajlm-1718	61	27	to	to	PART
ajlm-1718	61	28	reach	reach	VERB
ajlm-1718	61	29	final	final	ADJ
ajlm-1718	61	30	concentrations	concentration	NOUN
ajlm-1718	61	31	of	of	ADP
ajlm-1718	61	32	5e5	5e5	NUM
ajlm-1718	61	33	,	,	PUNCT
ajlm-1718	61	34	5e4	5e4	NUM
ajlm-1718	61	35	,	,	PUNCT
ajlm-1718	61	36	5e3	5e3	NUM
ajlm-1718	61	37	,	,	PUNCT
ajlm-1718	61	38	5e2	5e2	NUM
ajlm-1718	61	39	,	,	PUNCT
ajlm-1718	61	40	5e1	5e1	NUM
ajlm-1718	61	41	,	,	PUNCT
ajlm-1718	61	42	5	5	NUM
ajlm-1718	61	43	and	and	CCONJ
ajlm-1718	61	44	1	1	NUM
ajlm-1718	61	45	virus	virus	NOUN
ajlm-1718	61	46	copy	copy	NOUN
ajlm-1718	61	47	.	.	PUNCT
ajlm-1718	62	1	real	real	ADJ
ajlm-1718	62	2	-	-	PUNCT
ajlm-1718	62	3	time	time	NOUN
ajlm-1718	62	4	cycler	cycler	NOUN
ajlm-1718	62	5	thermal	thermal	ADJ
ajlm-1718	62	6	condition	condition	NOUN
ajlm-1718	62	7	was	be	AUX
ajlm-1718	62	8	as	as	SCONJ
ajlm-1718	62	9	follows	follow	VERB
ajlm-1718	62	10	:	:	PUNCT
ajlm-1718	62	11	heating	heat	VERB
ajlm-1718	62	12	at	at	ADP
ajlm-1718	62	13	50	50	NUM
ajlm-1718	62	14	°	°	NOUN
ajlm-1718	62	15	c	c	NOUN
ajlm-1718	62	16	for	for	ADP
ajlm-1718	62	17	2	2	NUM
ajlm-1718	62	18	min	min	NOUN
ajlm-1718	62	19	,	,	PUNCT
ajlm-1718	62	20	initial	initial	ADJ
ajlm-1718	62	21	activation	activation	NOUN
ajlm-1718	62	22	of	of	ADP
ajlm-1718	62	23	hotstartaq	hotstartaq	NOUN
ajlm-1718	62	24	®	®	NOUN
ajlm-1718	62	25	dna	dna	NOUN
ajlm-1718	62	26	polymerase	polymerase	NOUN
ajlm-1718	62	27	(	(	PUNCT
ajlm-1718	62	28	qiagen	qiagen	PROPN
ajlm-1718	62	29	®	®	PROPN
ajlm-1718	62	30	,	,	PUNCT
ajlm-1718	62	31	hilden	hilden	PROPN
ajlm-1718	62	32	,	,	PUNCT
ajlm-1718	62	33	germany	germany	PROPN
ajlm-1718	62	34	)	)	PUNCT
ajlm-1718	62	35	at	at	ADP
ajlm-1718	62	36	95	95	NUM
ajlm-1718	62	37	°	°	ADP
ajlm-1718	62	38	c	c	NOUN
ajlm-1718	62	39	for	for	ADP
ajlm-1718	62	40	10	10	NUM
ajlm-1718	62	41	min	min	NOUN
ajlm-1718	62	42	,	,	PUNCT
ajlm-1718	62	43	denaturation	denaturation	NOUN
ajlm-1718	62	44	at	at	ADP
ajlm-1718	62	45	94	94	NUM
ajlm-1718	62	46	°	°	ADP
ajlm-1718	62	47	c	c	NOUN
ajlm-1718	62	48	for	for	ADP
ajlm-1718	62	49	15	15	NUM
ajlm-1718	62	50	s	s	NOUN
ajlm-1718	62	51	and	and	CCONJ
ajlm-1718	62	52	combined	combined	ADJ
ajlm-1718	62	53	annealing	annealing	NOUN
ajlm-1718	62	54	and	and	CCONJ
ajlm-1718	62	55	extension	extension	NOUN
ajlm-1718	62	56	at	at	ADP
ajlm-1718	62	57	60	60	NUM
ajlm-1718	62	58	°	°	ADP
ajlm-1718	62	59	c	c	NOUN
ajlm-1718	62	60	for	for	ADP
ajlm-1718	62	61	60	60	NUM
ajlm-1718	62	62	s.	s.	PROPN
ajlm-1718	62	63	the	the	DET
ajlm-1718	62	64	cycle	cycle	NOUN
ajlm-1718	62	65	was	be	AUX
ajlm-1718	62	66	repeated	repeat	VERB
ajlm-1718	62	67	45	45	NUM
ajlm-1718	62	68	times	time	NOUN
ajlm-1718	62	69	taking	take	VERB
ajlm-1718	62	70	an	an	DET
ajlm-1718	62	71	approximate	approximate	ADJ
ajlm-1718	62	72	duration	duration	NOUN
ajlm-1718	62	73	of	of	ADP
ajlm-1718	62	74	90	90	NUM
ajlm-1718	62	75	min	min	NOUN
ajlm-1718	62	76	including	include	VERB
ajlm-1718	62	77	generation	generation	NOUN
ajlm-1718	62	78	of	of	ADP
ajlm-1718	62	79	amplification	amplification	NOUN
ajlm-1718	62	80	curve	curve	NOUN
ajlm-1718	62	81	.	.	PUNCT
ajlm-1718	63	1	data	datum	NOUN
ajlm-1718	63	2	were	be	AUX
ajlm-1718	63	3	analysed	analyse	VERB
ajlm-1718	63	4	using	use	VERB
ajlm-1718	63	5	the	the	DET
ajlm-1718	63	6	software	software	NOUN
ajlm-1718	63	7	abi	abi	PROPN
ajlm-1718	63	8	7900ht	7900ht	PROPN
ajlm-1718	63	9	sds	sds	PROPN
ajlm-1718	63	10	plate	plate	NOUN
ajlm-1718	63	11	utility	utility	NOUN
ajlm-1718	63	12	version	version	NOUN
ajlm-1718	63	13	2.4	2.4	NUM
ajlm-1718	63	14	(	(	PUNCT
ajlm-1718	63	15	applied	apply	VERB
ajlm-1718	63	16	biosystems	biosystem	NOUN
ajlm-1718	63	17	®	®	NOUN
ajlm-1718	63	18	)	)	PUNCT
ajlm-1718	63	19	.	.	PUNCT
ajlm-1718	64	1	statistical	statistical	ADJ
ajlm-1718	64	2	analysis	analysis	NOUN
ajlm-1718	64	3	statistical	statistical	ADJ
ajlm-1718	64	4	package	package	NOUN
ajlm-1718	64	5	program	program	NOUN
ajlm-1718	64	6	statistical	statistical	ADJ
ajlm-1718	64	7	package	package	NOUN
ajlm-1718	64	8	for	for	ADP
ajlm-1718	64	9	social	social	ADJ
ajlm-1718	64	10	sciences	science	NOUN
ajlm-1718	64	11	version	version	NOUN
ajlm-1718	64	12	21	21	NUM
ajlm-1718	64	13	(	(	PUNCT
ajlm-1718	64	14	ibm	ibm	PROPN
ajlm-1718	64	15	corp	corp	PROPN
ajlm-1718	64	16	.	.	PROPN
ajlm-1718	64	17	,	,	PUNCT
ajlm-1718	64	18	chicago	chicago	PROPN
ajlm-1718	64	19	,	,	PUNCT
ajlm-1718	64	20	illinois	illinois	PROPN
ajlm-1718	64	21	,	,	PUNCT
ajlm-1718	64	22	united	united	PROPN
ajlm-1718	64	23	states	states	PROPN
ajlm-1718	64	24	)	)	PUNCT
ajlm-1718	64	25	was	be	AUX
ajlm-1718	64	26	used	use	VERB
ajlm-1718	64	27	.	.	PUNCT
ajlm-1718	65	1	categorical	categorical	ADJ
ajlm-1718	65	2	variables	variable	NOUN
ajlm-1718	65	3	were	be	AUX
ajlm-1718	65	4	expressed	express	VERB
ajlm-1718	65	5	in	in	ADP
ajlm-1718	65	6	frequencies	frequency	NOUN
ajlm-1718	65	7	and	and	CCONJ
ajlm-1718	65	8	percentages	percentage	NOUN
ajlm-1718	65	9	and	and	CCONJ
ajlm-1718	65	10	cross	cros	VERB
ajlm-1718	65	11	-	-	ADJ
ajlm-1718	65	12	tabulated	tabulate	VERB
ajlm-1718	65	13	and	and	CCONJ
ajlm-1718	65	14	pearson	pearson	PROPN
ajlm-1718	65	15	chi	chi	PROPN
ajlm-1718	65	16	-	-	PUNCT
ajlm-1718	65	17	square	square	PROPN
ajlm-1718	65	18	tested	test	VERB
ajlm-1718	65	19	for	for	ADP
ajlm-1718	65	20	statistically	statistically	ADV
ajlm-1718	65	21	significant	significant	ADJ
ajlm-1718	65	22	differences	difference	NOUN
ajlm-1718	65	23	under	under	ADP
ajlm-1718	65	24	the	the	DET
ajlm-1718	65	25	0.05	0.05	NUM
ajlm-1718	65	26	level	level	NOUN
ajlm-1718	65	27	.	.	PUNCT
ajlm-1718	66	1	numerical	numerical	ADJ
ajlm-1718	66	2	variables	variable	NOUN
ajlm-1718	66	3	were	be	AUX
ajlm-1718	66	4	described	describe	VERB
ajlm-1718	66	5	using	use	VERB
ajlm-1718	66	6	measures	measure	NOUN
ajlm-1718	66	7	of	of	ADP
ajlm-1718	66	8	central	central	ADJ
ajlm-1718	66	9	tendency	tendency	NOUN
ajlm-1718	66	10	and	and	CCONJ
ajlm-1718	66	11	of	of	ADP
ajlm-1718	66	12	dispersion	dispersion	NOUN
ajlm-1718	66	13	;	;	PUNCT
ajlm-1718	66	14	pearson	pearson	PROPN
ajlm-1718	66	15	’s	’s	PART
ajlm-1718	66	16	correlation	correlation	NOUN
ajlm-1718	66	17	and	and	CCONJ
ajlm-1718	66	18	its	its	PRON
ajlm-1718	66	19	95	95	NUM
ajlm-1718	66	20	%	%	NOUN
ajlm-1718	66	21	confidence	confidence	NOUN
ajlm-1718	66	22	intervals	interval	NOUN
ajlm-1718	66	23	were	be	AUX
ajlm-1718	66	24	calculated	calculate	VERB
ajlm-1718	66	25	.	.	PUNCT
ajlm-1718	67	1	results	result	NOUN
ajlm-1718	67	2	clinical	clinical	ADJ
ajlm-1718	67	3	,	,	PUNCT
ajlm-1718	67	4	demographic	demographic	ADJ
ajlm-1718	67	5	and	and	CCONJ
ajlm-1718	67	6	conventional	conventional	ADJ
ajlm-1718	67	7	laboratory	laboratory	NOUN
ajlm-1718	67	8	findings	finding	NOUN
ajlm-1718	67	9	all	all	PRON
ajlm-1718	67	10	of	of	ADP
ajlm-1718	67	11	the	the	DET
ajlm-1718	67	12	following	following	NOUN
ajlm-1718	67	13	describe	describe	VERB
ajlm-1718	67	14	patients	patient	NOUN
ajlm-1718	67	15	with	with	ADP
ajlm-1718	67	16	positive	positive	ADJ
ajlm-1718	67	17	csf	csf	ADJ
ajlm-1718	67	18	hhv-6	hhv-6	NOUN
ajlm-1718	67	19	dna	dna	NOUN
ajlm-1718	67	20	:	:	PUNCT
ajlm-1718	67	21	all	all	DET
ajlm-1718	67	22	patients	patient	NOUN
ajlm-1718	67	23	with	with	ADP
ajlm-1718	67	24	clinical	clinical	ADJ
ajlm-1718	67	25	data	datum	NOUN
ajlm-1718	67	26	(	(	PUNCT
ajlm-1718	67	27	100	100	NUM
ajlm-1718	67	28	%	%	NOUN
ajlm-1718	67	29	;	;	PUNCT
ajlm-1718	67	30	7/7	7/7	NUM
ajlm-1718	67	31	;	;	PUNCT
ajlm-1718	67	32	six	six	NUM
ajlm-1718	67	33	cases	case	NOUN
ajlm-1718	67	34	out	out	ADP
ajlm-1718	67	35	of	of	ADP
ajlm-1718	67	36	a	a	DET
ajlm-1718	67	37	total	total	NOUN
ajlm-1718	67	38	of	of	ADP
ajlm-1718	67	39	13	13	NUM
ajlm-1718	67	40	had	have	AUX
ajlm-1718	67	41	missing	miss	VERB
ajlm-1718	67	42	clinical	clinical	ADJ
ajlm-1718	67	43	data	datum	NOUN
ajlm-1718	67	44	)	)	PUNCT
ajlm-1718	67	45	presented	present	VERB
ajlm-1718	67	46	with	with	ADP
ajlm-1718	67	47	fever	fever	NOUN
ajlm-1718	67	48	(	(	PUNCT
ajlm-1718	67	49	˃	˃	NOUN
ajlm-1718	67	50	37	37	NUM
ajlm-1718	67	51	°	°	NOUN
ajlm-1718	67	52	c	c	NOUN
ajlm-1718	67	53	)	)	PUNCT
ajlm-1718	67	54	and	and	CCONJ
ajlm-1718	67	55	vomiting	vomiting	NOUN
ajlm-1718	67	56	and	and	CCONJ
ajlm-1718	67	57	six	six	NUM
ajlm-1718	67	58	(	(	PUNCT
ajlm-1718	67	59	86	86	NUM
ajlm-1718	67	60	%	%	NOUN
ajlm-1718	67	61	)	)	PUNCT
ajlm-1718	67	62	with	with	ADP
ajlm-1718	67	63	seizures	seizure	NOUN
ajlm-1718	67	64	(	(	PUNCT
ajlm-1718	67	65	figure	figure	NOUN
ajlm-1718	67	66	2	2	NUM
ajlm-1718	67	67	)	)	PUNCT
ajlm-1718	67	68	.	.	PUNCT
ajlm-1718	68	1	for	for	ADP
ajlm-1718	68	2	the	the	DET
ajlm-1718	68	3	12	12	NUM
ajlm-1718	68	4	patients	patient	NOUN
ajlm-1718	68	5	with	with	ADP
ajlm-1718	68	6	available	available	ADJ
ajlm-1718	68	7	demographic	demographic	ADJ
ajlm-1718	68	8	data	datum	NOUN
ajlm-1718	68	9	,	,	PUNCT
ajlm-1718	68	10	the	the	DET
ajlm-1718	68	11	male	male	NOUN
ajlm-1718	68	12	-	-	PUNCT
ajlm-1718	68	13	to	to	ADP
ajlm-1718	68	14	-	-	PUNCT
ajlm-1718	68	15	female	female	ADJ
ajlm-1718	68	16	ratio	ratio	NOUN
ajlm-1718	68	17	was	be	AUX
ajlm-1718	68	18	1:1	1:1	NUM
ajlm-1718	68	19	(	(	PUNCT
ajlm-1718	68	20	figure	figure	NOUN
ajlm-1718	68	21	2	2	NUM
ajlm-1718	68	22	)	)	PUNCT
ajlm-1718	68	23	.	.	PUNCT
ajlm-1718	69	1	figure	figure	VERB
ajlm-1718	69	2	2	2	NUM
ajlm-1718	69	3	:	:	PUNCT
ajlm-1718	69	4	demographic	demographic	ADJ
ajlm-1718	69	5	,	,	PUNCT
ajlm-1718	69	6	clinical	clinical	ADJ
ajlm-1718	69	7	and	and	CCONJ
ajlm-1718	69	8	conventional	conventional	ADJ
ajlm-1718	69	9	laboratory	laboratory	NOUN
ajlm-1718	69	10	data	datum	NOUN
ajlm-1718	69	11	for	for	ADP
ajlm-1718	69	12	human	human	ADJ
ajlm-1718	69	13	herpes	herpe	NOUN
ajlm-1718	69	14	virus	virus	NOUN
ajlm-1718	69	15	type-6	type-6	PROPN
ajlm-1718	69	16	positive	positive	ADJ
ajlm-1718	69	17	patients	patient	NOUN
ajlm-1718	69	18	,	,	PUNCT
ajlm-1718	69	19	khartoum	khartoum	PROPN
ajlm-1718	69	20	,	,	PUNCT
ajlm-1718	69	21	sudan	sudan	PROPN
ajlm-1718	69	22	,	,	PUNCT
ajlm-1718	69	23	december	december	PROPN
ajlm-1718	69	24	2009	2009	NUM
ajlm-1718	69	25	–	–	PUNCT
ajlm-1718	69	26	august	august	PROPN
ajlm-1718	69	27	2010	2010	NUM
ajlm-1718	69	28	.	.	PUNCT
ajlm-1718	70	1	half	half	NOUN
ajlm-1718	70	2	of	of	ADP
ajlm-1718	70	3	the	the	DET
ajlm-1718	70	4	patients	patient	NOUN
ajlm-1718	70	5	were	be	AUX
ajlm-1718	70	6	toddlers	toddler	NOUN
ajlm-1718	70	7	,	,	PUNCT
ajlm-1718	70	8	followed	follow	VERB
ajlm-1718	70	9	by	by	ADP
ajlm-1718	70	10	42	42	NUM
ajlm-1718	70	11	%	%	NOUN
ajlm-1718	70	12	(	(	PUNCT
ajlm-1718	70	13	5/12	5/12	NUM
ajlm-1718	70	14	;	;	PUNCT
ajlm-1718	70	15	1	1	NUM
ajlm-1718	70	16	missing	missing	ADJ
ajlm-1718	70	17	case	case	NOUN
ajlm-1718	70	18	)	)	PUNCT
ajlm-1718	70	19	infants	infant	NOUN
ajlm-1718	70	20	and	and	CCONJ
ajlm-1718	70	21	8	8	NUM
ajlm-1718	70	22	%	%	NOUN
ajlm-1718	70	23	(	(	PUNCT
ajlm-1718	70	24	1/12	1/12	NUM
ajlm-1718	70	25	)	)	PUNCT
ajlm-1718	70	26	a	a	DET
ajlm-1718	70	27	15	15	NUM
ajlm-1718	70	28	-	-	PUNCT
ajlm-1718	70	29	year	year	NOUN
ajlm-1718	70	30	-	-	PUNCT
ajlm-1718	70	31	old	old	ADJ
ajlm-1718	70	32	teenager	teenager	NOUN
ajlm-1718	70	33	.	.	PUNCT
ajlm-1718	71	1	most	most	ADJ
ajlm-1718	71	2	patients	patient	NOUN
ajlm-1718	71	3	(	(	PUNCT
ajlm-1718	71	4	83	83	NUM
ajlm-1718	71	5	%	%	NOUN
ajlm-1718	71	6	;	;	PUNCT
ajlm-1718	71	7	10/12	10/12	NUM
ajlm-1718	71	8	)	)	PUNCT
ajlm-1718	71	9	were	be	AUX
ajlm-1718	71	10	admitted	admit	VERB
ajlm-1718	71	11	to	to	ADP
ajlm-1718	71	12	the	the	DET
ajlm-1718	71	13	hospital	hospital	NOUN
ajlm-1718	71	14	in	in	ADP
ajlm-1718	71	15	the	the	DET
ajlm-1718	71	16	dry	dry	ADJ
ajlm-1718	71	17	season	season	NOUN
ajlm-1718	71	18	(	(	PUNCT
ajlm-1718	71	19	december	december	PROPN
ajlm-1718	71	20	to	to	ADP
ajlm-1718	71	21	june	june	PROPN
ajlm-1718	71	22	)	)	PUNCT
ajlm-1718	71	23	and	and	CCONJ
ajlm-1718	71	24	the	the	DET
ajlm-1718	71	25	remaining	remain	VERB
ajlm-1718	71	26	17	17	NUM
ajlm-1718	71	27	%	%	NOUN
ajlm-1718	71	28	(	(	PUNCT
ajlm-1718	71	29	2/12	2/12	NUM
ajlm-1718	71	30	)	)	PUNCT
ajlm-1718	71	31	admitted	admit	VERB
ajlm-1718	71	32	in	in	ADP
ajlm-1718	71	33	the	the	DET
ajlm-1718	71	34	rainy	rainy	ADJ
ajlm-1718	71	35	season	season	NOUN
ajlm-1718	71	36	(	(	PUNCT
ajlm-1718	71	37	july	july	PROPN
ajlm-1718	71	38	to	to	ADP
ajlm-1718	71	39	august	august	PROPN
ajlm-1718	71	40	)	)	PUNCT
ajlm-1718	71	41	.	.	PUNCT
ajlm-1718	72	1	cerebrospinal	cerebrospinal	ADJ
ajlm-1718	72	2	fluid	fluid	NOUN
ajlm-1718	72	3	specimens	specimen	NOUN
ajlm-1718	72	4	from	from	ADP
ajlm-1718	72	5	42	42	NUM
ajlm-1718	72	6	%	%	NOUN
ajlm-1718	72	7	(	(	PUNCT
ajlm-1718	72	8	5/12	5/12	NOUN
ajlm-1718	72	9	)	)	PUNCT
ajlm-1718	72	10	were	be	AUX
ajlm-1718	72	11	traumatic	traumatic	ADJ
ajlm-1718	72	12	;	;	PUNCT
ajlm-1718	72	13	cytological	cytological	ADJ
ajlm-1718	72	14	and	and	CCONJ
ajlm-1718	72	15	chemical	chemical	NOUN
ajlm-1718	72	16	analyses	analysis	NOUN
ajlm-1718	72	17	were	be	AUX
ajlm-1718	72	18	not	not	PART
ajlm-1718	72	19	performed	perform	VERB
ajlm-1718	72	20	.	.	PUNCT
ajlm-1718	73	1	the	the	DET
ajlm-1718	73	2	remaining	remain	VERB
ajlm-1718	73	3	58	58	NUM
ajlm-1718	73	4	%	%	NOUN
ajlm-1718	73	5	(	(	PUNCT
ajlm-1718	73	6	7/12	7/12	NUM
ajlm-1718	73	7	)	)	PUNCT
ajlm-1718	73	8	were	be	AUX
ajlm-1718	73	9	clear	clear	ADJ
ajlm-1718	73	10	;	;	PUNCT
ajlm-1718	73	11	33	33	NUM
ajlm-1718	73	12	%	%	NOUN
ajlm-1718	73	13	(	(	PUNCT
ajlm-1718	73	14	1/7	1/7	NUM
ajlm-1718	73	15	)	)	PUNCT
ajlm-1718	73	16	showed	show	VERB
ajlm-1718	73	17	increased	increase	VERB
ajlm-1718	73	18	csf	csf	ADJ
ajlm-1718	73	19	white	white	ADJ
ajlm-1718	73	20	blood	blood	NOUN
ajlm-1718	73	21	cells	cell	NOUN
ajlm-1718	73	22	(	(	PUNCT
ajlm-1718	73	23	50	50	NUM
ajlm-1718	73	24	cells	cell	NOUN
ajlm-1718	73	25	/	/	SYM
ajlm-1718	73	26	mm3	mm3	NOUN
ajlm-1718	73	27	)	)	PUNCT
ajlm-1718	73	28	with	with	ADP
ajlm-1718	73	29	60	60	NUM
ajlm-1718	73	30	%	%	NOUN
ajlm-1718	73	31	lymphocytosis	lymphocytosis	NOUN
ajlm-1718	73	32	and	and	CCONJ
ajlm-1718	73	33	the	the	DET
ajlm-1718	73	34	remaining	remain	VERB
ajlm-1718	73	35	67	67	NUM
ajlm-1718	73	36	%	%	NOUN
ajlm-1718	73	37	(	(	PUNCT
ajlm-1718	73	38	6/7	6/7	NUM
ajlm-1718	73	39	)	)	PUNCT
ajlm-1718	73	40	showed	show	VERB
ajlm-1718	73	41	normal	normal	ADJ
ajlm-1718	73	42	csf	csf	ADJ
ajlm-1718	73	43	white	white	ADJ
ajlm-1718	73	44	blood	blood	NOUN
ajlm-1718	73	45	cell	cell	NOUN
ajlm-1718	73	46	count	count	NOUN
ajlm-1718	73	47	(	(	PUNCT
ajlm-1718	73	48	<	<	X
ajlm-1718	73	49	5	5	NUM
ajlm-1718	73	50	cells	cell	NOUN
ajlm-1718	73	51	/	/	SYM
ajlm-1718	73	52	mm3	mm3	NOUN
ajlm-1718	73	53	)	)	PUNCT
ajlm-1718	73	54	.	.	PUNCT
ajlm-1718	74	1	cerebrospinal	cerebrospinal	ADJ
ajlm-1718	74	2	fluid	fluid	NOUN
ajlm-1718	74	3	glucose	glucose	NOUN
ajlm-1718	74	4	levels	level	NOUN
ajlm-1718	74	5	for	for	ADP
ajlm-1718	74	6	most	most	ADJ
ajlm-1718	74	7	specimens	specimen	NOUN
ajlm-1718	74	8	(	(	PUNCT
ajlm-1718	74	9	86	86	NUM
ajlm-1718	74	10	%	%	NOUN
ajlm-1718	74	11	;	;	PUNCT
ajlm-1718	74	12	6/7	6/7	NUM
ajlm-1718	74	13	)	)	PUNCT
ajlm-1718	74	14	were	be	AUX
ajlm-1718	74	15	normal	normal	ADJ
ajlm-1718	74	16	(	(	PUNCT
ajlm-1718	74	17	45	45	NUM
ajlm-1718	74	18	mg	mg	PROPN
ajlm-1718	74	19	/	/	SYM
ajlm-1718	74	20	dl	dl	PROPN
ajlm-1718	74	21	–	–	PUNCT
ajlm-1718	74	22	100	100	NUM
ajlm-1718	74	23	mg	mg	PROPN
ajlm-1718	74	24	/	/	SYM
ajlm-1718	74	25	dl	dl	PROPN
ajlm-1718	74	26	)	)	PUNCT
ajlm-1718	74	27	and	and	CCONJ
ajlm-1718	74	28	one	one	NUM
ajlm-1718	74	29	specimen	speciman	NOUN
ajlm-1718	74	30	(	(	PUNCT
ajlm-1718	74	31	14	14	NUM
ajlm-1718	74	32	%	%	NOUN
ajlm-1718	74	33	)	)	PUNCT
ajlm-1718	74	34	was	be	AUX
ajlm-1718	74	35	low	low	ADJ
ajlm-1718	74	36	(	(	PUNCT
ajlm-1718	74	37	30	30	NUM
ajlm-1718	74	38	mg	mg	PROPN
ajlm-1718	74	39	/	/	SYM
ajlm-1718	74	40	dl	dl	NOUN
ajlm-1718	74	41	)	)	PUNCT
ajlm-1718	74	42	.	.	PUNCT
ajlm-1718	75	1	cerebrospinal	cerebrospinal	ADJ
ajlm-1718	75	2	fluid	fluid	ADJ
ajlm-1718	75	3	proteins	protein	NOUN
ajlm-1718	75	4	levels	level	NOUN
ajlm-1718	75	5	were	be	AUX
ajlm-1718	75	6	high	high	ADJ
ajlm-1718	75	7	(	(	PUNCT
ajlm-1718	75	8	>	>	X
ajlm-1718	75	9	45	45	NUM
ajlm-1718	75	10	mg	mg	PROPN
ajlm-1718	75	11	/	/	SYM
ajlm-1718	75	12	dl	dl	NOUN
ajlm-1718	75	13	)	)	PUNCT
ajlm-1718	75	14	in	in	ADP
ajlm-1718	75	15	43	43	NUM
ajlm-1718	75	16	%	%	NOUN
ajlm-1718	75	17	(	(	PUNCT
ajlm-1718	75	18	3/7	3/7	NUM
ajlm-1718	75	19	)	)	PUNCT
ajlm-1718	75	20	,	,	PUNCT
ajlm-1718	75	21	normal	normal	ADJ
ajlm-1718	75	22	(	(	PUNCT
ajlm-1718	75	23	14	14	NUM
ajlm-1718	75	24	mg	mg	PROPN
ajlm-1718	75	25	/	/	SYM
ajlm-1718	75	26	dl	dl	PROPN
ajlm-1718	75	27	–	–	PUNCT
ajlm-1718	75	28	45	45	NUM
ajlm-1718	75	29	mg	mg	PROPN
ajlm-1718	75	30	/	/	SYM
ajlm-1718	75	31	dl	dl	PROPN
ajlm-1718	75	32	)	)	PUNCT
ajlm-1718	75	33	in	in	ADP
ajlm-1718	75	34	43	43	NUM
ajlm-1718	75	35	%	%	NOUN
ajlm-1718	75	36	(	(	PUNCT
ajlm-1718	75	37	3/7	3/7	NUM
ajlm-1718	75	38	)	)	PUNCT
ajlm-1718	75	39	and	and	CCONJ
ajlm-1718	75	40	low	low	ADJ
ajlm-1718	75	41	(	(	PUNCT
ajlm-1718	75	42	11	11	NUM
ajlm-1718	75	43	mg	mg	PROPN
ajlm-1718	75	44	/	/	SYM
ajlm-1718	75	45	dl	dl	NOUN
ajlm-1718	75	46	)	)	PUNCT
ajlm-1718	75	47	in	in	ADP
ajlm-1718	75	48	14	14	NUM
ajlm-1718	75	49	%	%	NOUN
ajlm-1718	75	50	(	(	PUNCT
ajlm-1718	75	51	1/7	1/7	NUM
ajlm-1718	75	52	)	)	PUNCT
ajlm-1718	75	53	(	(	PUNCT
ajlm-1718	75	54	figure	figure	NOUN
ajlm-1718	75	55	2	2	NUM
ajlm-1718	75	56	)	)	PUNCT
ajlm-1718	75	57	.	.	PUNCT
ajlm-1718	76	1	all	all	DET
ajlm-1718	76	2	13	13	NUM
ajlm-1718	76	3	hhv-6	hhv-6	NUM
ajlm-1718	76	4	positive	positive	ADJ
ajlm-1718	76	5	cases	case	NOUN
ajlm-1718	76	6	did	do	AUX
ajlm-1718	76	7	not	not	PART
ajlm-1718	76	8	show	show	VERB
ajlm-1718	76	9	evidence	evidence	NOUN
ajlm-1718	76	10	of	of	ADP
ajlm-1718	76	11	rapid	rapid	ADJ
ajlm-1718	76	12	-	-	PUNCT
ajlm-1718	76	13	growing	grow	VERB
ajlm-1718	76	14	-	-	PUNCT
ajlm-1718	76	15	bacteria	bacteria	NOUN
ajlm-1718	76	16	coexisting	coexisting	NOUN
ajlm-1718	76	17	in	in	ADP
ajlm-1718	76	18	csf	csf	NOUN
ajlm-1718	76	19	on	on	ADP
ajlm-1718	76	20	gram	gram	PROPN
ajlm-1718	76	21	’s	’s	PART
ajlm-1718	76	22	stain	stain	NOUN
ajlm-1718	76	23	and	and	CCONJ
ajlm-1718	76	24	in	in	ADP
ajlm-1718	76	25	vitro	vitro	X
ajlm-1718	76	26	bacterial	bacterial	ADJ
ajlm-1718	76	27	culture	culture	NOUN
ajlm-1718	76	28	.	.	PUNCT
ajlm-1718	77	1	however	however	ADV
ajlm-1718	77	2	,	,	PUNCT
ajlm-1718	77	3	23	23	NUM
ajlm-1718	77	4	%	%	NOUN
ajlm-1718	77	5	(	(	PUNCT
ajlm-1718	77	6	3/13	3/13	NOUN
ajlm-1718	77	7	)	)	PUNCT
ajlm-1718	77	8	were	be	AUX
ajlm-1718	77	9	positive	positive	ADJ
ajlm-1718	77	10	for	for	ADP
ajlm-1718	77	11	other	other	ADJ
ajlm-1718	77	12	non	non	ADJ
ajlm-1718	77	13	-	-	ADJ
ajlm-1718	77	14	cultivable	cultivable	ADJ
ajlm-1718	77	15	microbes	microbe	NOUN
ajlm-1718	77	16	.	.	PUNCT
ajlm-1718	78	1	all	all	DET
ajlm-1718	78	2	patients	patient	NOUN
ajlm-1718	78	3	(	(	PUNCT
ajlm-1718	78	4	100	100	NUM
ajlm-1718	78	5	%	%	NOUN
ajlm-1718	78	6	;	;	PUNCT
ajlm-1718	78	7	7/7	7/7	NUM
ajlm-1718	78	8	)	)	PUNCT
ajlm-1718	78	9	recovered	recover	VERB
ajlm-1718	78	10	and	and	CCONJ
ajlm-1718	78	11	were	be	AUX
ajlm-1718	78	12	discharged	discharge	VERB
ajlm-1718	78	13	.	.	PUNCT
ajlm-1718	79	1	real	real	ADJ
ajlm-1718	79	2	-	-	PUNCT
ajlm-1718	79	3	time	time	NOUN
ajlm-1718	79	4	polymerase	polymerase	NOUN
ajlm-1718	79	5	chain	chain	NOUN
ajlm-1718	79	6	reaction	reaction	NOUN
ajlm-1718	79	7	findings	finding	VERB
ajlm-1718	79	8	polymerase	polymerase	NOUN
ajlm-1718	79	9	chain	chain	NOUN
ajlm-1718	79	10	reaction	reaction	NOUN
ajlm-1718	79	11	testing	testing	NOUN
ajlm-1718	79	12	for	for	ADP
ajlm-1718	79	13	hhv-6	hhv-6	SYM
ajlm-1718	79	14	dna	dna	NOUN
ajlm-1718	79	15	in	in	ADP
ajlm-1718	79	16	csf	csf	NOUN
ajlm-1718	79	17	revealed	reveal	VERB
ajlm-1718	79	18	13	13	NUM
ajlm-1718	79	19	(	(	PUNCT
ajlm-1718	79	20	2.6	2.6	NUM
ajlm-1718	79	21	%	%	NOUN
ajlm-1718	79	22	)	)	PUNCT
ajlm-1718	79	23	positive	positive	ADJ
ajlm-1718	79	24	specimens	specimen	NOUN
ajlm-1718	79	25	out	out	ADP
ajlm-1718	79	26	of	of	ADP
ajlm-1718	79	27	a	a	DET
ajlm-1718	79	28	total	total	NOUN
ajlm-1718	79	29	of	of	ADP
ajlm-1718	79	30	503	503	NUM
ajlm-1718	79	31	.	.	PUNCT
ajlm-1718	80	1	median	median	ADJ
ajlm-1718	80	2	cycle	cycle	NOUN
ajlm-1718	80	3	threshold	threshold	NOUN
ajlm-1718	80	4	(	(	PUNCT
ajlm-1718	80	5	ct	ct	NOUN
ajlm-1718	80	6	)	)	PUNCT
ajlm-1718	80	7	for	for	ADP
ajlm-1718	80	8	all	all	DET
ajlm-1718	80	9	hhv-6	hhv-6	ADJ
ajlm-1718	80	10	positive	positive	ADJ
ajlm-1718	80	11	specimens	specimen	NOUN
ajlm-1718	80	12	was	be	AUX
ajlm-1718	80	13	38	38	NUM
ajlm-1718	80	14	with	with	ADP
ajlm-1718	80	15	a	a	DET
ajlm-1718	80	16	range	range	NOUN
ajlm-1718	80	17	of	of	ADP
ajlm-1718	80	18	31.9	31.9	NUM
ajlm-1718	80	19	to	to	PART
ajlm-1718	80	20	40.8	40.8	NUM
ajlm-1718	80	21	.	.	PUNCT
ajlm-1718	81	1	median	median	ADJ
ajlm-1718	81	2	virus	virus	NOUN
ajlm-1718	81	3	copy	copy	NOUN
ajlm-1718	81	4	was	be	AUX
ajlm-1718	81	5	281.3	281.3	NUM
ajlm-1718	81	6	per	per	ADP
ajlm-1718	81	7	pcr	pcr	ADJ
ajlm-1718	81	8	run	run	NOUN
ajlm-1718	81	9	(	(	PUNCT
ajlm-1718	81	10	1	1	NUM
ajlm-1718	81	11	×	×	NOUN
ajlm-1718	81	12	105	105	NUM
ajlm-1718	81	13	virus	virus	NOUN
ajlm-1718	81	14	copies	copy	NOUN
ajlm-1718	81	15	/	/	SYM
ajlm-1718	81	16	ml	ml	X
ajlm-1718	81	17	csf	csf	NOUN
ajlm-1718	81	18	)	)	PUNCT
ajlm-1718	81	19	with	with	ADP
ajlm-1718	81	20	a	a	DET
ajlm-1718	81	21	range	range	NOUN
ajlm-1718	81	22	of	of	ADP
ajlm-1718	81	23	30	30	NUM
ajlm-1718	81	24	to	to	PART
ajlm-1718	81	25	44	44	NUM
ajlm-1718	81	26	×	×	NOUN
ajlm-1718	81	27	103	103	NUM
ajlm-1718	81	28	copies	copy	NOUN
ajlm-1718	81	29	per	per	ADP
ajlm-1718	81	30	pcr	pcr	ADJ
ajlm-1718	81	31	run	run	NOUN
ajlm-1718	81	32	(	(	PUNCT
ajlm-1718	81	33	12	12	NUM
ajlm-1718	81	34	×	×	NOUN
ajlm-1718	81	35	103	103	NUM
ajlm-1718	81	36	and	and	CCONJ
ajlm-1718	81	37	18	18	NUM
ajlm-1718	81	38	×	×	NOUN
ajlm-1718	81	39	106	106	NUM
ajlm-1718	81	40	virus	virus	NOUN
ajlm-1718	81	41	copies	copy	NOUN
ajlm-1718	81	42	/	/	SYM
ajlm-1718	81	43	ml	ml	X
ajlm-1718	81	44	csf	csf	NOUN
ajlm-1718	81	45	)	)	PUNCT
ajlm-1718	81	46	.	.	PUNCT
ajlm-1718	82	1	individual	individual	ADJ
ajlm-1718	82	2	pcr	pcr	PROPN
ajlm-1718	82	3	data	datum	NOUN
ajlm-1718	82	4	for	for	ADP
ajlm-1718	82	5	all	all	DET
ajlm-1718	82	6	13	13	NUM
ajlm-1718	82	7	positive	positive	ADJ
ajlm-1718	82	8	specimens	specimen	NOUN
ajlm-1718	82	9	are	be	AUX
ajlm-1718	82	10	shown	show	VERB
ajlm-1718	82	11	in	in	ADP
ajlm-1718	82	12	table	table	NOUN
ajlm-1718	82	13	1	1	NUM
ajlm-1718	82	14	.	.	PUNCT
ajlm-1718	82	15	standard	standard	ADJ
ajlm-1718	82	16	dilutions	dilution	NOUN
ajlm-1718	82	17	with	with	ADP
ajlm-1718	82	18	viral	viral	ADJ
ajlm-1718	82	19	copies	copy	NOUN
ajlm-1718	82	20	of	of	ADP
ajlm-1718	82	21	5e6	5e6	NUM
ajlm-1718	82	22	to	to	ADP
ajlm-1718	82	23	5e2	5e2	NUM
ajlm-1718	82	24	produced	produce	VERB
ajlm-1718	82	25	amplification	amplification	NOUN
ajlm-1718	82	26	curves	curve	NOUN
ajlm-1718	82	27	between	between	ADP
ajlm-1718	82	28	ct	ct	PROPN
ajlm-1718	82	29	24	24	NUM
ajlm-1718	82	30	and	and	CCONJ
ajlm-1718	82	31	ct	ct	NUM
ajlm-1718	82	32	36	36	NUM
ajlm-1718	82	33	.	.	PUNCT
ajlm-1718	83	1	the	the	DET
ajlm-1718	83	2	generated	generate	VERB
ajlm-1718	83	3	standard	standard	ADJ
ajlm-1718	83	4	curve	curve	NOUN
ajlm-1718	83	5	plot	plot	NOUN
ajlm-1718	83	6	showed	show	VERB
ajlm-1718	83	7	perfect	perfect	ADJ
ajlm-1718	83	8	negative	negative	ADJ
ajlm-1718	83	9	association	association	NOUN
ajlm-1718	83	10	between	between	ADP
ajlm-1718	83	11	ct	ct	PROPN
ajlm-1718	83	12	and	and	CCONJ
ajlm-1718	83	13	viral	viral	ADJ
ajlm-1718	83	14	quantity	quantity	NOUN
ajlm-1718	83	15	.	.	PUNCT
ajlm-1718	84	1	this	this	PRON
ajlm-1718	84	2	was	be	AUX
ajlm-1718	84	3	repeatable	repeatable	ADJ
ajlm-1718	84	4	in	in	ADP
ajlm-1718	84	5	all	all	DET
ajlm-1718	84	6	pcr	pcr	ADJ
ajlm-1718	84	7	runs	run	NOUN
ajlm-1718	84	8	.	.	PUNCT
ajlm-1718	85	1	table	table	NOUN
ajlm-1718	85	2	1	1	NUM
ajlm-1718	85	3	:	:	PUNCT
ajlm-1718	85	4	 	 	SPACE
ajlm-1718	85	5	thermal	thermal	ADJ
ajlm-1718	85	6	cycle	cycle	NOUN
ajlm-1718	85	7	and	and	CCONJ
ajlm-1718	85	8	virus	virus	NOUN
ajlm-1718	85	9	load	load	NOUN
ajlm-1718	85	10	for	for	ADP
ajlm-1718	85	11	human	human	ADJ
ajlm-1718	85	12	herpes	herpe	NOUN
ajlm-1718	85	13	virus	virus	NOUN
ajlm-1718	85	14	type-6	type-6	PROPN
ajlm-1718	85	15	positive	positive	ADJ
ajlm-1718	85	16	individual	individual	ADJ
ajlm-1718	85	17	cerebrospinal	cerebrospinal	ADJ
ajlm-1718	85	18	fluid	fluid	NOUN
ajlm-1718	85	19	specimens	specimen	NOUN
ajlm-1718	85	20	using	use	VERB
ajlm-1718	85	21	quantitative	quantitative	ADJ
ajlm-1718	85	22	taqman	taqman	NOUN
ajlm-1718	85	23	real	real	ADJ
ajlm-1718	85	24	-	-	PUNCT
ajlm-1718	85	25	time	time	NOUN
ajlm-1718	85	26	polymerase	polymerase	NOUN
ajlm-1718	85	27	chain	chain	NOUN
ajlm-1718	85	28	reaction	reaction	NOUN
ajlm-1718	85	29	,	,	PUNCT
ajlm-1718	85	30	khartoum	khartoum	PROPN
ajlm-1718	85	31	,	,	PUNCT
ajlm-1718	85	32	sudan	sudan	PROPN
ajlm-1718	85	33	,	,	PUNCT
ajlm-1718	85	34	december	december	PROPN
ajlm-1718	85	35	2009	2009	NUM
ajlm-1718	85	36	–	–	PUNCT
ajlm-1718	85	37	august	august	PROPN
ajlm-1718	85	38	2010	2010	NUM
ajlm-1718	85	39	.	.	PUNCT
ajlm-1718	86	1	the	the	DET
ajlm-1718	86	2	final	final	ADJ
ajlm-1718	86	3	classification	classification	NOUN
ajlm-1718	86	4	of	of	ADP
ajlm-1718	86	5	cases	case	NOUN
ajlm-1718	86	6	based	base	VERB
ajlm-1718	86	7	on	on	ADP
ajlm-1718	86	8	clinical	clinical	ADJ
ajlm-1718	86	9	and	and	CCONJ
ajlm-1718	86	10	molecular	molecular	ADJ
ajlm-1718	86	11	findings	finding	NOUN
ajlm-1718	86	12	is	be	AUX
ajlm-1718	86	13	shown	show	VERB
ajlm-1718	86	14	in	in	ADP
ajlm-1718	86	15	table	table	NOUN
ajlm-1718	86	16	2	2	NUM
ajlm-1718	86	17	.	.	PUNCT
ajlm-1718	86	18	table	table	NOUN
ajlm-1718	86	19	2	2	NUM
ajlm-1718	86	20	:	:	PUNCT
ajlm-1718	86	21	 	 	SPACE
ajlm-1718	86	22	classification	classification	NOUN
ajlm-1718	86	23	of	of	ADP
ajlm-1718	86	24	cases	case	NOUN
ajlm-1718	86	25	based	base	VERB
ajlm-1718	86	26	on	on	ADP
ajlm-1718	86	27	clinical	clinical	ADJ
ajlm-1718	86	28	and	and	CCONJ
ajlm-1718	86	29	molecular	molecular	ADJ
ajlm-1718	86	30	findings	finding	NOUN
ajlm-1718	86	31	,	,	PUNCT
ajlm-1718	86	32	khartoum	khartoum	PROPN
ajlm-1718	86	33	,	,	PUNCT
ajlm-1718	86	34	sudan	sudan	PROPN
ajlm-1718	86	35	,	,	PUNCT
ajlm-1718	86	36	december	december	PROPN
ajlm-1718	86	37	2009	2009	NUM
ajlm-1718	86	38	–	–	PUNCT
ajlm-1718	86	39	august	august	PROPN
ajlm-1718	86	40	2010	2010	NUM
ajlm-1718	86	41	.	.	PUNCT
ajlm-1718	87	1	discussion	discussion	NOUN
ajlm-1718	87	2	human	human	ADJ
ajlm-1718	87	3	herpes	herpe	NOUN
ajlm-1718	87	4	virus	virus	NOUN
ajlm-1718	87	5	type-6	type-6	PROPN
ajlm-1718	87	6	is	be	AUX
ajlm-1718	87	7	becoming	becoming	AUX
ajlm-1718	87	8	increasingly	increasingly	ADV
ajlm-1718	87	9	recognised	recognise	VERB
ajlm-1718	87	10	as	as	ADP
ajlm-1718	87	11	an	an	DET
ajlm-1718	87	12	emerging	emerge	VERB
ajlm-1718	87	13	cns	cns	NOUN
ajlm-1718	87	14	pathogen	pathogen	NOUN
ajlm-1718	87	15	;	;	PUNCT
ajlm-1718	87	16	nevertheless	nevertheless	ADV
ajlm-1718	87	17	,	,	PUNCT
ajlm-1718	87	18	it	it	PRON
ajlm-1718	87	19	has	have	AUX
ajlm-1718	87	20	never	never	ADV
ajlm-1718	87	21	been	be	AUX
ajlm-1718	87	22	investigated	investigate	VERB
ajlm-1718	87	23	in	in	ADP
ajlm-1718	87	24	sudan	sudan	PROPN
ajlm-1718	87	25	and	and	CCONJ
ajlm-1718	87	26	very	very	ADV
ajlm-1718	87	27	little	little	ADJ
ajlm-1718	87	28	is	be	AUX
ajlm-1718	87	29	known	know	VERB
ajlm-1718	87	30	about	about	ADP
ajlm-1718	87	31	it	it	PRON
ajlm-1718	87	32	in	in	ADP
ajlm-1718	87	33	sub	sub	ADJ
ajlm-1718	87	34	-	-	ADJ
ajlm-1718	87	35	saharan	saharan	ADJ
ajlm-1718	87	36	african	african	ADJ
ajlm-1718	87	37	countries	country	NOUN
ajlm-1718	87	38	or	or	CCONJ
ajlm-1718	87	39	those	those	PRON
ajlm-1718	87	40	of	of	ADP
ajlm-1718	87	41	the	the	DET
ajlm-1718	87	42	meningitis	meningitis	NOUN
ajlm-1718	87	43	belt	belt	NOUN
ajlm-1718	87	44	.	.	PUNCT
ajlm-1718	88	1	in	in	ADP
ajlm-1718	88	2	the	the	DET
ajlm-1718	88	3	present	present	ADJ
ajlm-1718	88	4	study	study	NOUN
ajlm-1718	88	5	,	,	PUNCT
ajlm-1718	88	6	hhv-6	hhv-6	NOUN
ajlm-1718	88	7	dna	dna	PROPN
ajlm-1718	88	8	was	be	AUX
ajlm-1718	88	9	identified	identify	VERB
ajlm-1718	88	10	in	in	ADP
ajlm-1718	88	11	the	the	DET
ajlm-1718	88	12	csf	csf	NOUN
ajlm-1718	88	13	of	of	ADP
ajlm-1718	88	14	2.6	2.6	NUM
ajlm-1718	88	15	%	%	NOUN
ajlm-1718	88	16	of	of	ADP
ajlm-1718	88	17	paediatric	paediatric	ADJ
ajlm-1718	88	18	patients	patient	NOUN
ajlm-1718	88	19	with	with	ADP
ajlm-1718	88	20	suspected	suspect	VERB
ajlm-1718	88	21	meningitis	meningitis	NOUN
ajlm-1718	88	22	.	.	PUNCT
ajlm-1718	89	1	this	this	DET
ajlm-1718	89	2	result	result	NOUN
ajlm-1718	89	3	is	be	AUX
ajlm-1718	89	4	close	close	ADJ
ajlm-1718	89	5	to	to	ADP
ajlm-1718	89	6	the	the	DET
ajlm-1718	89	7	findings	finding	NOUN
ajlm-1718	89	8	of	of	ADP
ajlm-1718	89	9	hosseininasab24	hosseininasab24	NOUN
ajlm-1718	89	10	who	who	PRON
ajlm-1718	89	11	identified	identify	VERB
ajlm-1718	89	12	csf	csf	ADJ
ajlm-1718	89	13	hhv-6	hhv-6	NOUN
ajlm-1718	89	14	dna	dna	NOUN
ajlm-1718	89	15	in	in	ADP
ajlm-1718	89	16	1.5	1.5	NUM
ajlm-1718	89	17	%	%	NOUN
ajlm-1718	89	18	(	(	PUNCT
ajlm-1718	89	19	1/65	1/65	NUM
ajlm-1718	89	20	)	)	PUNCT
ajlm-1718	89	21	of	of	ADP
ajlm-1718	89	22	children	child	NOUN
ajlm-1718	89	23	with	with	ADP
ajlm-1718	89	24	aseptic	aseptic	ADJ
ajlm-1718	89	25	meningitis	meningitis	NOUN
ajlm-1718	89	26	in	in	ADP
ajlm-1718	89	27	southern	southern	ADJ
ajlm-1718	89	28	iran	iran	PROPN
ajlm-1718	89	29	.	.	PUNCT
ajlm-1718	90	1	tavakoli21	tavakoli21	NOUN
ajlm-1718	90	2	reported	report	VERB
ajlm-1718	90	3	similar	similar	ADJ
ajlm-1718	90	4	findings	finding	NOUN
ajlm-1718	90	5	of	of	ADP
ajlm-1718	90	6	1.8	1.8	NUM
ajlm-1718	90	7	%	%	NOUN
ajlm-1718	90	8	(	(	PUNCT
ajlm-1718	90	9	27/1482	27/1482	NUM
ajlm-1718	90	10	)	)	PUNCT
ajlm-1718	90	11	in	in	ADP
ajlm-1718	90	12	new	new	PROPN
ajlm-1718	90	13	york	york	PROPN
ajlm-1718	90	14	,	,	PUNCT
ajlm-1718	90	15	united	united	PROPN
ajlm-1718	90	16	states	states	PROPN
ajlm-1718	90	17	.	.	PUNCT
ajlm-1718	91	1	another	another	DET
ajlm-1718	91	2	study	study	NOUN
ajlm-1718	91	3	in	in	ADP
ajlm-1718	91	4	new	new	PROPN
ajlm-1718	91	5	york	york	PROPN
ajlm-1718	91	6	by	by	ADP
ajlm-1718	91	7	yao11	yao11	PROPN
ajlm-1718	91	8	revealed	reveal	VERB
ajlm-1718	91	9	a	a	DET
ajlm-1718	91	10	significantly	significantly	ADV
ajlm-1718	91	11	higher	high	ADJ
ajlm-1718	91	12	prevalence	prevalence	NOUN
ajlm-1718	91	13	of	of	ADP
ajlm-1718	91	14	40.0	40.0	NUM
ajlm-1718	91	15	%	%	NOUN
ajlm-1718	91	16	(	(	PUNCT
ajlm-1718	91	17	14/35	14/35	NUM
ajlm-1718	91	18	)	)	PUNCT
ajlm-1718	91	19	in	in	ADP
ajlm-1718	91	20	patients	patient	NOUN
ajlm-1718	91	21	with	with	ADP
ajlm-1718	91	22	cns	cns	PROPN
ajlm-1718	91	23	infections	infection	NOUN
ajlm-1718	91	24	who	who	PRON
ajlm-1718	91	25	tested	test	VERB
ajlm-1718	91	26	negative	negative	ADJ
ajlm-1718	91	27	for	for	ADP
ajlm-1718	91	28	other	other	ADJ
ajlm-1718	91	29	cns	cns	NOUN
ajlm-1718	91	30	pathogens	pathogen	NOUN
ajlm-1718	91	31	.	.	PUNCT
ajlm-1718	92	1	among	among	ADP
ajlm-1718	92	2	well	well	ADV
ajlm-1718	92	3	-	-	PUNCT
ajlm-1718	92	4	defined	define	VERB
ajlm-1718	92	5	groups	group	NOUN
ajlm-1718	92	6	in	in	ADP
ajlm-1718	92	7	our	our	PRON
ajlm-1718	92	8	study	study	NOUN
ajlm-1718	92	9	,	,	PUNCT
ajlm-1718	92	10	the	the	DET
ajlm-1718	92	11	prevalence	prevalence	NOUN
ajlm-1718	92	12	was	be	AUX
ajlm-1718	92	13	also	also	ADV
ajlm-1718	92	14	high	high	ADJ
ajlm-1718	92	15	,	,	PUNCT
ajlm-1718	92	16	accounting	account	VERB
ajlm-1718	92	17	for	for	ADP
ajlm-1718	92	18	33.0	33.0	NUM
ajlm-1718	92	19	%	%	NOUN
ajlm-1718	92	20	out	out	ADP
ajlm-1718	92	21	of	of	ADP
ajlm-1718	92	22	40	40	NUM
ajlm-1718	92	23	cases	case	NOUN
ajlm-1718	92	24	with	with	ADP
ajlm-1718	92	25	proven	prove	VERB
ajlm-1718	92	26	infectious	infectious	ADJ
ajlm-1718	92	27	meningitis	meningitis	NOUN
ajlm-1718	92	28	(	(	PUNCT
ajlm-1718	92	29	table	table	NOUN
ajlm-1718	92	30	2	2	NUM
ajlm-1718	92	31	)	)	PUNCT
ajlm-1718	92	32	.	.	PUNCT
ajlm-1718	93	1	in	in	ADP
ajlm-1718	93	2	the	the	DET
ajlm-1718	93	3	present	present	ADJ
ajlm-1718	93	4	study	study	NOUN
ajlm-1718	93	5	,	,	PUNCT
ajlm-1718	93	6	unlike	unlike	ADP
ajlm-1718	93	7	yao	yao	PROPN
ajlm-1718	93	8	’s	’s	PART
ajlm-1718	93	9	approach	approach	NOUN
ajlm-1718	93	10	,	,	PUNCT
ajlm-1718	93	11	cases	case	NOUN
ajlm-1718	93	12	with	with	ADP
ajlm-1718	93	13	other	other	ADJ
ajlm-1718	93	14	detectable	detectable	ADJ
ajlm-1718	93	15	cns	cns	NOUN
ajlm-1718	93	16	pathogens	pathogen	NOUN
ajlm-1718	93	17	were	be	AUX
ajlm-1718	93	18	not	not	PART
ajlm-1718	93	19	excluded	exclude	VERB
ajlm-1718	93	20	because	because	SCONJ
ajlm-1718	93	21	of	of	ADP
ajlm-1718	93	22	possible	possible	ADJ
ajlm-1718	93	23	co	co	NOUN
ajlm-1718	93	24	-	-	NOUN
ajlm-1718	93	25	infections	infection	NOUN
ajlm-1718	93	26	,	,	PUNCT
ajlm-1718	93	27	as	as	ADP
ajlm-1718	93	28	frequently	frequently	ADV
ajlm-1718	93	29	reported.21,25,26,27	reported.21,25,26,27	NOUN
ajlm-1718	93	30	it	it	PRON
ajlm-1718	93	31	has	have	AUX
ajlm-1718	93	32	been	be	AUX
ajlm-1718	93	33	reported	report	VERB
ajlm-1718	93	34	that	that	SCONJ
ajlm-1718	93	35	primary	primary	ADJ
ajlm-1718	93	36	infection	infection	NOUN
ajlm-1718	93	37	with	with	ADP
ajlm-1718	93	38	hhv-6	hhv-6	NOUN
ajlm-1718	93	39	always	always	ADV
ajlm-1718	93	40	occurs	occur	VERB
ajlm-1718	93	41	in	in	ADP
ajlm-1718	93	42	young	young	ADJ
ajlm-1718	93	43	children	child	NOUN
ajlm-1718	93	44	(	(	PUNCT
ajlm-1718	93	45	age	age	NOUN
ajlm-1718	93	46	0	0	NUM
ajlm-1718	93	47	to	to	ADP
ajlm-1718	93	48	2	2	NUM
ajlm-1718	93	49	years).5,28,29	years).5,28,29	NOUN
ajlm-1718	93	50	human	human	ADJ
ajlm-1718	93	51	herpes	herpe	NOUN
ajlm-1718	93	52	virus	virus	NOUN
ajlm-1718	93	53	type-6	type-6	NUM
ajlm-1718	93	54	infections	infection	NOUN
ajlm-1718	93	55	,	,	PUNCT
ajlm-1718	93	56	especially	especially	ADV
ajlm-1718	93	57	to	to	ADP
ajlm-1718	93	58	the	the	DET
ajlm-1718	93	59	cns	cns	NOUN
ajlm-1718	93	60	,	,	PUNCT
ajlm-1718	93	61	can	can	AUX
ajlm-1718	93	62	also	also	ADV
ajlm-1718	93	63	occur	occur	VERB
ajlm-1718	93	64	in	in	ADP
ajlm-1718	93	65	healthy	healthy	ADJ
ajlm-1718	93	66	older	old	ADJ
ajlm-1718	93	67	children	child	NOUN
ajlm-1718	93	68	and	and	CCONJ
ajlm-1718	93	69	adults	adult	NOUN
ajlm-1718	93	70	,	,	PUNCT
ajlm-1718	93	71	but	but	CCONJ
ajlm-1718	93	72	it	it	PRON
ajlm-1718	93	73	is	be	AUX
ajlm-1718	93	74	thought	think	VERB
ajlm-1718	93	75	to	to	PART
ajlm-1718	93	76	be	be	AUX
ajlm-1718	93	77	due	due	ADJ
ajlm-1718	93	78	to	to	ADP
ajlm-1718	93	79	virus	virus	NOUN
ajlm-1718	93	80	reactivation.22	reactivation.22	NOUN
ajlm-1718	93	81	among	among	ADP
ajlm-1718	93	82	24	24	NUM
ajlm-1718	93	83	hhv-6	hhv-6	NUM
ajlm-1718	93	84	positive	positive	ADJ
ajlm-1718	93	85	patients	patient	NOUN
ajlm-1718	93	86	in	in	ADP
ajlm-1718	93	87	tavakoli	tavakoli	PROPN
ajlm-1718	93	88	’s	’s	PART
ajlm-1718	93	89	study,21	study,21	NOUN
ajlm-1718	93	90	42	42	NUM
ajlm-1718	93	91	%	%	NOUN
ajlm-1718	93	92	were	be	AUX
ajlm-1718	93	93	infants	infant	NOUN
ajlm-1718	93	94	≤	≤	NUM
ajlm-1718	93	95	3	3	NUM
ajlm-1718	93	96	years	year	NOUN
ajlm-1718	93	97	and	and	CCONJ
ajlm-1718	93	98	12.5	12.5	NUM
ajlm-1718	93	99	%	%	NOUN
ajlm-1718	93	100	were	be	AUX
ajlm-1718	93	101	teenagers	teenager	NOUN
ajlm-1718	93	102	11–17	11–17	NUM
ajlm-1718	93	103	years	year	NOUN
ajlm-1718	93	104	old	old	ADJ
ajlm-1718	93	105	.	.	PUNCT
ajlm-1718	94	1	out	out	ADP
ajlm-1718	94	2	of	of	ADP
ajlm-1718	94	3	our	our	PRON
ajlm-1718	94	4	13	13	NUM
ajlm-1718	94	5	hhv-6	hhv-6	NUM
ajlm-1718	94	6	positive	positive	ADJ
ajlm-1718	94	7	cases	case	NOUN
ajlm-1718	94	8	,	,	PUNCT
ajlm-1718	94	9	92	92	NUM
ajlm-1718	94	10	%	%	NOUN
ajlm-1718	94	11	were	be	AUX
ajlm-1718	94	12	infants	infant	NOUN
ajlm-1718	94	13	≤	≤	NUM
ajlm-1718	94	14	2.3	2.3	NUM
ajlm-1718	94	15	years	year	NOUN
ajlm-1718	94	16	and	and	CCONJ
ajlm-1718	94	17	one	one	NUM
ajlm-1718	94	18	(	(	PUNCT
ajlm-1718	94	19	8	8	NUM
ajlm-1718	94	20	%	%	NOUN
ajlm-1718	94	21	)	)	PUNCT
ajlm-1718	94	22	was	be	AUX
ajlm-1718	94	23	a	a	DET
ajlm-1718	94	24	15	15	NUM
ajlm-1718	94	25	-	-	PUNCT
ajlm-1718	94	26	year	year	NOUN
ajlm-1718	94	27	-	-	PUNCT
ajlm-1718	94	28	old	old	ADJ
ajlm-1718	94	29	teenager	teenager	NOUN
ajlm-1718	94	30	.	.	PUNCT
ajlm-1718	95	1	the	the	DET
ajlm-1718	95	2	ratio	ratio	NOUN
ajlm-1718	95	3	of	of	ADP
ajlm-1718	95	4	boys	boy	NOUN
ajlm-1718	95	5	to	to	ADP
ajlm-1718	95	6	girls	girl	NOUN
ajlm-1718	95	7	in	in	ADP
ajlm-1718	95	8	this	this	DET
ajlm-1718	95	9	study	study	NOUN
ajlm-1718	95	10	was	be	AUX
ajlm-1718	95	11	1:1	1:1	NUM
ajlm-1718	95	12	which	which	PRON
ajlm-1718	95	13	agrees	agree	VERB
ajlm-1718	95	14	with	with	ADP
ajlm-1718	95	15	tavakoli	tavakoli	NOUN
ajlm-1718	95	16	’s	’s	PART
ajlm-1718	95	17	findings	finding	NOUN
ajlm-1718	95	18	of	of	ADP
ajlm-1718	95	19	1.3:1.1	1.3:1.1	NUM
ajlm-1718	95	20	.	.	PUNCT
ajlm-1718	96	1	clinical	clinical	ADJ
ajlm-1718	96	2	signs	sign	NOUN
ajlm-1718	96	3	and	and	CCONJ
ajlm-1718	96	4	symptoms	symptom	NOUN
ajlm-1718	96	5	in	in	ADP
ajlm-1718	96	6	hhv-6	hhv-6	NUM
ajlm-1718	96	7	meningitis	meningiti	NOUN
ajlm-1718	96	8	are	be	AUX
ajlm-1718	96	9	not	not	PART
ajlm-1718	96	10	specific.30	specific.30	VERB
ajlm-1718	96	11	out	out	ADP
ajlm-1718	96	12	of	of	ADP
ajlm-1718	96	13	the	the	DET
ajlm-1718	96	14	24	24	NUM
ajlm-1718	96	15	examined	examine	VERB
ajlm-1718	96	16	patients	patient	NOUN
ajlm-1718	96	17	,	,	PUNCT
ajlm-1718	96	18	tavakoli	tavakoli	NOUN
ajlm-1718	96	19	reported	report	VERB
ajlm-1718	96	20	fever	fever	NOUN
ajlm-1718	96	21	in	in	ADP
ajlm-1718	96	22	71.0	71.0	NUM
ajlm-1718	96	23	%	%	NOUN
ajlm-1718	96	24	,	,	PUNCT
ajlm-1718	96	25	altered	alter	VERB
ajlm-1718	96	26	mental	mental	ADJ
ajlm-1718	96	27	status	status	NOUN
ajlm-1718	96	28	in	in	ADP
ajlm-1718	96	29	67.0	67.0	NUM
ajlm-1718	96	30	%	%	NOUN
ajlm-1718	96	31	,	,	PUNCT
ajlm-1718	96	32	headache	headache	NOUN
ajlm-1718	96	33	in	in	ADP
ajlm-1718	96	34	29.0	29.0	NUM
ajlm-1718	96	35	%	%	NOUN
ajlm-1718	96	36	and	and	CCONJ
ajlm-1718	96	37	seizures	seizure	NOUN
ajlm-1718	96	38	in	in	ADP
ajlm-1718	96	39	33.0	33.0	NUM
ajlm-1718	96	40	%	%	NOUN
ajlm-1718	96	41	.	.	PUNCT
ajlm-1718	97	1	other	other	ADJ
ajlm-1718	97	2	reported	report	VERB
ajlm-1718	97	3	symptoms	symptom	NOUN
ajlm-1718	97	4	were	be	AUX
ajlm-1718	97	5	muscle	muscle	NOUN
ajlm-1718	97	6	weakness	weakness	NOUN
ajlm-1718	97	7	,	,	PUNCT
ajlm-1718	97	8	muscle	muscle	NOUN
ajlm-1718	97	9	pain	pain	NOUN
ajlm-1718	97	10	and	and	CCONJ
ajlm-1718	97	11	stiff	stiff	ADJ
ajlm-1718	97	12	neck	neck	NOUN
ajlm-1718	97	13	,	,	PUNCT
ajlm-1718	97	14	which	which	PRON
ajlm-1718	97	15	are	be	AUX
ajlm-1718	97	16	general	general	ADJ
ajlm-1718	97	17	symptoms	symptom	NOUN
ajlm-1718	97	18	for	for	ADP
ajlm-1718	97	19	meningitis	meningitis	NOUN
ajlm-1718	97	20	or	or	CCONJ
ajlm-1718	97	21	encephalitis.21	encephalitis.21	NOUN
ajlm-1718	97	22	in	in	ADP
ajlm-1718	97	23	the	the	DET
ajlm-1718	97	24	present	present	ADJ
ajlm-1718	97	25	study	study	NOUN
ajlm-1718	97	26	,	,	PUNCT
ajlm-1718	97	27	all	all	PRON
ajlm-1718	97	28	hhv-6	hhv-6	ADJ
ajlm-1718	97	29	positive	positive	ADJ
ajlm-1718	97	30	cases	case	NOUN
ajlm-1718	97	31	presented	present	VERB
ajlm-1718	97	32	with	with	ADP
ajlm-1718	97	33	fever	fever	NOUN
ajlm-1718	97	34	and	and	CCONJ
ajlm-1718	97	35	vomiting	vomiting	NOUN
ajlm-1718	97	36	,	,	PUNCT
ajlm-1718	97	37	86.0	86.0	NUM
ajlm-1718	97	38	%	%	NOUN
ajlm-1718	97	39	presented	present	VERB
ajlm-1718	97	40	with	with	ADP
ajlm-1718	97	41	seizures	seizure	NOUN
ajlm-1718	97	42	,	,	PUNCT
ajlm-1718	97	43	14.3	14.3	NUM
ajlm-1718	97	44	%	%	NOUN
ajlm-1718	97	45	with	with	ADP
ajlm-1718	97	46	chills	chill	NOUN
ajlm-1718	97	47	and	and	CCONJ
ajlm-1718	97	48	14.3	14.3	NUM
ajlm-1718	97	49	%	%	NOUN
ajlm-1718	97	50	with	with	ADP
ajlm-1718	97	51	a	a	DET
ajlm-1718	97	52	stiff	stiff	ADJ
ajlm-1718	97	53	neck	neck	NOUN
ajlm-1718	97	54	.	.	PUNCT
ajlm-1718	98	1	none	none	NOUN
ajlm-1718	98	2	of	of	ADP
ajlm-1718	98	3	our	our	PRON
ajlm-1718	98	4	patients	patient	NOUN
ajlm-1718	98	5	developed	develop	VERB
ajlm-1718	98	6	skin	skin	NOUN
ajlm-1718	98	7	rash	rash	NOUN
ajlm-1718	98	8	,	,	PUNCT
ajlm-1718	98	9	which	which	PRON
ajlm-1718	98	10	is	be	AUX
ajlm-1718	98	11	the	the	DET
ajlm-1718	98	12	only	only	ADJ
ajlm-1718	98	13	specific	specific	ADJ
ajlm-1718	98	14	–	–	PUNCT
ajlm-1718	98	15	but	but	CCONJ
ajlm-1718	98	16	rare	rare	ADJ
ajlm-1718	98	17	–	–	PUNCT
ajlm-1718	98	18	symptom	symptom	NOUN
ajlm-1718	98	19	in	in	ADP
ajlm-1718	98	20	hhv-6	hhv-6	ADV
ajlm-1718	98	21	meningitis.30	meningitis.30	PROPN
ajlm-1718	98	22	findings	finding	NOUN
ajlm-1718	98	23	of	of	ADP
ajlm-1718	98	24	both	both	PRON
ajlm-1718	98	25	tavakoli	tavakoli	NOUN
ajlm-1718	98	26	and	and	CCONJ
ajlm-1718	98	27	hosseininasab	hosseininasab	VERB
ajlm-1718	98	28	concur	concur	NOUN
ajlm-1718	98	29	.	.	PUNCT
ajlm-1718	99	1	normal	normal	ADJ
ajlm-1718	99	2	csf	csf	ADJ
ajlm-1718	99	3	glucose	glucose	NOUN
ajlm-1718	99	4	with	with	ADP
ajlm-1718	99	5	normal	normal	ADJ
ajlm-1718	99	6	or	or	CCONJ
ajlm-1718	99	7	elevated	elevated	ADJ
ajlm-1718	99	8	proteins	protein	NOUN
ajlm-1718	99	9	is	be	AUX
ajlm-1718	99	10	the	the	DET
ajlm-1718	99	11	usual	usual	ADJ
ajlm-1718	99	12	finding	finding	NOUN
ajlm-1718	99	13	in	in	ADP
ajlm-1718	99	14	viral	viral	ADJ
ajlm-1718	99	15	infections	infection	NOUN
ajlm-1718	99	16	of	of	ADP
ajlm-1718	99	17	the	the	DET
ajlm-1718	99	18	cns,17	cns,17	NOUN
ajlm-1718	99	19	as	as	SCONJ
ajlm-1718	99	20	found	find	VERB
ajlm-1718	99	21	in	in	ADP
ajlm-1718	99	22	this	this	DET
ajlm-1718	99	23	study	study	NOUN
ajlm-1718	99	24	,	,	PUNCT
ajlm-1718	99	25	where	where	SCONJ
ajlm-1718	99	26	all	all	DET
ajlm-1718	99	27	specimens	specimen	NOUN
ajlm-1718	99	28	showed	show	VERB
ajlm-1718	99	29	normal	normal	ADJ
ajlm-1718	99	30	csf	csf	ADJ
ajlm-1718	99	31	glucose	glucose	NOUN
ajlm-1718	99	32	concentration	concentration	NOUN
ajlm-1718	99	33	,	,	PUNCT
ajlm-1718	99	34	33	33	NUM
ajlm-1718	99	35	%	%	NOUN
ajlm-1718	99	36	normal	normal	ADJ
ajlm-1718	99	37	proteins	protein	NOUN
ajlm-1718	99	38	and	and	CCONJ
ajlm-1718	99	39	67	67	NUM
ajlm-1718	99	40	%	%	NOUN
ajlm-1718	99	41	high	high	ADJ
ajlm-1718	99	42	proteins	protein	NOUN
ajlm-1718	99	43	.	.	PUNCT
ajlm-1718	100	1	unfortunately	unfortunately	ADV
ajlm-1718	100	2	,	,	PUNCT
ajlm-1718	100	3	chemical	chemical	ADJ
ajlm-1718	100	4	analysis	analysis	NOUN
ajlm-1718	100	5	of	of	ADP
ajlm-1718	100	6	the	the	DET
ajlm-1718	100	7	csf	csf	NOUN
ajlm-1718	100	8	is	be	AUX
ajlm-1718	100	9	ineffective	ineffective	ADJ
ajlm-1718	100	10	in	in	ADP
ajlm-1718	100	11	case	case	NOUN
ajlm-1718	100	12	of	of	ADP
ajlm-1718	100	13	viral	viral	ADJ
ajlm-1718	100	14	infections	infection	NOUN
ajlm-1718	100	15	;	;	PUNCT
ajlm-1718	100	16	however	however	ADV
ajlm-1718	100	17	,	,	PUNCT
ajlm-1718	100	18	its	its	PRON
ajlm-1718	100	19	significance	significance	NOUN
ajlm-1718	100	20	is	be	AUX
ajlm-1718	100	21	in	in	ADP
ajlm-1718	100	22	distinguishing	distinguish	VERB
ajlm-1718	100	23	bacterial	bacterial	ADJ
ajlm-1718	100	24	from	from	ADP
ajlm-1718	100	25	aseptic	aseptic	ADJ
ajlm-1718	100	26	aetiologies	aetiology	NOUN
ajlm-1718	100	27	which	which	PRON
ajlm-1718	100	28	is	be	AUX
ajlm-1718	100	29	a	a	DET
ajlm-1718	100	30	crucial	crucial	ADJ
ajlm-1718	100	31	preliminary	preliminary	ADJ
ajlm-1718	100	32	step	step	NOUN
ajlm-1718	100	33	in	in	ADP
ajlm-1718	100	34	deciding	decide	VERB
ajlm-1718	100	35	adequate	adequate	ADJ
ajlm-1718	100	36	treatment	treatment	NOUN
ajlm-1718	100	37	.	.	PUNCT
ajlm-1718	101	1	cerebrospinal	cerebrospinal	ADJ
ajlm-1718	101	2	fluid	fluid	NOUN
ajlm-1718	101	3	leukocytosis	leukocytosis	NOUN
ajlm-1718	101	4	was	be	AUX
ajlm-1718	101	5	seen	see	VERB
ajlm-1718	101	6	in	in	ADP
ajlm-1718	101	7	33	33	NUM
ajlm-1718	101	8	%	%	NOUN
ajlm-1718	101	9	.	.	PUNCT
ajlm-1718	102	1	increased	increase	VERB
ajlm-1718	102	2	csf	csf	ADJ
ajlm-1718	102	3	white	white	ADJ
ajlm-1718	102	4	blood	blood	NOUN
ajlm-1718	102	5	cell	cell	NOUN
ajlm-1718	102	6	numbers	number	NOUN
ajlm-1718	102	7	indicate	indicate	VERB
ajlm-1718	102	8	inflammation	inflammation	NOUN
ajlm-1718	102	9	;	;	PUNCT
ajlm-1718	102	10	however	however	ADV
ajlm-1718	102	11	,	,	PUNCT
ajlm-1718	102	12	normal	normal	ADJ
ajlm-1718	102	13	csf	csf	ADJ
ajlm-1718	102	14	cellular	cellular	ADJ
ajlm-1718	102	15	counts	count	NOUN
ajlm-1718	102	16	do	do	AUX
ajlm-1718	102	17	not	not	PART
ajlm-1718	102	18	rule	rule	VERB
ajlm-1718	102	19	out	out	ADP
ajlm-1718	102	20	viral	viral	ADJ
ajlm-1718	102	21	aetiologies	aetiology	NOUN
ajlm-1718	102	22	.	.	PUNCT
ajlm-1718	103	1	in	in	ADP
ajlm-1718	103	2	fact	fact	NOUN
ajlm-1718	103	3	,	,	PUNCT
ajlm-1718	103	4	normal	normal	ADJ
ajlm-1718	103	5	csf	csf	ADJ
ajlm-1718	103	6	cellular	cellular	ADJ
ajlm-1718	103	7	counts	count	NOUN
ajlm-1718	103	8	in	in	ADP
ajlm-1718	103	9	patients	patient	NOUN
ajlm-1718	103	10	with	with	ADP
ajlm-1718	103	11	proven	prove	VERB
ajlm-1718	103	12	cns	cns	PROPN
ajlm-1718	103	13	infections	infection	NOUN
ajlm-1718	103	14	were	be	AUX
ajlm-1718	103	15	frequently	frequently	ADV
ajlm-1718	103	16	reported.17,18,19,20	reported.17,18,19,20	ADJ
ajlm-1718	103	17	normal	normal	ADJ
ajlm-1718	103	18	csf	csf	NOUN
ajlm-1718	103	19	profile	profile	NOUN
ajlm-1718	103	20	was	be	AUX
ajlm-1718	103	21	reported	report	VERB
ajlm-1718	103	22	in	in	ADP
ajlm-1718	103	23	25	25	NUM
ajlm-1718	103	24	%	%	NOUN
ajlm-1718	103	25	of	of	ADP
ajlm-1718	103	26	hhv-6	hhv-6	NOUN
ajlm-1718	103	27	positive	positive	ADJ
ajlm-1718	103	28	cases	case	NOUN
ajlm-1718	103	29	in	in	ADP
ajlm-1718	103	30	tavakoli	tavakoli	NOUN
ajlm-1718	103	31	’s	’s	PART
ajlm-1718	103	32	study21	study21	NOUN
ajlm-1718	103	33	;	;	PUNCT
ajlm-1718	103	34	accordingly	accordingly	ADV
ajlm-1718	103	35	,	,	PUNCT
ajlm-1718	103	36	hhv-6	hhv-6	NOUN
ajlm-1718	103	37	testing	testing	NOUN
ajlm-1718	103	38	should	should	AUX
ajlm-1718	103	39	not	not	PART
ajlm-1718	103	40	be	be	AUX
ajlm-1718	103	41	limited	limit	VERB
ajlm-1718	103	42	to	to	ADP
ajlm-1718	103	43	patients	patient	NOUN
ajlm-1718	103	44	with	with	ADP
ajlm-1718	103	45	abnormal	abnormal	ADJ
ajlm-1718	103	46	csf	csf	ADJ
ajlm-1718	103	47	profiles	profile	NOUN
ajlm-1718	103	48	.	.	PUNCT
ajlm-1718	104	1	thermal	thermal	ADJ
ajlm-1718	104	2	ct	ct	NUM
ajlm-1718	104	3	is	be	AUX
ajlm-1718	104	4	defined	define	VERB
ajlm-1718	104	5	as	as	ADP
ajlm-1718	104	6	the	the	DET
ajlm-1718	104	7	number	number	NOUN
ajlm-1718	104	8	of	of	ADP
ajlm-1718	104	9	cycles	cycle	NOUN
ajlm-1718	104	10	required	require	VERB
ajlm-1718	104	11	for	for	ADP
ajlm-1718	104	12	the	the	DET
ajlm-1718	104	13	fluorescent	fluorescent	NOUN
ajlm-1718	104	14	signal	signal	NOUN
ajlm-1718	104	15	to	to	PART
ajlm-1718	104	16	cross	cross	VERB
ajlm-1718	104	17	the	the	DET
ajlm-1718	104	18	threshold	threshold	NOUN
ajlm-1718	104	19	(	(	PUNCT
ajlm-1718	104	20	i.e.	i.e.	X
ajlm-1718	104	21	exceed	exceed	VERB
ajlm-1718	104	22	background	background	NOUN
ajlm-1718	104	23	level	level	NOUN
ajlm-1718	104	24	)	)	PUNCT
ajlm-1718	104	25	.	.	PUNCT
ajlm-1718	105	1	median	median	PROPN
ajlm-1718	105	2	ct	ct	PROPN
ajlm-1718	105	3	for	for	ADP
ajlm-1718	105	4	our	our	PRON
ajlm-1718	105	5	positive	positive	ADJ
ajlm-1718	105	6	cases	case	NOUN
ajlm-1718	105	7	was	be	AUX
ajlm-1718	105	8	38	38	NUM
ajlm-1718	105	9	with	with	ADP
ajlm-1718	105	10	a	a	DET
ajlm-1718	105	11	range	range	NOUN
ajlm-1718	105	12	of	of	ADP
ajlm-1718	105	13	31.9	31.9	NUM
ajlm-1718	105	14	to	to	PART
ajlm-1718	105	15	40.8	40.8	NUM
ajlm-1718	105	16	.	.	PUNCT
ajlm-1718	106	1	in	in	ADP
ajlm-1718	106	2	tavakoli	tavakoli	PROPN
ajlm-1718	106	3	’s	’s	PART
ajlm-1718	106	4	study	study	NOUN
ajlm-1718	106	5	,	,	PUNCT
ajlm-1718	106	6	ct	ct	NUM
ajlm-1718	106	7	values	value	NOUN
ajlm-1718	106	8	ranged	range	VERB
ajlm-1718	106	9	from	from	ADP
ajlm-1718	106	10	25.03	25.03	NUM
ajlm-1718	106	11	to	to	ADP
ajlm-1718	106	12	39.92	39.92	NUM
ajlm-1718	106	13	.	.	PUNCT
ajlm-1718	107	1	in	in	ADP
ajlm-1718	107	2	quantitative	quantitative	ADJ
ajlm-1718	107	3	real	real	ADJ
ajlm-1718	107	4	-	-	PUNCT
ajlm-1718	107	5	time	time	NOUN
ajlm-1718	107	6	pcr	pcr	NOUN
ajlm-1718	107	7	,	,	PUNCT
ajlm-1718	107	8	ct	ct	PROPN
ajlm-1718	107	9	values	value	NOUN
ajlm-1718	107	10	inversely	inversely	ADV
ajlm-1718	107	11	correlate	correlate	VERB
ajlm-1718	107	12	with	with	ADP
ajlm-1718	107	13	viral	viral	ADJ
ajlm-1718	107	14	loads	load	NOUN
ajlm-1718	107	15	;	;	PUNCT
ajlm-1718	107	16	therefore	therefore	ADV
ajlm-1718	107	17	,	,	PUNCT
ajlm-1718	107	18	a	a	DET
ajlm-1718	107	19	low	low	ADJ
ajlm-1718	107	20	ct	ct	NOUN
ajlm-1718	107	21	value	value	NOUN
ajlm-1718	107	22	indicates	indicate	VERB
ajlm-1718	107	23	a	a	DET
ajlm-1718	107	24	high	high	ADJ
ajlm-1718	107	25	viral	viral	ADJ
ajlm-1718	107	26	load	load	NOUN
ajlm-1718	107	27	and	and	CCONJ
ajlm-1718	107	28	vice	vice	NOUN
ajlm-1718	107	29	versa	versa	ADV
ajlm-1718	107	30	.	.	PUNCT
ajlm-1718	108	1	our	our	PRON
ajlm-1718	108	2	ct	ct	PROPN
ajlm-1718	108	3	values	value	NOUN
ajlm-1718	108	4	and	and	CCONJ
ajlm-1718	108	5	viral	viral	ADJ
ajlm-1718	108	6	loads	load	NOUN
ajlm-1718	108	7	were	be	AUX
ajlm-1718	108	8	found	find	VERB
ajlm-1718	108	9	to	to	PART
ajlm-1718	108	10	be	be	AUX
ajlm-1718	108	11	significantly	significantly	ADV
ajlm-1718	108	12	(	(	PUNCT
ajlm-1718	108	13	p	p	X
ajlm-1718	108	14	=	=	NOUN
ajlm-1718	108	15	0.029	0.029	NUM
ajlm-1718	108	16	)	)	PUNCT
ajlm-1718	108	17	inversely	inversely	ADV
ajlm-1718	108	18	correlated	correlate	VERB
ajlm-1718	108	19	(	(	PUNCT
ajlm-1718	108	20	r	r	NOUN
ajlm-1718	108	21	=	=	SYM
ajlm-1718	108	22	−0.6	−0.6	PROPN
ajlm-1718	108	23	,	,	PUNCT
ajlm-1718	108	24	95	95	NUM
ajlm-1718	108	25	%	%	NOUN
ajlm-1718	108	26	confidence	confidence	NOUN
ajlm-1718	108	27	interval	interval	NOUN
ajlm-1718	108	28	:	:	PUNCT
ajlm-1718	108	29	−0.1	−0.1	PROPN
ajlm-1718	108	30	to	to	PART
ajlm-1718	108	31	−0.9	−0.9	VERB
ajlm-1718	108	32	)	)	PUNCT
ajlm-1718	108	33	indicating	indicate	VERB
ajlm-1718	108	34	significant	significant	ADJ
ajlm-1718	108	35	variation	variation	NOUN
ajlm-1718	108	36	of	of	ADP
ajlm-1718	108	37	viral	viral	ADJ
ajlm-1718	108	38	loads	load	NOUN
ajlm-1718	108	39	among	among	ADP
ajlm-1718	108	40	our	our	PRON
ajlm-1718	108	41	patients	patient	NOUN
ajlm-1718	108	42	.	.	PUNCT
ajlm-1718	109	1	substantial	substantial	ADJ
ajlm-1718	109	2	variation	variation	NOUN
ajlm-1718	109	3	among	among	ADP
ajlm-1718	109	4	viral	viral	ADJ
ajlm-1718	109	5	loads	load	NOUN
ajlm-1718	109	6	in	in	ADP
ajlm-1718	109	7	patients	patient	NOUN
ajlm-1718	109	8	was	be	AUX
ajlm-1718	109	9	also	also	ADV
ajlm-1718	109	10	reported	report	VERB
ajlm-1718	109	11	by	by	ADP
ajlm-1718	109	12	tavakoli.21	tavakoli.21	PROPN
ajlm-1718	109	13	the	the	DET
ajlm-1718	109	14	phenomenon	phenomenon	NOUN
ajlm-1718	109	15	of	of	ADP
ajlm-1718	109	16	hhv-6	hhv-6	NOUN
ajlm-1718	109	17	chromosomal	chromosomal	ADJ
ajlm-1718	109	18	integration	integration	NOUN
ajlm-1718	109	19	is	be	AUX
ajlm-1718	109	20	in	in	ADP
ajlm-1718	109	21	debate	debate	NOUN
ajlm-1718	109	22	;	;	PUNCT
ajlm-1718	109	23	while	while	SCONJ
ajlm-1718	109	24	some11,12,13	some11,12,13	NOUN
ajlm-1718	109	25	consider	consider	VERB
ajlm-1718	109	26	it	it	PRON
ajlm-1718	109	27	an	an	DET
ajlm-1718	109	28	easily	easily	ADV
ajlm-1718	109	29	identifiable	identifiable	ADJ
ajlm-1718	109	30	condition	condition	NOUN
ajlm-1718	109	31	based	base	VERB
ajlm-1718	109	32	on	on	ADP
ajlm-1718	109	33	the	the	DET
ajlm-1718	109	34	presence	presence	NOUN
ajlm-1718	109	35	or	or	CCONJ
ajlm-1718	109	36	absence	absence	NOUN
ajlm-1718	109	37	of	of	ADP
ajlm-1718	109	38	nucleus	nucleus	NOUN
ajlm-1718	109	39	containing	contain	VERB
ajlm-1718	109	40	blood	blood	NOUN
ajlm-1718	109	41	cells	cell	NOUN
ajlm-1718	109	42	in	in	ADP
ajlm-1718	109	43	different	different	ADJ
ajlm-1718	109	44	body	body	NOUN
ajlm-1718	109	45	compartments	compartment	NOUN
ajlm-1718	109	46	,	,	PUNCT
ajlm-1718	109	47	ward16	ward16	PROPN
ajlm-1718	109	48	believes	believe	VERB
ajlm-1718	109	49	the	the	DET
ajlm-1718	109	50	few	few	ADJ
ajlm-1718	109	51	leukocytes	leukocyte	NOUN
ajlm-1718	109	52	that	that	PRON
ajlm-1718	109	53	are	be	AUX
ajlm-1718	109	54	usually	usually	ADV
ajlm-1718	109	55	present	present	ADJ
ajlm-1718	109	56	in	in	ADP
ajlm-1718	109	57	normal	normal	ADJ
ajlm-1718	109	58	csf	csf	NOUN
ajlm-1718	109	59	can	can	AUX
ajlm-1718	109	60	reveal	reveal	VERB
ajlm-1718	109	61	positive	positive	ADJ
ajlm-1718	109	62	viral	viral	ADJ
ajlm-1718	109	63	dna	dna	NOUN
ajlm-1718	109	64	in	in	ADP
ajlm-1718	109	65	the	the	DET
ajlm-1718	109	66	case	case	NOUN
ajlm-1718	109	67	of	of	ADP
ajlm-1718	109	68	hhv-6	hhv-6	NOUN
ajlm-1718	109	69	integration	integration	NOUN
ajlm-1718	109	70	.	.	PUNCT
ajlm-1718	110	1	in	in	ADP
ajlm-1718	110	2	the	the	DET
ajlm-1718	110	3	present	present	ADJ
ajlm-1718	110	4	study	study	NOUN
ajlm-1718	110	5	,	,	PUNCT
ajlm-1718	110	6	the	the	DET
ajlm-1718	110	7	csf	csf	NOUN
ajlm-1718	110	8	was	be	AUX
ajlm-1718	110	9	clear	clear	ADJ
ajlm-1718	110	10	with	with	ADP
ajlm-1718	110	11	no	no	DET
ajlm-1718	110	12	observed	observed	ADJ
ajlm-1718	110	13	cells	cell	NOUN
ajlm-1718	110	14	in	in	ADP
ajlm-1718	110	15	most	most	ADJ
ajlm-1718	110	16	cases	case	NOUN
ajlm-1718	110	17	(	(	PUNCT
ajlm-1718	110	18	86	86	NUM
ajlm-1718	110	19	%	%	NOUN
ajlm-1718	110	20	)	)	PUNCT
ajlm-1718	110	21	,	,	PUNCT
ajlm-1718	110	22	while	while	SCONJ
ajlm-1718	110	23	a	a	DET
ajlm-1718	110	24	single	single	ADJ
ajlm-1718	110	25	case	case	NOUN
ajlm-1718	110	26	(	(	PUNCT
ajlm-1718	110	27	14	14	NUM
ajlm-1718	110	28	%	%	NOUN
ajlm-1718	110	29	)	)	PUNCT
ajlm-1718	110	30	showed	show	VERB
ajlm-1718	110	31	an	an	DET
ajlm-1718	110	32	increased	increase	VERB
ajlm-1718	110	33	csf	csf	ADJ
ajlm-1718	110	34	cell	cell	NOUN
ajlm-1718	110	35	count	count	NOUN
ajlm-1718	110	36	.	.	PUNCT
ajlm-1718	111	1	ward16	ward16	PROPN
ajlm-1718	111	2	elaborated	elaborate	VERB
ajlm-1718	111	3	that	that	SCONJ
ajlm-1718	111	4	in	in	ADP
ajlm-1718	111	5	order	order	NOUN
ajlm-1718	111	6	to	to	PART
ajlm-1718	111	7	identify	identify	VERB
ajlm-1718	111	8	a	a	DET
ajlm-1718	111	9	condition	condition	NOUN
ajlm-1718	111	10	as	as	ADP
ajlm-1718	111	11	chromosomal	chromosomal	ADJ
ajlm-1718	111	12	integration	integration	NOUN
ajlm-1718	111	13	,	,	PUNCT
ajlm-1718	111	14	viral	viral	ADJ
ajlm-1718	111	15	load	load	NOUN
ajlm-1718	111	16	should	should	AUX
ajlm-1718	111	17	be	be	AUX
ajlm-1718	111	18	high	high	ADJ
ajlm-1718	111	19	while	while	SCONJ
ajlm-1718	111	20	low	low	ADJ
ajlm-1718	111	21	virus	virus	NOUN
ajlm-1718	111	22	copies	copy	NOUN
ajlm-1718	111	23	would	would	AUX
ajlm-1718	111	24	indicate	indicate	VERB
ajlm-1718	111	25	an	an	DET
ajlm-1718	111	26	infection	infection	NOUN
ajlm-1718	111	27	.	.	PUNCT
ajlm-1718	112	1	they16	they16	PROPN
ajlm-1718	112	2	reported	report	VERB
ajlm-1718	112	3	a	a	DET
ajlm-1718	112	4	significantly	significantly	ADV
ajlm-1718	112	5	lower	low	ADJ
ajlm-1718	112	6	(	(	PUNCT
ajlm-1718	112	7	i.e.	i.e.	X
ajlm-1718	112	8	2.4	2.4	NUM
ajlm-1718	112	9	log10	log10	PROPN
ajlm-1718	112	10	copies	copy	NOUN
ajlm-1718	112	11	/	/	SYM
ajlm-1718	112	12	ml	ml	NOUN
ajlm-1718	112	13	)	)	PUNCT
ajlm-1718	112	14	csf	csf	ADJ
ajlm-1718	112	15	hhv-6	hhv-6	ADJ
ajlm-1718	112	16	dna	dna	PROPN
ajlm-1718	112	17	concentration	concentration	NOUN
ajlm-1718	112	18	in	in	ADP
ajlm-1718	112	19	9	9	NUM
ajlm-1718	112	20	children	child	NOUN
ajlm-1718	112	21	with	with	ADP
ajlm-1718	112	22	primary	primary	ADJ
ajlm-1718	112	23	infection	infection	NOUN
ajlm-1718	112	24	in	in	ADP
ajlm-1718	112	25	comparison	comparison	NOUN
ajlm-1718	112	26	with	with	ADP
ajlm-1718	112	27	21	21	NUM
ajlm-1718	112	28	patients	patient	NOUN
ajlm-1718	112	29	with	with	ADP
ajlm-1718	112	30	viral	viral	ADJ
ajlm-1718	112	31	chromosomal	chromosomal	ADJ
ajlm-1718	112	32	integration	integration	NOUN
ajlm-1718	112	33	(	(	PUNCT
ajlm-1718	112	34	i.e.	i.e.	X
ajlm-1718	112	35	4.0	4.0	NUM
ajlm-1718	112	36	log10	log10	PROPN
ajlm-1718	112	37	copies	copy	NOUN
ajlm-1718	112	38	/	/	SYM
ajlm-1718	112	39	ml	ml	NOUN
ajlm-1718	112	40	)	)	PUNCT
ajlm-1718	112	41	.	.	PUNCT
ajlm-1718	113	1	in	in	ADP
ajlm-1718	113	2	the	the	DET
ajlm-1718	113	3	present	present	ADJ
ajlm-1718	113	4	study	study	NOUN
ajlm-1718	113	5	,	,	PUNCT
ajlm-1718	113	6	the	the	DET
ajlm-1718	113	7	median	median	ADJ
ajlm-1718	113	8	csf	csf	PROPN
ajlm-1718	113	9	virus	virus	NOUN
ajlm-1718	113	10	concentration	concentration	NOUN
ajlm-1718	113	11	was	be	AUX
ajlm-1718	113	12	1	1	NUM
ajlm-1718	113	13	×	×	NOUN
ajlm-1718	113	14	105	105	NUM
ajlm-1718	113	15	copies	copy	NOUN
ajlm-1718	113	16	per	per	ADP
ajlm-1718	113	17	ml	ml	NOUN
ajlm-1718	113	18	with	with	ADP
ajlm-1718	113	19	a	a	DET
ajlm-1718	113	20	minimum	minimum	ADJ
ajlm-1718	113	21	virus	virus	NOUN
ajlm-1718	113	22	concentration	concentration	NOUN
ajlm-1718	113	23	of	of	ADP
ajlm-1718	113	24	12	12	NUM
ajlm-1718	113	25	×	×	NOUN
ajlm-1718	113	26	103	103	NUM
ajlm-1718	113	27	copies	copy	NOUN
ajlm-1718	113	28	per	per	ADP
ajlm-1718	113	29	ml	ml	NOUN
ajlm-1718	113	30	and	and	CCONJ
ajlm-1718	113	31	a	a	DET
ajlm-1718	113	32	maximum	maximum	NOUN
ajlm-1718	113	33	of	of	ADP
ajlm-1718	113	34	18	18	NUM
ajlm-1718	113	35	×	×	NOUN
ajlm-1718	113	36	106	106	NUM
ajlm-1718	113	37	copies	copy	NOUN
ajlm-1718	113	38	per	per	ADP
ajlm-1718	113	39	ml	ml	NOUN
ajlm-1718	113	40	.	.	PUNCT
ajlm-1718	114	1	while	while	SCONJ
ajlm-1718	114	2	ward16	ward16	NOUN
ajlm-1718	114	3	recommended	recommend	VERB
ajlm-1718	114	4	identifying	identify	VERB
ajlm-1718	114	5	low	low	ADJ
ajlm-1718	114	6	virus	virus	NOUN
ajlm-1718	114	7	copies	copy	NOUN
ajlm-1718	114	8	(	(	PUNCT
ajlm-1718	114	9	≤	≤	NOUN
ajlm-1718	114	10	103	103	NUM
ajlm-1718	114	11	)	)	PUNCT
ajlm-1718	114	12	as	as	ADP
ajlm-1718	114	13	an	an	DET
ajlm-1718	114	14	acute	acute	ADJ
ajlm-1718	114	15	hhv-6	hhv-6	NOUN
ajlm-1718	114	16	infection	infection	NOUN
ajlm-1718	114	17	and	and	CCONJ
ajlm-1718	114	18	high	high	ADJ
ajlm-1718	114	19	virus	virus	NOUN
ajlm-1718	114	20	copies	copy	NOUN
ajlm-1718	114	21	(	(	PUNCT
ajlm-1718	114	22	≥	≥	NOUN
ajlm-1718	114	23	104	104	NUM
ajlm-1718	114	24	)	)	PUNCT
ajlm-1718	114	25	as	as	ADP
ajlm-1718	114	26	chromosomal	chromosomal	ADJ
ajlm-1718	114	27	integration	integration	NOUN
ajlm-1718	114	28	,	,	PUNCT
ajlm-1718	114	29	collot31	collot31	PROPN
ajlm-1718	114	30	identified	identify	VERB
ajlm-1718	114	31	viral	viral	ADJ
ajlm-1718	114	32	integration	integration	NOUN
ajlm-1718	114	33	in	in	ADP
ajlm-1718	114	34	approximate	approximate	ADJ
ajlm-1718	114	35	concentrations	concentration	NOUN
ajlm-1718	114	36	of	of	ADP
ajlm-1718	114	37	103	103	NUM
ajlm-1718	114	38	to	to	PART
ajlm-1718	114	39	106	106	NUM
ajlm-1718	114	40	copies	copy	NOUN
ajlm-1718	114	41	per	per	ADP
ajlm-1718	114	42	ml	ml	NOUN
ajlm-1718	114	43	.	.	PUNCT
ajlm-1718	115	1	in	in	ADP
ajlm-1718	115	2	the	the	DET
ajlm-1718	115	3	present	present	ADJ
ajlm-1718	115	4	study	study	NOUN
ajlm-1718	115	5	,	,	PUNCT
ajlm-1718	115	6	we	we	PRON
ajlm-1718	115	7	identified	identify	VERB
ajlm-1718	115	8	viral	viral	ADJ
ajlm-1718	115	9	concentrations	concentration	NOUN
ajlm-1718	115	10	as	as	ADV
ajlm-1718	115	11	low	low	ADJ
ajlm-1718	115	12	as	as	ADP
ajlm-1718	115	13	104	104	NUM
ajlm-1718	115	14	and	and	CCONJ
ajlm-1718	115	15	as	as	ADV
ajlm-1718	115	16	high	high	ADJ
ajlm-1718	115	17	as	as	ADP
ajlm-1718	115	18	107	107	NUM
ajlm-1718	115	19	.	.	PUNCT
ajlm-1718	116	1	several	several	ADJ
ajlm-1718	116	2	other	other	ADJ
ajlm-1718	116	3	studies	study	NOUN
ajlm-1718	116	4	reported	report	VERB
ajlm-1718	116	5	high	high	ADJ
ajlm-1718	116	6	csf	csf	ADJ
ajlm-1718	116	7	viral	viral	ADJ
ajlm-1718	116	8	loads	load	NOUN
ajlm-1718	116	9	in	in	ADP
ajlm-1718	116	10	patients	patient	NOUN
ajlm-1718	116	11	with	with	ADP
ajlm-1718	116	12	hhv-6	hhv-6	NOUN
ajlm-1718	116	13	cns	cns	NOUN
ajlm-1718	116	14	infections.11,21	infections.11,21	NOUN
ajlm-1718	116	15	in	in	ADP
ajlm-1718	116	16	addition	addition	NOUN
ajlm-1718	116	17	,	,	PUNCT
ajlm-1718	116	18	other	other	ADJ
ajlm-1718	116	19	authors12,13	authors12,13	NOUN
ajlm-1718	116	20	insist	insist	VERB
ajlm-1718	116	21	that	that	SCONJ
ajlm-1718	116	22	chromosomal	chromosomal	ADJ
ajlm-1718	116	23	integration	integration	NOUN
ajlm-1718	116	24	is	be	AUX
ajlm-1718	116	25	a	a	DET
ajlm-1718	116	26	rare	rare	ADJ
ajlm-1718	116	27	condition	condition	NOUN
ajlm-1718	116	28	.	.	PUNCT
ajlm-1718	117	1	accordingly	accordingly	ADV
ajlm-1718	117	2	,	,	PUNCT
ajlm-1718	117	3	we	we	PRON
ajlm-1718	117	4	assume	assume	VERB
ajlm-1718	117	5	the	the	DET
ajlm-1718	117	6	detected	detect	VERB
ajlm-1718	117	7	hhv-6	hhv-6	NOUN
ajlm-1718	117	8	dna	dna	NOUN
ajlm-1718	117	9	in	in	ADP
ajlm-1718	117	10	our	our	PRON
ajlm-1718	117	11	mostly	mostly	ADV
ajlm-1718	117	12	cell	cell	NOUN
ajlm-1718	117	13	-	-	PUNCT
ajlm-1718	117	14	free	free	ADJ
ajlm-1718	117	15	csf	csf	ADJ
ajlm-1718	117	16	specimens	specimen	NOUN
ajlm-1718	117	17	is	be	AUX
ajlm-1718	117	18	more	more	ADV
ajlm-1718	117	19	likely	likely	ADJ
ajlm-1718	117	20	to	to	PART
ajlm-1718	117	21	be	be	AUX
ajlm-1718	117	22	from	from	ADP
ajlm-1718	117	23	free	free	ADJ
ajlm-1718	117	24	replicating	replicate	VERB
ajlm-1718	117	25	virus	virus	NOUN
ajlm-1718	117	26	than	than	ADP
ajlm-1718	117	27	from	from	ADP
ajlm-1718	117	28	chromosomally	chromosomally	ADV
ajlm-1718	117	29	integrated	integrate	VERB
ajlm-1718	117	30	virus	virus	NOUN
ajlm-1718	117	31	.	.	PUNCT
ajlm-1718	118	1	in	in	ADP
ajlm-1718	118	2	infants	infant	NOUN
ajlm-1718	118	3	,	,	PUNCT
ajlm-1718	118	4	primary	primary	ADJ
ajlm-1718	118	5	hhv-6	hhv-6	NOUN
ajlm-1718	118	6	infection	infection	NOUN
ajlm-1718	118	7	is	be	AUX
ajlm-1718	118	8	an	an	DET
ajlm-1718	118	9	important	important	ADJ
ajlm-1718	118	10	cause	cause	NOUN
ajlm-1718	118	11	of	of	ADP
ajlm-1718	118	12	febrile	febrile	NOUN
ajlm-1718	118	13	seizures	seizure	NOUN
ajlm-1718	118	14	with	with	ADP
ajlm-1718	118	15	an	an	DET
ajlm-1718	118	16	incidence	incidence	NOUN
ajlm-1718	118	17	of	of	ADP
ajlm-1718	118	18	13	13	NUM
ajlm-1718	118	19	%	%	NOUN
ajlm-1718	118	20	in	in	ADP
ajlm-1718	118	21	the	the	DET
ajlm-1718	118	22	united	united	PROPN
ajlm-1718	118	23	states.4	states.4	PROPN
ajlm-1718	118	24	knowing	know	VERB
ajlm-1718	118	25	that	that	SCONJ
ajlm-1718	118	26	febrile	febrile	NOUN
ajlm-1718	118	27	seizures	seizure	NOUN
ajlm-1718	118	28	and	and	CCONJ
ajlm-1718	118	29	vomiting	vomiting	NOUN
ajlm-1718	118	30	were	be	AUX
ajlm-1718	118	31	dominant	dominant	ADJ
ajlm-1718	118	32	symptoms	symptom	NOUN
ajlm-1718	118	33	among	among	ADP
ajlm-1718	118	34	our	our	PRON
ajlm-1718	118	35	population	population	NOUN
ajlm-1718	118	36	and	and	CCONJ
ajlm-1718	118	37	the	the	DET
ajlm-1718	118	38	most	most	ADV
ajlm-1718	118	39	frequent	frequent	ADJ
ajlm-1718	118	40	age	age	NOUN
ajlm-1718	118	41	group	group	NOUN
ajlm-1718	118	42	was	be	AUX
ajlm-1718	118	43	children	child	NOUN
ajlm-1718	118	44	up	up	ADP
ajlm-1718	118	45	to	to	ADP
ajlm-1718	118	46	the	the	DET
ajlm-1718	118	47	age	age	NOUN
ajlm-1718	118	48	of	of	ADP
ajlm-1718	118	49	2.3	2.3	NUM
ajlm-1718	118	50	years	year	NOUN
ajlm-1718	118	51	,	,	PUNCT
ajlm-1718	118	52	therefore	therefore	ADV
ajlm-1718	118	53	,	,	PUNCT
ajlm-1718	118	54	further	far	ADV
ajlm-1718	118	55	supported	support	VERB
ajlm-1718	118	56	our	our	PRON
ajlm-1718	118	57	assumption	assumption	NOUN
ajlm-1718	118	58	.	.	PUNCT
ajlm-1718	119	1	despite	despite	SCONJ
ajlm-1718	119	2	this	this	PRON
ajlm-1718	119	3	,	,	PUNCT
ajlm-1718	119	4	and	and	CCONJ
ajlm-1718	119	5	for	for	ADP
ajlm-1718	119	6	the	the	DET
ajlm-1718	119	7	sake	sake	NOUN
ajlm-1718	119	8	of	of	ADP
ajlm-1718	119	9	scientific	scientific	ADJ
ajlm-1718	119	10	relevance	relevance	NOUN
ajlm-1718	119	11	,	,	PUNCT
ajlm-1718	119	12	we	we	PRON
ajlm-1718	119	13	are	be	AUX
ajlm-1718	119	14	not	not	PART
ajlm-1718	119	15	ruling	rule	VERB
ajlm-1718	119	16	out	out	ADP
ajlm-1718	119	17	the	the	DET
ajlm-1718	119	18	possibility	possibility	NOUN
ajlm-1718	119	19	of	of	ADP
ajlm-1718	119	20	integration	integration	NOUN
ajlm-1718	119	21	among	among	ADP
ajlm-1718	119	22	our	our	PRON
ajlm-1718	119	23	identified	identify	VERB
ajlm-1718	119	24	cases	case	NOUN
ajlm-1718	119	25	.	.	PUNCT
ajlm-1718	120	1	for	for	ADP
ajlm-1718	120	2	this	this	DET
ajlm-1718	120	3	reason	reason	NOUN
ajlm-1718	120	4	,	,	PUNCT
ajlm-1718	120	5	studies	study	NOUN
ajlm-1718	120	6	to	to	PART
ajlm-1718	120	7	identify	identify	VERB
ajlm-1718	120	8	the	the	DET
ajlm-1718	120	9	prevalence	prevalence	NOUN
ajlm-1718	120	10	of	of	ADP
ajlm-1718	120	11	hhv-6	hhv-6	NOUN
ajlm-1718	120	12	integration	integration	NOUN
ajlm-1718	120	13	among	among	ADP
ajlm-1718	120	14	healthy	healthy	ADJ
ajlm-1718	120	15	sudanese	sudanese	ADJ
ajlm-1718	120	16	population	population	NOUN
ajlm-1718	120	17	are	be	AUX
ajlm-1718	120	18	warranted	warrant	VERB
ajlm-1718	120	19	.	.	PUNCT
ajlm-1718	121	1	alongside	alongside	ADP
ajlm-1718	121	2	hhv-6	hhv-6	NUM
ajlm-1718	121	3	,	,	PUNCT
ajlm-1718	121	4	mixed	mixed	ADJ
ajlm-1718	121	5	microbial	microbial	ADJ
ajlm-1718	121	6	infections	infection	NOUN
ajlm-1718	121	7	were	be	AUX
ajlm-1718	121	8	identified	identify	VERB
ajlm-1718	121	9	in	in	ADP
ajlm-1718	121	10	three	three	NUM
ajlm-1718	121	11	cases	case	NOUN
ajlm-1718	121	12	in	in	ADP
ajlm-1718	121	13	this	this	DET
ajlm-1718	121	14	study	study	NOUN
ajlm-1718	121	15	.	.	PUNCT
ajlm-1718	122	1	several	several	ADJ
ajlm-1718	122	2	authors	author	NOUN
ajlm-1718	122	3	also	also	ADV
ajlm-1718	122	4	reported	report	VERB
ajlm-1718	122	5	mixed	mixed	ADJ
ajlm-1718	122	6	viral	viral	ADJ
ajlm-1718	122	7	infections	infection	NOUN
ajlm-1718	122	8	to	to	ADP
ajlm-1718	122	9	the	the	DET
ajlm-1718	122	10	cns.21,25,26,27	cns.21,25,26,27	NOUN
ajlm-1718	122	11	despite	despite	SCONJ
ajlm-1718	122	12	moderate	moderate	ADJ
ajlm-1718	122	13	neurological	neurological	ADJ
ajlm-1718	122	14	sequel	sequel	NOUN
ajlm-1718	122	15	,	,	PUNCT
ajlm-1718	122	16	and	and	CCONJ
ajlm-1718	122	17	less	less	ADV
ajlm-1718	122	18	likely	likely	ADJ
ajlm-1718	122	19	death	death	NOUN
ajlm-1718	122	20	,	,	PUNCT
ajlm-1718	122	21	patients	patient	NOUN
ajlm-1718	122	22	usually	usually	ADV
ajlm-1718	122	23	recover	recover	VERB
ajlm-1718	122	24	fully	fully	ADV
ajlm-1718	122	25	from	from	ADP
ajlm-1718	122	26	an	an	DET
ajlm-1718	122	27	hhv-6	hhv-6	NOUN
ajlm-1718	122	28	infection22,23	infection22,23	NOUN
ajlm-1718	122	29	,	,	PUNCT
ajlm-1718	122	30	as	as	SCONJ
ajlm-1718	122	31	fortunately	fortunately	ADV
ajlm-1718	122	32	observed	observe	VERB
ajlm-1718	122	33	in	in	ADP
ajlm-1718	122	34	this	this	DET
ajlm-1718	122	35	population	population	NOUN
ajlm-1718	122	36	.	.	PUNCT
ajlm-1718	123	1	limitations	limitation	VERB
ajlm-1718	123	2	a	a	DET
ajlm-1718	123	3	major	major	ADJ
ajlm-1718	123	4	limitation	limitation	NOUN
ajlm-1718	123	5	in	in	ADP
ajlm-1718	123	6	this	this	DET
ajlm-1718	123	7	study	study	NOUN
ajlm-1718	123	8	,	,	PUNCT
ajlm-1718	123	9	however	however	ADV
ajlm-1718	123	10	,	,	PUNCT
ajlm-1718	123	11	is	be	AUX
ajlm-1718	123	12	that	that	SCONJ
ajlm-1718	123	13	we	we	PRON
ajlm-1718	123	14	were	be	AUX
ajlm-1718	123	15	unable	unable	ADJ
ajlm-1718	123	16	to	to	PART
ajlm-1718	123	17	further	far	ADV
ajlm-1718	123	18	genotype	genotype	VERB
ajlm-1718	123	19	our	our	PRON
ajlm-1718	123	20	identified	identify	VERB
ajlm-1718	123	21	hhv-6	hhv-6	ADJ
ajlm-1718	123	22	viral	viral	ADJ
ajlm-1718	123	23	dna	dna	NOUN
ajlm-1718	123	24	because	because	SCONJ
ajlm-1718	123	25	of	of	ADP
ajlm-1718	123	26	a	a	DET
ajlm-1718	123	27	limited	limited	ADJ
ajlm-1718	123	28	csf	csf	ADJ
ajlm-1718	123	29	volume	volume	NOUN
ajlm-1718	123	30	(	(	PUNCT
ajlm-1718	123	31	i.e.	i.e.	X
ajlm-1718	123	32	all	all	DET
ajlm-1718	123	33	available	available	ADJ
ajlm-1718	123	34	csf	csf	NOUN
ajlm-1718	123	35	was	be	AUX
ajlm-1718	123	36	consumed	consume	VERB
ajlm-1718	123	37	in	in	ADP
ajlm-1718	123	38	testing	testing	NOUN
ajlm-1718	123	39	and	and	CCONJ
ajlm-1718	123	40	identifying	identify	VERB
ajlm-1718	123	41	multiple	multiple	ADJ
ajlm-1718	123	42	microbes	microbe	NOUN
ajlm-1718	123	43	–	–	PUNCT
ajlm-1718	123	44	reported	report	VERB
ajlm-1718	123	45	in	in	ADP
ajlm-1718	123	46	other	other	ADJ
ajlm-1718	123	47	publications	publication	NOUN
ajlm-1718	123	48	)	)	PUNCT
ajlm-1718	123	49	.	.	PUNCT
ajlm-1718	124	1	conclusion	conclusion	NOUN
ajlm-1718	124	2	human	human	ADJ
ajlm-1718	124	3	herpes	herpe	NOUN
ajlm-1718	124	4	virus	virus	NOUN
ajlm-1718	124	5	type-6	type-6	PROPN
ajlm-1718	124	6	cns	cns	PROPN
ajlm-1718	124	7	infection	infection	NOUN
ajlm-1718	124	8	is	be	AUX
ajlm-1718	124	9	frequent	frequent	ADJ
ajlm-1718	124	10	in	in	ADP
ajlm-1718	124	11	this	this	DET
ajlm-1718	124	12	population	population	NOUN
ajlm-1718	124	13	(	(	PUNCT
ajlm-1718	124	14	i.e.	i.e.	X
ajlm-1718	124	15	identified	identify	VERB
ajlm-1718	124	16	in	in	ADP
ajlm-1718	124	17	one	one	NUM
ajlm-1718	124	18	-	-	PUNCT
ajlm-1718	124	19	third	third	NOUN
ajlm-1718	124	20	of	of	ADP
ajlm-1718	124	21	cases	case	NOUN
ajlm-1718	124	22	with	with	ADP
ajlm-1718	124	23	proven	prove	VERB
ajlm-1718	124	24	infectious	infectious	ADJ
ajlm-1718	124	25	meningitis	meningiti	NOUN
ajlm-1718	124	26	)	)	PUNCT
ajlm-1718	124	27	.	.	PUNCT
ajlm-1718	125	1	we	we	PRON
ajlm-1718	125	2	recommend	recommend	VERB
ajlm-1718	125	3	studying	study	VERB
ajlm-1718	125	4	the	the	DET
ajlm-1718	125	5	existence	existence	NOUN
ajlm-1718	125	6	and	and	CCONJ
ajlm-1718	125	7	spread	spread	VERB
ajlm-1718	125	8	of	of	ADP
ajlm-1718	125	9	hhv-6	hhv-6	NOUN
ajlm-1718	125	10	chromosomal	chromosomal	ADJ
ajlm-1718	125	11	integration	integration	NOUN
ajlm-1718	125	12	in	in	ADP
ajlm-1718	125	13	the	the	DET
ajlm-1718	125	14	healthy	healthy	ADJ
ajlm-1718	125	15	sudanese	sudanese	ADJ
ajlm-1718	125	16	population	population	NOUN
ajlm-1718	125	17	.	.	PUNCT
ajlm-1718	126	1	acknowledgements	acknowledgement	NOUN
ajlm-1718	126	2	we	we	PRON
ajlm-1718	126	3	acknowledge	acknowledge	VERB
ajlm-1718	126	4	all	all	DET
ajlm-1718	126	5	laboratory	laboratory	NOUN
ajlm-1718	126	6	technologists	technologist	NOUN
ajlm-1718	126	7	in	in	ADP
ajlm-1718	126	8	the	the	DET
ajlm-1718	126	9	bacteriology	bacteriology	NOUN
ajlm-1718	126	10	departments	department	NOUN
ajlm-1718	126	11	of	of	ADP
ajlm-1718	126	12	omdurman	omdurman	ADJ
ajlm-1718	126	13	hospital	hospital	NOUN
ajlm-1718	126	14	for	for	ADP
ajlm-1718	126	15	children	child	NOUN
ajlm-1718	126	16	,	,	PUNCT
ajlm-1718	126	17	the	the	DET
ajlm-1718	126	18	national	national	PROPN
ajlm-1718	126	19	health	health	PROPN
ajlm-1718	126	20	laboratory	laboratory	PROPN
ajlm-1718	126	21	and	and	CCONJ
ajlm-1718	126	22	the	the	DET
ajlm-1718	126	23	central	central	ADJ
ajlm-1718	126	24	public	public	ADJ
ajlm-1718	126	25	laboratories	laboratory	NOUN
ajlm-1718	126	26	at	at	ADP
ajlm-1718	126	27	the	the	DET
ajlm-1718	126	28	ministry	ministry	PROPN
ajlm-1718	126	29	of	of	ADP
ajlm-1718	126	30	health	health	PROPN
ajlm-1718	126	31	for	for	ADP
ajlm-1718	126	32	providing	provide	VERB
ajlm-1718	126	33	clinical	clinical	ADJ
ajlm-1718	126	34	data	datum	NOUN
ajlm-1718	126	35	and	and	CCONJ
ajlm-1718	126	36	specimens	specimen	NOUN
ajlm-1718	126	37	.	.	PUNCT
ajlm-1718	127	1	we	we	PRON
ajlm-1718	127	2	also	also	ADV
ajlm-1718	127	3	thank	thank	VERB
ajlm-1718	127	4	the	the	DET
ajlm-1718	127	5	administrations	administration	NOUN
ajlm-1718	127	6	of	of	ADP
ajlm-1718	127	7	sudan	sudan	PROPN
ajlm-1718	127	8	medical	medical	ADJ
ajlm-1718	127	9	and	and	CCONJ
ajlm-1718	127	10	scientific	scientific	ADJ
ajlm-1718	127	11	research	research	NOUN
ajlm-1718	127	12	institute	institute	PROPN
ajlm-1718	127	13	(	(	PUNCT
ajlm-1718	127	14	sumasri	sumasri	PROPN
ajlm-1718	127	15	)	)	PUNCT
ajlm-1718	127	16	of	of	ADP
ajlm-1718	127	17	the	the	DET
ajlm-1718	127	18	university	university	PROPN
ajlm-1718	127	19	of	of	ADP
ajlm-1718	127	20	medical	medical	ADJ
ajlm-1718	127	21	sciences	science	NOUN
ajlm-1718	127	22	and	and	CCONJ
ajlm-1718	127	23	technology	technology	NOUN
ajlm-1718	127	24	(	(	PUNCT
ajlm-1718	127	25	umst	umst	ADJ
ajlm-1718	127	26	)	)	PUNCT
ajlm-1718	127	27	and	and	CCONJ
ajlm-1718	127	28	that	that	PRON
ajlm-1718	127	29	of	of	ADP
ajlm-1718	127	30	the	the	DET
ajlm-1718	127	31	faculty	faculty	NOUN
ajlm-1718	127	32	of	of	ADP
ajlm-1718	127	33	medical	medical	ADJ
ajlm-1718	127	34	laboratory	laboratory	NOUN
ajlm-1718	127	35	sciences	sciences	PROPN
ajlm-1718	127	36	of	of	ADP
ajlm-1718	127	37	al	al	PROPN
ajlm-1718	127	38	-	-	PUNCT
ajlm-1718	127	39	neelain	neelain	PROPN
ajlm-1718	127	40	university	university	NOUN
ajlm-1718	127	41	in	in	ADP
ajlm-1718	127	42	khartoum	khartoum	PROPN
ajlm-1718	127	43	,	,	PUNCT
ajlm-1718	127	44	sudan	sudan	PROPN
ajlm-1718	127	45	,	,	PUNCT
ajlm-1718	127	46	for	for	ADP
ajlm-1718	127	47	providing	provide	VERB
ajlm-1718	127	48	working	work	VERB
ajlm-1718	127	49	space	space	NOUN
ajlm-1718	127	50	and	and	CCONJ
ajlm-1718	127	51	allowing	allow	VERB
ajlm-1718	127	52	use	use	NOUN
ajlm-1718	127	53	of	of	ADP
ajlm-1718	127	54	laboratory	laboratory	NOUN
ajlm-1718	127	55	ware	ware	NOUN
ajlm-1718	127	56	.	.	PUNCT
ajlm-1718	128	1	we	we	PRON
ajlm-1718	128	2	are	be	AUX
ajlm-1718	128	3	indebted	indebte	VERB
ajlm-1718	128	4	for	for	ADP
ajlm-1718	128	5	the	the	DET
ajlm-1718	128	6	kind	kind	ADJ
ajlm-1718	128	7	gesture	gesture	NOUN
ajlm-1718	128	8	of	of	ADP
ajlm-1718	128	9	a	a	DET
ajlm-1718	128	10	complete	complete	ADJ
ajlm-1718	128	11	bench	bench	NOUN
ajlm-1718	128	12	fee	fee	NOUN
ajlm-1718	128	13	waiver	waiver	NOUN
ajlm-1718	128	14	that	that	PRON
ajlm-1718	128	15	was	be	AUX
ajlm-1718	128	16	provided	provide	VERB
ajlm-1718	128	17	by	by	ADP
ajlm-1718	128	18	the	the	DET
ajlm-1718	128	19	department	department	NOUN
ajlm-1718	128	20	of	of	ADP
ajlm-1718	128	21	clinical	clinical	ADJ
ajlm-1718	128	22	microbiology	microbiology	NOUN
ajlm-1718	128	23	,	,	PUNCT
ajlm-1718	128	24	umeå	umeå	PROPN
ajlm-1718	128	25	university	university	PROPN
ajlm-1718	128	26	in	in	ADP
ajlm-1718	128	27	umeå	umeå	PROPN
ajlm-1718	128	28	,	,	PUNCT
ajlm-1718	128	29	sweden	sweden	PROPN
ajlm-1718	128	30	,	,	PUNCT
ajlm-1718	128	31	to	to	PART
ajlm-1718	128	32	perform	perform	VERB
ajlm-1718	128	33	all	all	DET
ajlm-1718	128	34	molecular	molecular	ADJ
ajlm-1718	128	35	investigations	investigation	NOUN
ajlm-1718	128	36	.	.	PUNCT
ajlm-1718	129	1	we	we	PRON
ajlm-1718	129	2	thank	thank	VERB
ajlm-1718	129	3	professor	professor	PROPN
ajlm-1718	129	4	hassan	hassan	PROPN
ajlm-1718	129	5	mohammed	mohammed	PROPN
ajlm-1718	129	6	ali	ali	PROPN
ajlm-1718	129	7	for	for	ADP
ajlm-1718	129	8	his	his	PRON
ajlm-1718	129	9	great	great	ADJ
ajlm-1718	129	10	efforts	effort	NOUN
ajlm-1718	129	11	in	in	ADP
ajlm-1718	129	12	revising	revise	VERB
ajlm-1718	129	13	the	the	DET
ajlm-1718	129	14	manuscript	manuscript	NOUN
ajlm-1718	129	15	.	.	PUNCT
ajlm-1718	130	1	competing	compete	VERB
ajlm-1718	130	2	interests	interest	NOUN
ajlm-1718	130	3	we	we	PRON
ajlm-1718	130	4	,	,	PUNCT
ajlm-1718	130	5	the	the	DET
ajlm-1718	130	6	authors	author	NOUN
ajlm-1718	130	7	,	,	PUNCT
ajlm-1718	130	8	declare	declare	VERB
ajlm-1718	130	9	that	that	SCONJ
ajlm-1718	130	10	we	we	PRON
ajlm-1718	130	11	have	have	VERB
ajlm-1718	130	12	no	no	DET
ajlm-1718	130	13	competing	compete	VERB
ajlm-1718	130	14	interests	interest	NOUN
ajlm-1718	130	15	with	with	ADP
ajlm-1718	130	16	respect	respect	NOUN
ajlm-1718	130	17	to	to	ADP
ajlm-1718	130	18	the	the	DET
ajlm-1718	130	19	research	research	NOUN
ajlm-1718	130	20	,	,	PUNCT
ajlm-1718	130	21	authorship	authorship	NOUN
ajlm-1718	130	22	or	or	CCONJ
ajlm-1718	130	23	publication	publication	NOUN
ajlm-1718	130	24	of	of	ADP
ajlm-1718	130	25	this	this	DET
ajlm-1718	130	26	article	article	NOUN
ajlm-1718	130	27	.	.	PUNCT
ajlm-1718	131	1	authors	author	NOUN
ajlm-1718	131	2	’	’	PART
ajlm-1718	131	3	contributions	contribution	NOUN
ajlm-1718	131	4	n.a.a	n.a.a	PROPN
ajlm-1718	131	5	.	.	PROPN
ajlm-1718	131	6	developed	develop	VERB
ajlm-1718	131	7	research	research	NOUN
ajlm-1718	131	8	questions	question	NOUN
ajlm-1718	131	9	and	and	CCONJ
ajlm-1718	131	10	design	design	NOUN
ajlm-1718	131	11	,	,	PUNCT
ajlm-1718	131	12	collected	collect	VERB
ajlm-1718	131	13	and	and	CCONJ
ajlm-1718	131	14	managed	manage	VERB
ajlm-1718	131	15	all	all	DET
ajlm-1718	131	16	data	datum	NOUN
ajlm-1718	131	17	,	,	PUNCT
ajlm-1718	131	18	performed	perform	VERB
ajlm-1718	131	19	all	all	DET
ajlm-1718	131	20	laboratory	laboratory	NOUN
ajlm-1718	131	21	work	work	NOUN
ajlm-1718	131	22	,	,	PUNCT
ajlm-1718	131	23	statistical	statistical	ADJ
ajlm-1718	131	24	analysis	analysis	NOUN
ajlm-1718	131	25	and	and	CCONJ
ajlm-1718	131	26	interpretation	interpretation	NOUN
ajlm-1718	131	27	,	,	PUNCT
ajlm-1718	131	28	wrote	write	VERB
ajlm-1718	131	29	and	and	CCONJ
ajlm-1718	131	30	edited	edit	VERB
ajlm-1718	131	31	the	the	DET
ajlm-1718	131	32	text	text	NOUN
ajlm-1718	131	33	.	.	PUNCT
ajlm-1718	132	1	n.m	n.m	NOUN
ajlm-1718	132	2	.	.	PROPN
ajlm-1718	132	3	advised	advise	VERB
ajlm-1718	132	4	on	on	ADP
ajlm-1718	132	5	the	the	DET
ajlm-1718	132	6	approach	approach	NOUN
ajlm-1718	132	7	and	and	CCONJ
ajlm-1718	132	8	methodology	methodology	NOUN
ajlm-1718	132	9	and	and	CCONJ
ajlm-1718	132	10	guided	guide	VERB
ajlm-1718	132	11	and	and	CCONJ
ajlm-1718	132	12	supervised	supervise	VERB
ajlm-1718	132	13	the	the	DET
ajlm-1718	132	14	molecular	molecular	ADJ
ajlm-1718	132	15	laboratory	laboratory	NOUN
ajlm-1718	132	16	work	work	NOUN
ajlm-1718	132	17	.	.	PUNCT
ajlm-1718	133	1	m.e	m.e	PROPN
ajlm-1718	133	2	.	.	PROPN
ajlm-1718	133	3	and	and	CCONJ
ajlm-1718	133	4	c.a	c.a	PROPN
ajlm-1718	133	5	.	.	PROPN
ajlm-1718	133	6	contributed	contribute	VERB
ajlm-1718	133	7	to	to	ADP
ajlm-1718	133	8	the	the	DET
ajlm-1718	133	9	approach	approach	NOUN
ajlm-1718	133	10	and	and	CCONJ
ajlm-1718	133	11	methodology	methodology	NOUN
ajlm-1718	133	12	,	,	PUNCT
ajlm-1718	133	13	supervised	supervise	VERB
ajlm-1718	133	14	the	the	DET
ajlm-1718	133	15	molecular	molecular	ADJ
ajlm-1718	133	16	laboratory	laboratory	NOUN
ajlm-1718	133	17	work	work	NOUN
ajlm-1718	133	18	,	,	PUNCT
ajlm-1718	133	19	edited	edit	VERB
ajlm-1718	133	20	and	and	CCONJ
ajlm-1718	133	21	proofread	proofread	VERB
ajlm-1718	133	22	the	the	DET
ajlm-1718	133	23	manuscript	manuscript	NOUN
ajlm-1718	133	24	and	and	CCONJ
ajlm-1718	133	25	were	be	AUX
ajlm-1718	133	26	major	major	ADJ
ajlm-1718	133	27	contributors	contributor	NOUN
ajlm-1718	133	28	in	in	ADP
ajlm-1718	133	29	the	the	DET
ajlm-1718	133	30	overall	overall	ADJ
ajlm-1718	133	31	study	study	NOUN
ajlm-1718	133	32	.	.	PUNCT
ajlm-1718	134	1	i.m.f.-e	i.m.f.-e	NOUN
ajlm-1718	134	2	.	.	PROPN
ajlm-1718	134	3	supervised	supervise	VERB
ajlm-1718	134	4	the	the	DET
ajlm-1718	134	5	research	research	NOUN
ajlm-1718	134	6	process	process	NOUN
ajlm-1718	134	7	throughout	throughout	ADV
ajlm-1718	134	8	,	,	PUNCT
ajlm-1718	134	9	contributed	contribute	VERB
ajlm-1718	134	10	in	in	ADP
ajlm-1718	134	11	the	the	DET
ajlm-1718	134	12	development	development	NOUN
ajlm-1718	134	13	of	of	ADP
ajlm-1718	134	14	research	research	NOUN
ajlm-1718	134	15	questions	question	NOUN
ajlm-1718	134	16	,	,	PUNCT
ajlm-1718	134	17	design	design	NOUN
ajlm-1718	134	18	and	and	CCONJ
ajlm-1718	134	19	methodology	methodology	NOUN
ajlm-1718	134	20	,	,	PUNCT
ajlm-1718	134	21	and	and	CCONJ
ajlm-1718	134	22	managed	manage	VERB
ajlm-1718	134	23	all	all	DET
ajlm-1718	134	24	logistics	logistic	NOUN
ajlm-1718	134	25	and	and	CCONJ
ajlm-1718	134	26	clinic	clinic	NOUN
ajlm-1718	134	27	-	-	PUNCT
ajlm-1718	134	28	based	base	VERB
ajlm-1718	134	29	activities	activity	NOUN
ajlm-1718	134	30	.	.	PUNCT
ajlm-1718	135	1	all	all	DET
ajlm-1718	135	2	authors	author	NOUN
ajlm-1718	135	3	have	have	AUX
ajlm-1718	135	4	read	read	VERB
ajlm-1718	135	5	and	and	CCONJ
ajlm-1718	135	6	approved	approve	VERB
ajlm-1718	135	7	the	the	DET
ajlm-1718	135	8	final	final	ADJ
ajlm-1718	135	9	manuscript	manuscript	NOUN
ajlm-1718	135	10	.	.	PUNCT
ajlm-1718	136	1	sources	source	NOUN
ajlm-1718	136	2	of	of	ADP
ajlm-1718	136	3	support	support	NOUN
ajlm-1718	136	4	molecular	molecular	ADJ
ajlm-1718	136	5	laboratory	laboratory	NOUN
ajlm-1718	136	6	investigations	investigation	NOUN
ajlm-1718	136	7	were	be	AUX
ajlm-1718	136	8	supported	support	VERB
ajlm-1718	136	9	by	by	ADP
ajlm-1718	136	10	the	the	DET
ajlm-1718	136	11	department	department	NOUN
ajlm-1718	136	12	of	of	ADP
ajlm-1718	136	13	clinical	clinical	ADJ
ajlm-1718	136	14	microbiology	microbiology	NOUN
ajlm-1718	136	15	at	at	ADP
ajlm-1718	136	16	umeå	umeå	PROPN
ajlm-1718	136	17	university	university	PROPN
ajlm-1718	136	18	in	in	ADP
ajlm-1718	136	19	umeå	umeå	PROPN
ajlm-1718	136	20	,	,	PUNCT
ajlm-1718	136	21	sweden	sweden	PROPN
ajlm-1718	136	22	.	.	PUNCT
ajlm-1718	137	1	all	all	DET
ajlm-1718	137	2	remaining	remain	VERB
ajlm-1718	137	3	project	project	NOUN
ajlm-1718	137	4	expenses	expense	NOUN
ajlm-1718	137	5	were	be	AUX
ajlm-1718	137	6	self	self	NOUN
ajlm-1718	137	7	-	-	PUNCT
ajlm-1718	137	8	financed	finance	VERB
ajlm-1718	137	9	.	.	PUNCT
ajlm-1718	138	1	data	datum	NOUN
ajlm-1718	138	2	availability	availability	NOUN
ajlm-1718	138	3	the	the	DET
ajlm-1718	138	4	data	data	NOUN
ajlm-1718	138	5	sets	set	NOUN
ajlm-1718	138	6	used	use	VERB
ajlm-1718	138	7	and	and	CCONJ
ajlm-1718	138	8	analysed	analyse	VERB
ajlm-1718	138	9	during	during	ADP
ajlm-1718	138	10	the	the	DET
ajlm-1718	138	11	current	current	ADJ
ajlm-1718	138	12	study	study	NOUN
ajlm-1718	138	13	will	will	AUX
ajlm-1718	138	14	be	be	AUX
ajlm-1718	138	15	available	available	ADJ
ajlm-1718	138	16	from	from	ADP
ajlm-1718	138	17	the	the	DET
ajlm-1718	138	18	corresponding	corresponding	ADJ
ajlm-1718	138	19	author	author	NOUN
ajlm-1718	138	20	,	,	PUNCT
ajlm-1718	138	21	n.a	n.a	PROPN
ajlm-1718	138	22	.	.	PROPN
ajlm-1718	138	23	,	,	PUNCT
ajlm-1718	138	24	on	on	ADP
ajlm-1718	138	25	reasonable	reasonable	ADJ
ajlm-1718	138	26	request	request	NOUN
ajlm-1718	138	27	once	once	ADV
ajlm-1718	138	28	all	all	DET
ajlm-1718	138	29	related	related	ADJ
ajlm-1718	138	30	articles	article	NOUN
ajlm-1718	138	31	are	be	AUX
ajlm-1718	138	32	published	publish	VERB
ajlm-1718	138	33	.	.	PUNCT
ajlm-1718	139	1	disclaimer	disclaimer	ADJ
ajlm-1718	139	2	views	view	NOUN
ajlm-1718	139	3	expressed	express	VERB
ajlm-1718	139	4	in	in	ADP
ajlm-1718	139	5	this	this	DET
ajlm-1718	139	6	article	article	NOUN
ajlm-1718	139	7	are	be	AUX
ajlm-1718	139	8	the	the	DET
ajlm-1718	139	9	authors	author	NOUN
ajlm-1718	139	10	’	'	PUNCT
ajlm-1718	139	11	own	own	ADJ
ajlm-1718	139	12	;	;	PUNCT
ajlm-1718	139	13	they	they	PRON
ajlm-1718	139	14	are	be	AUX
ajlm-1718	139	15	not	not	PART
ajlm-1718	139	16	an	an	DET
ajlm-1718	139	17	official	official	ADJ
ajlm-1718	139	18	position	position	NOUN
ajlm-1718	139	19	of	of	ADP
ajlm-1718	139	20	the	the	DET
ajlm-1718	139	21	institution	institution	NOUN
ajlm-1718	139	22	or	or	CCONJ
ajlm-1718	139	23	funder	funder	NOUN
ajlm-1718	139	24	.	.	PUNCT
ajlm-1718	140	1	references	reference	NOUN
ajlm-1718	140	2	pruksananonda	pruksananonda	PROPN
ajlm-1718	140	3	p	p	PROPN
ajlm-1718	140	4	,	,	PUNCT
ajlm-1718	140	5	hall	hall	PROPN
ajlm-1718	140	6	cb	cb	PROPN
ajlm-1718	140	7	,	,	PUNCT
ajlm-1718	140	8	insel	insel	PROPN
ajlm-1718	140	9	ra	ra	PROPN
ajlm-1718	140	10	,	,	PUNCT
ajlm-1718	140	11	et	et	PROPN
ajlm-1718	140	12	al	al	PROPN
ajlm-1718	140	13	.	.	PROPN
ajlm-1718	141	1	primary	primary	ADJ
ajlm-1718	141	2	human	human	ADJ
ajlm-1718	141	3	herpesvirus	herpesvirus	NOUN
ajlm-1718	141	4	6	6	NUM
ajlm-1718	141	5	infection	infection	NOUN
ajlm-1718	141	6	in	in	ADP
ajlm-1718	141	7	young	young	ADJ
ajlm-1718	141	8	children	child	NOUN
ajlm-1718	141	9	.	.	PUNCT
ajlm-1718	142	1	n	n	PROPN
ajlm-1718	142	2	engl	engl	PROPN
ajlm-1718	142	3	j	j	PROPN
ajlm-1718	142	4	med	med	PROPN
ajlm-1718	142	5	.	.	PUNCT
ajlm-1718	143	1	1992;326(22):1445–1450	1992;326(22):1445–1450	NUM
ajlm-1718	143	2	.	.	PUNCT
ajlm-1718	144	1	https://doi.org/10.1056/nejm199205283262201	https://doi.org/10.1056/nejm199205283262201	PROPN
ajlm-1718	144	2	briggs	briggs	PROPN
ajlm-1718	144	3	m	m	PROPN
ajlm-1718	144	4	,	,	PUNCT
ajlm-1718	144	5	fox	fox	PROPN
ajlm-1718	144	6	j	j	PROPN
ajlm-1718	144	7	,	,	PUNCT
ajlm-1718	144	8	tedder	tedder	PROPN
ajlm-1718	144	9	rs	rs	NOUN
ajlm-1718	144	10	.	.	PUNCT
ajlm-1718	145	1	age	age	NOUN
ajlm-1718	145	2	prevalence	prevalence	NOUN
ajlm-1718	145	3	of	of	ADP
ajlm-1718	145	4	antibody	antibody	NOUN
ajlm-1718	145	5	to	to	ADP
ajlm-1718	145	6	human	human	ADJ
ajlm-1718	145	7	herpesvirus	herpesvirus	NOUN
ajlm-1718	145	8	6	6	NUM
ajlm-1718	145	9	.	.	PUNCT
ajlm-1718	146	1	lancet	lancet	NOUN
ajlm-1718	146	2	.	.	PUNCT
ajlm-1718	147	1	1988;1(8593):1058–1059	1988;1(8593):1058–1059	NUM
ajlm-1718	147	2	.	.	PUNCT
ajlm-1718	147	3	https://doi.org/10.1016/s0140-6736(88)91883-1	https://doi.org/10.1016/s0140-6736(88)91883-1	PROPN
ajlm-1718	147	4	lusso	lusso	PROPN
ajlm-1718	147	5	p	p	NOUN
ajlm-1718	147	6	,	,	PUNCT
ajlm-1718	147	7	gallo	gallo	PROPN
ajlm-1718	147	8	rc	rc	PROPN
ajlm-1718	147	9	.	.	PUNCT
ajlm-1718	147	10	human	human	ADJ
ajlm-1718	147	11	herpesvirus	herpesvirus	NOUN
ajlm-1718	147	12	6	6	NUM
ajlm-1718	147	13	in	in	ADP
ajlm-1718	147	14	aids	aids	PROPN
ajlm-1718	147	15	.	.	PUNCT
ajlm-1718	148	1	immunol	immunol	NOUN
ajlm-1718	148	2	today	today	NOUN
ajlm-1718	148	3	.	.	PUNCT
ajlm-1718	149	1	1995;16(2):67–71	1995;16(2):67–71	X
ajlm-1718	149	2	.	.	PUNCT
ajlm-1718	150	1	https://doi.org/10.1016/0167-5699(95)80090-5	https://doi.org/10.1016/0167-5699(95)80090-5	PROPN
ajlm-1718	150	2	kondo	kondo	PROPN
ajlm-1718	150	3	k	k	PROPN
ajlm-1718	150	4	,	,	PUNCT
ajlm-1718	150	5	nagafuji	nagafuji	ADJ
ajlm-1718	150	6	h	h	NOUN
ajlm-1718	150	7	,	,	PUNCT
ajlm-1718	150	8	hata	hata	VERB
ajlm-1718	150	9	a	a	PRON
ajlm-1718	150	10	,	,	PUNCT
ajlm-1718	150	11	tomomori	tomomori	NOUN
ajlm-1718	150	12	c	c	NOUN
ajlm-1718	150	13	,	,	PUNCT
ajlm-1718	150	14	yamanishi	yamanishi	PROPN
ajlm-1718	150	15	k.	k.	PROPN
ajlm-1718	150	16	association	association	PROPN
ajlm-1718	150	17	of	of	ADP
ajlm-1718	150	18	human	human	ADJ
ajlm-1718	150	19	herpesvirus	herpesvirus	NOUN
ajlm-1718	150	20	6	6	NUM
ajlm-1718	150	21	infection	infection	NOUN
ajlm-1718	150	22	of	of	ADP
ajlm-1718	150	23	the	the	DET
ajlm-1718	150	24	central	central	ADJ
ajlm-1718	150	25	nervous	nervous	ADJ
ajlm-1718	150	26	system	system	NOUN
ajlm-1718	150	27	with	with	ADP
ajlm-1718	150	28	recurrence	recurrence	NOUN
ajlm-1718	150	29	of	of	ADP
ajlm-1718	150	30	febrile	febrile	NOUN
ajlm-1718	150	31	convulsions	convulsion	NOUN
ajlm-1718	150	32	.	.	PUNCT
ajlm-1718	151	1	j	j	PROPN
ajlm-1718	151	2	infect	infect	VERB
ajlm-1718	151	3	dis	dis	PROPN
ajlm-1718	151	4	.	.	PUNCT
ajlm-1718	152	1	1993;167(5):1197–1200	1993;167(5):1197–1200	NUM
ajlm-1718	152	2	.	.	PUNCT
ajlm-1718	153	1	https://doi.org/10.1093/infdis/167.5.1197	https://doi.org/10.1093/infdis/167.5.1197	PROPN
ajlm-1718	153	2	hall	hall	PROPN
ajlm-1718	153	3	cb	cb	PROPN
ajlm-1718	153	4	,	,	PUNCT
ajlm-1718	153	5	long	long	PROPN
ajlm-1718	153	6	ce	ce	PROPN
ajlm-1718	153	7	,	,	PUNCT
ajlm-1718	153	8	schnabel	schnabel	PROPN
ajlm-1718	153	9	kc	kc	PROPN
ajlm-1718	153	10	,	,	PUNCT
ajlm-1718	153	11	et	et	PROPN
ajlm-1718	153	12	al	al	PROPN
ajlm-1718	153	13	.	.	PUNCT
ajlm-1718	154	1	human	human	NOUN
ajlm-1718	154	2	herpesvirus-6	herpesvirus-6	NUM
ajlm-1718	154	3	infection	infection	NOUN
ajlm-1718	154	4	in	in	ADP
ajlm-1718	154	5	children	child	NOUN
ajlm-1718	154	6	;	;	PUNCT
ajlm-1718	154	7	a	a	DET
ajlm-1718	154	8	prospective	prospective	ADJ
ajlm-1718	154	9	study	study	NOUN
ajlm-1718	154	10	of	of	ADP
ajlm-1718	154	11	complications	complication	NOUN
ajlm-1718	154	12	and	and	CCONJ
ajlm-1718	154	13	reactivation	reactivation	NOUN
ajlm-1718	154	14	.	.	PUNCT
ajlm-1718	155	1	n	n	PROPN
ajlm-1718	155	2	engl	engl	PROPN
ajlm-1718	155	3	j	j	PROPN
ajlm-1718	155	4	med	med	PROPN
ajlm-1718	155	5	.	.	PUNCT
ajlm-1718	156	1	1994;331(7):432–438	1994;331(7):432–438	X
ajlm-1718	156	2	.	.	PUNCT
ajlm-1718	156	3	https://doi.org/10.1056/nejm199408183310703	https://doi.org/10.1056/nejm199408183310703	VERB
ajlm-1718	156	4	koskiniemi	koskiniemi	PROPN
ajlm-1718	156	5	m	m	PROPN
ajlm-1718	156	6	,	,	PUNCT
ajlm-1718	156	7	rautonen	rautonen	PROPN
ajlm-1718	156	8	j	j	PROPN
ajlm-1718	156	9	,	,	PUNCT
ajlm-1718	156	10	lehtokoski	lehtokoski	ADJ
ajlm-1718	156	11	-	-	PUNCT
ajlm-1718	156	12	lehtiniemi	lehtiniemi	ADJ
ajlm-1718	156	13	e	e	NOUN
ajlm-1718	156	14	,	,	PUNCT
ajlm-1718	156	15	vaheri	vaheri	ADJ
ajlm-1718	156	16	a.	a.	NOUN
ajlm-1718	156	17	epidemiology	epidemiology	NOUN
ajlm-1718	156	18	of	of	ADP
ajlm-1718	156	19	encephalitis	encephalitis	NOUN
ajlm-1718	156	20	in	in	ADP
ajlm-1718	156	21	children	child	NOUN
ajlm-1718	156	22	:	:	PUNCT
ajlm-1718	156	23	a	a	DET
ajlm-1718	156	24	20	20	NUM
ajlm-1718	156	25	-	-	PUNCT
ajlm-1718	156	26	year	year	NOUN
ajlm-1718	156	27	survey	survey	NOUN
ajlm-1718	156	28	.	.	PUNCT
ajlm-1718	157	1	ann	ann	PROPN
ajlm-1718	157	2	neurol	neurol	PROPN
ajlm-1718	157	3	.	.	PUNCT
ajlm-1718	158	1	1991;29(5):492–499	1991;29(5):492–499	NUM
ajlm-1718	158	2	.	.	PUNCT
ajlm-1718	159	1	https://doi.org/10.1002/ana.410290508	https://doi.org/10.1002/ana.410290508	PROPN
ajlm-1718	159	2	kolski	kolski	PROPN
ajlm-1718	159	3	h	h	PROPN
ajlm-1718	159	4	,	,	PUNCT
ajlm-1718	159	5	ford	ford	PROPN
ajlm-1718	159	6	-	-	PUNCT
ajlm-1718	159	7	jones	jones	PROPN
ajlm-1718	159	8	el	el	PROPN
ajlm-1718	159	9	,	,	PUNCT
ajlm-1718	159	10	richardson	richardson	PROPN
ajlm-1718	159	11	s	s	PROPN
ajlm-1718	159	12	,	,	PUNCT
ajlm-1718	159	13	et	et	PROPN
ajlm-1718	159	14	al	al	PROPN
ajlm-1718	159	15	.	.	PROPN
ajlm-1718	159	16	etiology	etiology	NOUN
ajlm-1718	159	17	of	of	ADP
ajlm-1718	159	18	acute	acute	ADJ
ajlm-1718	159	19	childhood	childhood	NOUN
ajlm-1718	159	20	encephalitis	encephalitis	NOUN
ajlm-1718	159	21	at	at	ADP
ajlm-1718	159	22	the	the	DET
ajlm-1718	159	23	hospital	hospital	NOUN
ajlm-1718	159	24	for	for	ADP
ajlm-1718	159	25	sick	sick	ADJ
ajlm-1718	159	26	children	child	NOUN
ajlm-1718	159	27	,	,	PUNCT
ajlm-1718	159	28	toronto	toronto	PROPN
ajlm-1718	159	29	,	,	PUNCT
ajlm-1718	159	30	1994–1995	1994–1995	NUM
ajlm-1718	159	31	.	.	PUNCT
ajlm-1718	160	1	clin	clin	PROPN
ajlm-1718	160	2	infect	infect	PROPN
ajlm-1718	160	3	dis	dis	PROPN
ajlm-1718	160	4	.	.	PUNCT
ajlm-1718	160	5	1998;26(2):398–409	1998;26(2):398–409	NUM
ajlm-1718	160	6	.	.	PUNCT
ajlm-1718	160	7	https://doi.org/10.1086/516301	https://doi.org/10.1086/516301	PROPN
ajlm-1718	161	1	yoshikawa	yoshikawa	PROPN
ajlm-1718	161	2	t	t	PROPN
ajlm-1718	161	3	,	,	PUNCT
ajlm-1718	161	4	asano	asano	PROPN
ajlm-1718	161	5	y.	y.	PROPN
ajlm-1718	161	6	central	central	ADJ
ajlm-1718	161	7	nervous	nervous	ADJ
ajlm-1718	161	8	system	system	NOUN
ajlm-1718	161	9	complications	complication	NOUN
ajlm-1718	161	10	in	in	ADP
ajlm-1718	161	11	human	human	ADJ
ajlm-1718	161	12	herpesvirus-6	herpesvirus-6	PRON
ajlm-1718	161	13	infection	infection	NOUN
ajlm-1718	161	14	.	.	PUNCT
ajlm-1718	162	1	brain	brain	PROPN
ajlm-1718	162	2	dev	dev	PROPN
ajlm-1718	162	3	.	.	PUNCT
ajlm-1718	163	1	2000;22(5):307–314	2000;22(5):307–314	X
ajlm-1718	163	2	.	.	PUNCT
ajlm-1718	164	1	https://doi.org/10.1016/s0387-7604(00)00113-3	https://doi.org/10.1016/s0387-7604(00)00113-3	PROPN
ajlm-1718	164	2	whitley	whitley	PROPN
ajlm-1718	164	3	rj	rj	PROPN
ajlm-1718	164	4	,	,	PUNCT
ajlm-1718	164	5	gnann	gnann	PROPN
ajlm-1718	164	6	jw	jw	PROPN
ajlm-1718	164	7	.	.	PROPN
ajlm-1718	164	8	viral	viral	ADJ
ajlm-1718	164	9	encephalitis	encephalitis	NOUN
ajlm-1718	164	10	:	:	PUNCT
ajlm-1718	164	11	familiar	familiar	ADJ
ajlm-1718	164	12	infections	infection	NOUN
ajlm-1718	164	13	and	and	CCONJ
ajlm-1718	164	14	emerging	emerge	VERB
ajlm-1718	164	15	pathogens	pathogen	NOUN
ajlm-1718	164	16	.	.	PUNCT
ajlm-1718	165	1	lancet	lancet	VERB
ajlm-1718	165	2	.	.	PUNCT
ajlm-1718	166	1	2002;359(9305):507–513	2002;359(9305):507–513	NUM
ajlm-1718	166	2	.	.	PUNCT
ajlm-1718	167	1	https://doi.org/10.1016/s0140-6736(02)07681-x	https://doi.org/10.1016/s0140-6736(02)07681-x	PROPN
ajlm-1718	167	2	theodore	theodore	PROPN
ajlm-1718	167	3	wh	wh	PROPN
ajlm-1718	167	4	,	,	PUNCT
ajlm-1718	167	5	epstein	epstein	PROPN
ajlm-1718	167	6	l	l	PROPN
ajlm-1718	167	7	,	,	PUNCT
ajlm-1718	167	8	gaillard	gaillard	PROPN
ajlm-1718	167	9	wd	wd	PROPN
ajlm-1718	167	10	,	,	PUNCT
ajlm-1718	167	11	shinnar	shinnar	PROPN
ajlm-1718	167	12	s	s	PROPN
ajlm-1718	167	13	,	,	PUNCT
ajlm-1718	167	14	wainwright	wainwright	PROPN
ajlm-1718	167	15	ms	ms	PROPN
ajlm-1718	167	16	,	,	PUNCT
ajlm-1718	167	17	jacobson	jacobson	PROPN
ajlm-1718	167	18	s.	s.	PROPN
ajlm-1718	167	19	human	human	PROPN
ajlm-1718	167	20	herpes	herpes	PROPN
ajlm-1718	167	21	virus	virus	NOUN
ajlm-1718	167	22	6b	6b	NOUN
ajlm-1718	167	23	:	:	PUNCT
ajlm-1718	167	24	a	a	DET
ajlm-1718	167	25	possible	possible	ADJ
ajlm-1718	167	26	role	role	NOUN
ajlm-1718	167	27	in	in	ADP
ajlm-1718	167	28	epilepsy	epilepsy	NOUN
ajlm-1718	167	29	?	?	PUNCT
ajlm-1718	168	1	epilepsia	epilepsia	NOUN
ajlm-1718	168	2	.	.	PUNCT
ajlm-1718	169	1	2008;49(11):1828–1837	2008;49(11):1828–1837	NUM
ajlm-1718	169	2	.	.	PUNCT
ajlm-1718	170	1	https://doi.org/10.1111/j.1528-1167.2008.01699.x	https://doi.org/10.1111/j.1528-1167.2008.01699.x	PROPN
ajlm-1718	170	2	yao	yao	PROPN
ajlm-1718	171	1	k	k	PROPN
ajlm-1718	171	2	,	,	PUNCT
ajlm-1718	171	3	honarmand	honarmand	PROPN
ajlm-1718	171	4	s	s	PROPN
ajlm-1718	171	5	,	,	PUNCT
ajlm-1718	171	6	espinosa	espinosa	PROPN
ajlm-1718	171	7	a	a	PRON
ajlm-1718	171	8	,	,	PUNCT
ajlm-1718	171	9	akhyani	akhyani	NOUN
ajlm-1718	171	10	n	n	CCONJ
ajlm-1718	171	11	,	,	PUNCT
ajlm-1718	171	12	glaser	glaser	PROPN
ajlm-1718	171	13	c	c	PROPN
ajlm-1718	171	14	,	,	PUNCT
ajlm-1718	171	15	jacobson	jacobson	PROPN
ajlm-1718	171	16	s.	s.	PROPN
ajlm-1718	171	17	detection	detection	PROPN
ajlm-1718	171	18	of	of	ADP
ajlm-1718	171	19	human	human	NOUN
ajlm-1718	171	20	herpesvirus-6	herpesvirus-6	NOUN
ajlm-1718	171	21	in	in	ADP
ajlm-1718	171	22	cerebrospinal	cerebrospinal	ADJ
ajlm-1718	171	23	fluid	fluid	NOUN
ajlm-1718	171	24	of	of	ADP
ajlm-1718	171	25	patients	patient	NOUN
ajlm-1718	171	26	with	with	ADP
ajlm-1718	171	27	encephalitis	encephalitis	NOUN
ajlm-1718	171	28	.	.	PUNCT
ajlm-1718	172	1	ann	ann	PROPN
ajlm-1718	172	2	neurol	neurol	PROPN
ajlm-1718	172	3	.	.	PUNCT
ajlm-1718	173	1	2009;65(3):257–267	2009;65(3):257–267	X
ajlm-1718	173	2	.	.	PUNCT
ajlm-1718	174	1	https://doi.org/10.1002/ana.21611	https://doi.org/10.1002/ana.21611	PROPN
ajlm-1718	174	2	clark	clark	PROPN
ajlm-1718	174	3	da	da	PROPN
ajlm-1718	174	4	,	,	PUNCT
ajlm-1718	174	5	nacheva	nacheva	VERB
ajlm-1718	174	6	ep	ep	PROPN
ajlm-1718	174	7	,	,	PUNCT
ajlm-1718	174	8	leong	leong	PROPN
ajlm-1718	174	9	hn	hn	PROPN
ajlm-1718	174	10	,	,	PUNCT
ajlm-1718	174	11	et	et	PROPN
ajlm-1718	174	12	al	al	PROPN
ajlm-1718	174	13	.	.	PUNCT
ajlm-1718	175	1	transmission	transmission	NOUN
ajlm-1718	175	2	of	of	ADP
ajlm-1718	175	3	integrated	integrate	VERB
ajlm-1718	175	4	human	human	ADJ
ajlm-1718	175	5	herpesvirus	herpesvirus	NOUN
ajlm-1718	175	6	6	6	NUM
ajlm-1718	175	7	through	through	ADP
ajlm-1718	175	8	stem	stem	NOUN
ajlm-1718	175	9	cell	cell	NOUN
ajlm-1718	175	10	transplantation	transplantation	NOUN
ajlm-1718	175	11	:	:	PUNCT
ajlm-1718	175	12	implications	implication	NOUN
ajlm-1718	175	13	for	for	ADP
ajlm-1718	175	14	laboratory	laboratory	NOUN
ajlm-1718	175	15	diagnosis	diagnosis	NOUN
ajlm-1718	175	16	.	.	PUNCT
ajlm-1718	176	1	j	j	PROPN
ajlm-1718	176	2	infect	infect	VERB
ajlm-1718	176	3	dis	dis	PROPN
ajlm-1718	176	4	.	.	PUNCT
ajlm-1718	177	1	2006;193(7):912–916	2006;193(7):912–916	NUM
ajlm-1718	177	2	.	.	PUNCT
ajlm-1718	177	3	https://doi.org/10.1086/500838	https://doi.org/10.1086/500838	PRON
ajlm-1718	177	4	ward	ward	PROPN
ajlm-1718	177	5	kn	kn	PROPN
ajlm-1718	177	6	,	,	PUNCT
ajlm-1718	177	7	leong	leong	PROPN
ajlm-1718	177	8	hn	hn	PROPN
ajlm-1718	177	9	,	,	PUNCT
ajlm-1718	177	10	nacheva	nacheva	VERB
ajlm-1718	177	11	ep	ep	PROPN
ajlm-1718	177	12	,	,	PUNCT
ajlm-1718	177	13	et	et	PROPN
ajlm-1718	177	14	al	al	PROPN
ajlm-1718	177	15	.	.	PUNCT
ajlm-1718	178	1	human	human	ADJ
ajlm-1718	178	2	herpesvirus	herpesvirus	NOUN
ajlm-1718	178	3	6	6	NUM
ajlm-1718	178	4	chromosomal	chromosomal	ADJ
ajlm-1718	178	5	integration	integration	NOUN
ajlm-1718	178	6	in	in	ADP
ajlm-1718	178	7	immunocompetent	immunocompetent	ADJ
ajlm-1718	178	8	patients	patient	NOUN
ajlm-1718	178	9	results	result	VERB
ajlm-1718	178	10	in	in	ADP
ajlm-1718	178	11	high	high	ADJ
ajlm-1718	178	12	levels	level	NOUN
ajlm-1718	178	13	of	of	ADP
ajlm-1718	178	14	viral	viral	ADJ
ajlm-1718	178	15	dna	dna	NOUN
ajlm-1718	178	16	in	in	ADP
ajlm-1718	178	17	blood	blood	NOUN
ajlm-1718	178	18	,	,	PUNCT
ajlm-1718	178	19	sera	sera	NOUN
ajlm-1718	178	20	,	,	PUNCT
ajlm-1718	178	21	and	and	CCONJ
ajlm-1718	178	22	hair	hair	NOUN
ajlm-1718	178	23	follicles	follicle	NOUN
ajlm-1718	178	24	.	.	PUNCT
ajlm-1718	179	1	j	j	PROPN
ajlm-1718	179	2	clin	clin	PROPN
ajlm-1718	179	3	microbiol	microbiol	PROPN
ajlm-1718	179	4	.	.	PUNCT
ajlm-1718	180	1	2006;44(4):1571–1574	2006;44(4):1571–1574	NUM
ajlm-1718	180	2	.	.	PUNCT
ajlm-1718	181	1	https://doi.org/10.1128/jcm.44.4.1571-1574.2006	https://doi.org/10.1128/jcm.44.4.1571-1574.2006	PROPN
ajlm-1718	181	2	tanaka	tanaka	PROPN
ajlm-1718	181	3	-	-	PUNCT
ajlm-1718	181	4	taya	taya	PROPN
ajlm-1718	181	5	k	k	PROPN
ajlm-1718	181	6	,	,	PUNCT
ajlm-1718	181	7	sashihara	sashihara	PROPN
ajlm-1718	181	8	j	j	PROPN
ajlm-1718	181	9	,	,	PUNCT
ajlm-1718	181	10	kurahashi	kurahashi	PROPN
ajlm-1718	181	11	h	h	PROPN
ajlm-1718	181	12	,	,	PUNCT
ajlm-1718	181	13	et	et	PROPN
ajlm-1718	181	14	al	al	PROPN
ajlm-1718	181	15	.	.	PUNCT
ajlm-1718	182	1	human	human	ADJ
ajlm-1718	182	2	herpesvirus	herpesvirus	NOUN
ajlm-1718	182	3	6	6	NUM
ajlm-1718	182	4	(	(	PUNCT
ajlm-1718	182	5	hhv-6	hhv-6	NOUN
ajlm-1718	182	6	)	)	PUNCT
ajlm-1718	182	7	is	be	AUX
ajlm-1718	182	8	transmitted	transmit	VERB
ajlm-1718	182	9	from	from	ADP
ajlm-1718	182	10	parent	parent	NOUN
ajlm-1718	182	11	to	to	ADP
ajlm-1718	182	12	child	child	NOUN
ajlm-1718	182	13	in	in	ADP
ajlm-1718	182	14	an	an	DET
ajlm-1718	182	15	integrated	integrate	VERB
ajlm-1718	182	16	form	form	NOUN
ajlm-1718	182	17	and	and	CCONJ
ajlm-1718	182	18	characterization	characterization	NOUN
ajlm-1718	182	19	of	of	ADP
ajlm-1718	182	20	cases	case	NOUN
ajlm-1718	182	21	with	with	ADP
ajlm-1718	182	22	chromosomally	chromosomally	ADV
ajlm-1718	182	23	integrated	integrate	VERB
ajlm-1718	182	24	hhv-6	hhv-6	ADJ
ajlm-1718	182	25	dna	dna	NOUN
ajlm-1718	182	26	.	.	PUNCT
ajlm-1718	183	1	j	j	PROPN
ajlm-1718	183	2	med	med	PROPN
ajlm-1718	183	3	virol	virol	NOUN
ajlm-1718	183	4	.	.	PUNCT
ajlm-1718	184	1	2004;73(3):465–473	2004;73(3):465–473	X
ajlm-1718	184	2	.	.	PUNCT
ajlm-1718	184	3	https://doi.org/10.1002/jmv.20113	https://doi.org/10.1002/jmv.20113	PROPN
ajlm-1718	184	4	leong	leong	PROPN
ajlm-1718	184	5	hn	hn	PROPN
ajlm-1718	184	6	,	,	PUNCT
ajlm-1718	184	7	tuke	tuke	PROPN
ajlm-1718	184	8	pw	pw	PROPN
ajlm-1718	184	9	,	,	PUNCT
ajlm-1718	184	10	tedder	tedder	NOUN
ajlm-1718	184	11	rs	rs	NOUN
ajlm-1718	184	12	,	,	PUNCT
ajlm-1718	184	13	et	et	PROPN
ajlm-1718	184	14	al	al	PROPN
ajlm-1718	184	15	.	.	PUNCT
ajlm-1718	185	1	the	the	DET
ajlm-1718	185	2	prevalence	prevalence	NOUN
ajlm-1718	185	3	of	of	ADP
ajlm-1718	185	4	chromosomally	chromosomally	ADV
ajlm-1718	185	5	integrated	integrate	VERB
ajlm-1718	185	6	human	human	ADJ
ajlm-1718	185	7	herpesvirus	herpesvirus	NOUN
ajlm-1718	185	8	6	6	NUM
ajlm-1718	185	9	genomes	genome	NOUN
ajlm-1718	185	10	in	in	ADP
ajlm-1718	185	11	the	the	DET
ajlm-1718	185	12	blood	blood	NOUN
ajlm-1718	185	13	of	of	ADP
ajlm-1718	185	14	uk	uk	PROPN
ajlm-1718	185	15	blood	blood	NOUN
ajlm-1718	185	16	donors	donor	NOUN
ajlm-1718	185	17	.	.	PUNCT
ajlm-1718	186	1	j	j	PROPN
ajlm-1718	186	2	med	med	PROPN
ajlm-1718	186	3	virol	virol	NOUN
ajlm-1718	186	4	.	.	PUNCT
ajlm-1718	187	1	2007;79(1):45–6	2007;79(1):45–6	ADJ
ajlm-1718	187	2	.	.	PUNCT
ajlm-1718	188	1	https://doi.org/10.1002/jmv.20760	https://doi.org/10.1002/jmv.20760	PROPN
ajlm-1718	188	2	ward	ward	NOUN
ajlm-1718	188	3	kn	kn	PROPN
ajlm-1718	188	4	,	,	PUNCT
ajlm-1718	188	5	leong	leong	PROPN
ajlm-1718	188	6	hn	hn	PROPN
ajlm-1718	188	7	,	,	PUNCT
ajlm-1718	188	8	thiruchelvam	thiruchelvam	ADJ
ajlm-1718	188	9	ad	ad	NOUN
ajlm-1718	188	10	,	,	PUNCT
ajlm-1718	188	11	atkinson	atkinson	PROPN
ajlm-1718	188	12	ce	ce	PROPN
ajlm-1718	188	13	,	,	PUNCT
ajlm-1718	188	14	clark	clark	PROPN
ajlm-1718	188	15	da	da	PROPN
ajlm-1718	188	16	.	.	PUNCT
ajlm-1718	189	1	human	human	ADJ
ajlm-1718	189	2	herpesvirus	herpesvirus	NOUN
ajlm-1718	189	3	6	6	NUM
ajlm-1718	189	4	dna	dna	PROPN
ajlm-1718	189	5	levels	level	NOUN
ajlm-1718	189	6	in	in	ADP
ajlm-1718	189	7	cerebrospinal	cerebrospinal	ADJ
ajlm-1718	189	8	fluid	fluid	NOUN
ajlm-1718	189	9	due	due	ADJ
ajlm-1718	189	10	to	to	ADP
ajlm-1718	189	11	primary	primary	ADJ
ajlm-1718	189	12	infection	infection	NOUN
ajlm-1718	189	13	differ	differ	VERB
ajlm-1718	189	14	from	from	ADP
ajlm-1718	189	15	those	those	PRON
ajlm-1718	189	16	due	due	ADJ
ajlm-1718	189	17	to	to	ADP
ajlm-1718	189	18	chromosomal	chromosomal	ADJ
ajlm-1718	189	19	viral	viral	ADJ
ajlm-1718	189	20	integration	integration	NOUN
ajlm-1718	189	21	and	and	CCONJ
ajlm-1718	189	22	have	have	VERB
ajlm-1718	189	23	implications	implication	NOUN
ajlm-1718	189	24	for	for	ADP
ajlm-1718	189	25	diagnosis	diagnosis	NOUN
ajlm-1718	189	26	of	of	ADP
ajlm-1718	189	27	encephalitis	encephalitis	NOUN
ajlm-1718	189	28	.	.	PUNCT
ajlm-1718	190	1	j	j	PROPN
ajlm-1718	190	2	clin	clin	PROPN
ajlm-1718	190	3	microbiol	microbiol	PROPN
ajlm-1718	190	4	.	.	PUNCT
ajlm-1718	191	1	2007;45(4):1298–1304	2007;45(4):1298–1304	PROPN
ajlm-1718	191	2	.	.	PUNCT
ajlm-1718	192	1	https://doi.org/10.1128/jcm.02115-06	https://doi.org/10.1128/jcm.02115-06	PROPN
ajlm-1718	192	2	logan	logan	PROPN
ajlm-1718	192	3	sa	sa	PROPN
ajlm-1718	192	4	,	,	PUNCT
ajlm-1718	192	5	macmahon	macmahon	PROPN
ajlm-1718	192	6	e.	e.	PROPN
ajlm-1718	192	7	viral	viral	PROPN
ajlm-1718	192	8	meningitis	meningitis	PROPN
ajlm-1718	192	9	.	.	PUNCT
ajlm-1718	193	1	bmj	bmj	PROPN
ajlm-1718	193	2	.	.	PUNCT
ajlm-1718	194	1	2008;336(7634):36–40	2008;336(7634):36–40	PROPN
ajlm-1718	194	2	.	.	PUNCT
ajlm-1718	195	1	https://doi.org/10.1136/bmj.39409.673657.ae	https://doi.org/10.1136/bmj.39409.673657.ae	AUX
ajlm-1718	196	1	big	big	ADJ
ajlm-1718	196	2	c	c	NOUN
ajlm-1718	196	3	,	,	PUNCT
ajlm-1718	196	4	reineck	reineck	NOUN
ajlm-1718	196	5	la	la	PROPN
ajlm-1718	196	6	,	,	PUNCT
ajlm-1718	196	7	aronoff	aronoff	PROPN
ajlm-1718	196	8	dm	dm	PROPN
ajlm-1718	196	9	.	.	PUNCT
ajlm-1718	196	10	viral	viral	ADJ
ajlm-1718	196	11	infections	infection	NOUN
ajlm-1718	196	12	of	of	ADP
ajlm-1718	196	13	the	the	DET
ajlm-1718	196	14	central	central	ADJ
ajlm-1718	196	15	nervous	nervous	ADJ
ajlm-1718	196	16	system	system	NOUN
ajlm-1718	196	17	:	:	PUNCT
ajlm-1718	196	18	a	a	DET
ajlm-1718	196	19	case	case	NOUN
ajlm-1718	196	20	-	-	PUNCT
ajlm-1718	196	21	based	base	VERB
ajlm-1718	196	22	review	review	NOUN
ajlm-1718	196	23	.	.	PUNCT
ajlm-1718	197	1	clin	clin	PROPN
ajlm-1718	197	2	med	med	PROPN
ajlm-1718	197	3	res	re	NOUN
ajlm-1718	197	4	.	.	PUNCT
ajlm-1718	198	1	2009;7(4):142–146	2009;7(4):142–146	X
ajlm-1718	198	2	.	.	PUNCT
ajlm-1718	199	1	https://doi.org/10.3121/cmr.2009.864	https://doi.org/10.3121/cmr.2009.864	PROPN
ajlm-1718	199	2	lee	lee	PROPN
ajlm-1718	199	3	be	be	VERB
ajlm-1718	199	4	,	,	PUNCT
ajlm-1718	199	5	davies	davies	PROPN
ajlm-1718	199	6	hd	hd	PROPN
ajlm-1718	199	7	.	.	PUNCT
ajlm-1718	200	1	aseptic	aseptic	ADJ
ajlm-1718	200	2	meningitis	meningitis	PROPN
ajlm-1718	200	3	.	.	PUNCT
ajlm-1718	201	1	curr	curr	PROPN
ajlm-1718	201	2	opin	opin	PROPN
ajlm-1718	201	3	infect	infect	PROPN
ajlm-1718	201	4	dis	dis	PROPN
ajlm-1718	201	5	.	.	PUNCT
ajlm-1718	202	1	2007;20(3):272–277	2007;20(3):272–277	X
ajlm-1718	202	2	.	.	PUNCT
ajlm-1718	203	1	https://doi.org/10.1097/qco.0b013e3280ad4672	https://doi.org/10.1097/qco.0b013e3280ad4672	PROPN
ajlm-1718	203	2	abdelrahim	abdelrahim	PRON
ajlm-1718	203	3	na	na	NOUN
ajlm-1718	203	4	,	,	PUNCT
ajlm-1718	203	5	fadl	fadl	NOUN
ajlm-1718	203	6	-	-	PUNCT
ajlm-1718	203	7	elmula	elmula	VERB
ajlm-1718	203	8	i	i	PRON
ajlm-1718	203	9	m	m	PROPN
ajlm-1718	203	10	,	,	PUNCT
ajlm-1718	203	11	ali	ali	PROPN
ajlm-1718	203	12	hm	hm	PROPN
ajlm-1718	203	13	.	.	PUNCT
ajlm-1718	204	1	bacterial	bacterial	ADJ
ajlm-1718	204	2	meningitis	meningitis	NOUN
ajlm-1718	204	3	in	in	ADP
ajlm-1718	204	4	sudanese	sudanese	ADJ
ajlm-1718	204	5	children	child	NOUN
ajlm-1718	204	6	;	;	PUNCT
ajlm-1718	204	7	critical	critical	ADJ
ajlm-1718	204	8	evaluation	evaluation	NOUN
ajlm-1718	204	9	of	of	ADP
ajlm-1718	204	10	the	the	DET
ajlm-1718	204	11	clinical	clinical	ADJ
ajlm-1718	204	12	decision	decision	NOUN
ajlm-1718	204	13	using	use	VERB
ajlm-1718	204	14	clinical	clinical	ADJ
ajlm-1718	204	15	prediction	prediction	NOUN
ajlm-1718	204	16	rules	rule	NOUN
ajlm-1718	204	17	.	.	PUNCT
ajlm-1718	205	1	bmc	bmc	ADJ
ajlm-1718	205	2	pediatr	pediatr	NOUN
ajlm-1718	205	3	.	.	PUNCT
ajlm-1718	206	1	2019;19(1):319	2019;19(1):319	NUM
ajlm-1718	206	2	.	.	PUNCT
ajlm-1718	207	1	https://doi.org/10.1186/s12887-019-1684-3	https://doi.org/10.1186/s12887-019-1684-3	PROPN
ajlm-1718	207	2	tavakoli	tavakoli	PROPN
ajlm-1718	207	3	np	np	PROPN
ajlm-1718	207	4	,	,	PUNCT
ajlm-1718	207	5	nattanmai	nattanmai	PROPN
ajlm-1718	207	6	s	s	PROPN
ajlm-1718	207	7	,	,	PUNCT
ajlm-1718	207	8	hull	hull	NOUN
ajlm-1718	207	9	r	r	NOUN
ajlm-1718	207	10	,	,	PUNCT
ajlm-1718	207	11	et	et	PROPN
ajlm-1718	207	12	al	al	PROPN
ajlm-1718	207	13	.	.	PUNCT
ajlm-1718	207	14	detection	detection	NOUN
ajlm-1718	207	15	and	and	CCONJ
ajlm-1718	207	16	typing	typing	NOUN
ajlm-1718	207	17	of	of	ADP
ajlm-1718	207	18	human	human	ADJ
ajlm-1718	207	19	herpesvirus	herpesvirus	NOUN
ajlm-1718	207	20	6	6	NUM
ajlm-1718	207	21	by	by	ADP
ajlm-1718	207	22	molecular	molecular	ADJ
ajlm-1718	207	23	methods	method	NOUN
ajlm-1718	207	24	in	in	ADP
ajlm-1718	207	25	specimens	specimen	NOUN
ajlm-1718	207	26	from	from	ADP
ajlm-1718	207	27	patients	patient	NOUN
ajlm-1718	207	28	diagnosed	diagnose	VERB
ajlm-1718	207	29	with	with	ADP
ajlm-1718	207	30	encephalitis	encephalitis	NOUN
ajlm-1718	207	31	or	or	CCONJ
ajlm-1718	207	32	meningitis	meningitis	NOUN
ajlm-1718	207	33	.	.	PUNCT
ajlm-1718	208	1	j	j	PROPN
ajlm-1718	208	2	clin	clin	PROPN
ajlm-1718	208	3	microbiol	microbiol	PROPN
ajlm-1718	208	4	.	.	PUNCT
ajlm-1718	209	1	2007;45(12):3972–3978	2007;45(12):3972–3978	X
ajlm-1718	209	2	.	.	PUNCT
ajlm-1718	210	1	https://doi.org/10.1128/jcm.01692-07	https://doi.org/10.1128/jcm.01692-07	PROPN
ajlm-1718	210	2	isaacson	isaacson	PROPN
ajlm-1718	210	3	e	e	PROPN
ajlm-1718	210	4	,	,	PUNCT
ajlm-1718	210	5	glaser	glaser	PROPN
ajlm-1718	210	6	ca	ca	PROPN
ajlm-1718	210	7	,	,	PUNCT
ajlm-1718	210	8	forghani	forghani	PROPN
ajlm-1718	210	9	b	b	PROPN
ajlm-1718	210	10	,	,	PUNCT
ajlm-1718	210	11	et	et	PROPN
ajlm-1718	210	12	al	al	PROPN
ajlm-1718	210	13	.	.	PROPN
ajlm-1718	210	14	evidence	evidence	NOUN
ajlm-1718	210	15	of	of	ADP
ajlm-1718	210	16	human	human	ADJ
ajlm-1718	210	17	herpesvirus	herpesvirus	NOUN
ajlm-1718	210	18	6	6	NUM
ajlm-1718	210	19	infection	infection	NOUN
ajlm-1718	210	20	in	in	ADP
ajlm-1718	210	21	4	4	NUM
ajlm-1718	210	22	immunocompetent	immunocompetent	ADJ
ajlm-1718	210	23	patients	patient	NOUN
ajlm-1718	210	24	with	with	ADP
ajlm-1718	210	25	encephalitis	encephalitis	NOUN
ajlm-1718	210	26	.	.	PUNCT
ajlm-1718	211	1	clin	clin	PROPN
ajlm-1718	211	2	infect	infect	PROPN
ajlm-1718	211	3	dis	dis	PROPN
ajlm-1718	211	4	.	.	PUNCT
ajlm-1718	212	1	2005;40(6):890–893	2005;40(6):890–893	X
ajlm-1718	212	2	.	.	PUNCT
ajlm-1718	212	3	https://doi.org/10.1086/427944	https://doi.org/10.1086/427944	X
ajlm-1718	213	1	takanashi	takanashi	PROPN
ajlm-1718	213	2	j	j	PROPN
ajlm-1718	213	3	,	,	PUNCT
ajlm-1718	213	4	barkovich	barkovich	PROPN
ajlm-1718	213	5	aj	aj	PROPN
ajlm-1718	213	6	,	,	PUNCT
ajlm-1718	213	7	tada	tada	PROPN
ajlm-1718	213	8	h	h	NOUN
ajlm-1718	213	9	,	,	PUNCT
ajlm-1718	213	10	takada	takada	PROPN
ajlm-1718	213	11	n	n	NUM
ajlm-1718	213	12	,	,	PUNCT
ajlm-1718	213	13	fujii	fujii	PROPN
ajlm-1718	213	14	k	k	PROPN
ajlm-1718	213	15	,	,	PUNCT
ajlm-1718	213	16	kohno	kohno	PROPN
ajlm-1718	213	17	y.	y.	PROPN
ajlm-1718	213	18	cortical	cortical	ADJ
ajlm-1718	213	19	liquefaction	liquefaction	NOUN
ajlm-1718	213	20	in	in	ADP
ajlm-1718	213	21	severe	severe	ADJ
ajlm-1718	213	22	human	human	ADJ
ajlm-1718	213	23	herpesvirus	herpesvirus	NOUN
ajlm-1718	213	24	6	6	NUM
ajlm-1718	213	25	encephalopathy	encephalopathy	NOUN
ajlm-1718	213	26	.	.	PUNCT
ajlm-1718	214	1	neurology	neurology	NOUN
ajlm-1718	214	2	.	.	PUNCT
ajlm-1718	215	1	2006;66(3):452–453	2006;66(3):452–453	NUM
ajlm-1718	215	2	.	.	PUNCT
ajlm-1718	216	1	https://doi.org/10.1212/01.wnl.0000196486.42635.f8	https://doi.org/10.1212/01.wnl.0000196486.42635.f8	PROPN
ajlm-1718	216	2	hosseininasab	hosseininasab	VERB
ajlm-1718	216	3	a	a	PRON
ajlm-1718	216	4	,	,	PUNCT
ajlm-1718	216	5	alborzi	alborzi	NOUN
ajlm-1718	216	6	a	a	DET
ajlm-1718	216	7	,	,	PUNCT
ajlm-1718	216	8	ziyaeyan	ziyaeyan	PROPN
ajlm-1718	216	9	m	m	PROPN
ajlm-1718	216	10	,	,	PUNCT
ajlm-1718	216	11	et	et	PROPN
ajlm-1718	216	12	al	al	PROPN
ajlm-1718	216	13	.	.	PROPN
ajlm-1718	216	14	viral	viral	ADJ
ajlm-1718	216	15	etiology	etiology	NOUN
ajlm-1718	216	16	of	of	ADP
ajlm-1718	216	17	aseptic	aseptic	ADJ
ajlm-1718	216	18	meningitis	meningitis	NOUN
ajlm-1718	216	19	among	among	ADP
ajlm-1718	216	20	children	child	NOUN
ajlm-1718	216	21	in	in	ADP
ajlm-1718	216	22	southern	southern	ADJ
ajlm-1718	216	23	iran	iran	PROPN
ajlm-1718	216	24	.	.	PUNCT
ajlm-1718	217	1	j	j	PROPN
ajlm-1718	217	2	med	med	PROPN
ajlm-1718	217	3	virol	virol	NOUN
ajlm-1718	217	4	.	.	PUNCT
ajlm-1718	218	1	2011;83(5):884–888	2011;83(5):884–888	X
ajlm-1718	218	2	.	.	PUNCT
ajlm-1718	219	1	https://doi.org/10.1002/jmv.22056	https://doi.org/10.1002/jmv.22056	PROPN
ajlm-1718	219	2	ibrahim	ibrahim	PROPN
ajlm-1718	219	3	ai	ai	VERB
ajlm-1718	219	4	,	,	PUNCT
ajlm-1718	219	5	obeid	obeid	PROPN
ajlm-1718	219	6	mt	mt	PROPN
ajlm-1718	219	7	,	,	PUNCT
ajlm-1718	219	8	jouma	jouma	PROPN
ajlm-1718	219	9	mj	mj	PROPN
ajlm-1718	219	10	,	,	PUNCT
ajlm-1718	219	11	roemer	roemer	PROPN
ajlm-1718	219	12	k	k	PROPN
ajlm-1718	219	13	,	,	PUNCT
ajlm-1718	219	14	mueller	mueller	PROPN
ajlm-1718	219	15	-	-	PUNCT
ajlm-1718	219	16	lantzsch	lantzsch	PROPN
ajlm-1718	219	17	n	n	CCONJ
ajlm-1718	219	18	,	,	PUNCT
ajlm-1718	219	19	gärtner	gärtner	PROPN
ajlm-1718	219	20	bc	bc	PROPN
ajlm-1718	219	21	.	.	PROPN
ajlm-1718	219	22	prevalence	prevalence	NOUN
ajlm-1718	219	23	of	of	ADP
ajlm-1718	219	24	herpes	herpe	NOUN
ajlm-1718	219	25	simplex	simplex	NOUN
ajlm-1718	219	26	virus	virus	NOUN
ajlm-1718	219	27	(	(	PUNCT
ajlm-1718	219	28	types	type	NOUN
ajlm-1718	219	29	1	1	NUM
ajlm-1718	219	30	and	and	CCONJ
ajlm-1718	219	31	2	2	NUM
ajlm-1718	219	32	)	)	PUNCT
ajlm-1718	219	33	,	,	PUNCT
ajlm-1718	219	34	varicella	varicella	NOUN
ajlm-1718	219	35	-	-	PUNCT
ajlm-1718	219	36	zoster	zoster	NOUN
ajlm-1718	219	37	virus	virus	NOUN
ajlm-1718	219	38	,	,	PUNCT
ajlm-1718	219	39	cytomegalovirus	cytomegalovirus	NOUN
ajlm-1718	219	40	,	,	PUNCT
ajlm-1718	219	41	and	and	CCONJ
ajlm-1718	219	42	human	human	ADJ
ajlm-1718	219	43	herpesvirus	herpesvirus	NOUN
ajlm-1718	219	44	6	6	NUM
ajlm-1718	219	45	and	and	CCONJ
ajlm-1718	219	46	7	7	NUM
ajlm-1718	219	47	dna	dna	NOUN
ajlm-1718	219	48	in	in	ADP
ajlm-1718	219	49	cerebrospinal	cerebrospinal	ADJ
ajlm-1718	219	50	fluid	fluid	NOUN
ajlm-1718	219	51	of	of	ADP
ajlm-1718	219	52	middle	middle	ADJ
ajlm-1718	219	53	eastern	eastern	ADJ
ajlm-1718	219	54	patients	patient	NOUN
ajlm-1718	219	55	with	with	ADP
ajlm-1718	219	56	encephalitis	encephalitis	NOUN
ajlm-1718	219	57	.	.	PUNCT
ajlm-1718	220	1	j	j	PROPN
ajlm-1718	220	2	clin	clin	PROPN
ajlm-1718	220	3	microbiol	microbiol	PROPN
ajlm-1718	220	4	.	.	PUNCT
ajlm-1718	221	1	2005;43(8):4172–4174	2005;43(8):4172–4174	INTJ
ajlm-1718	221	2	.	.	PUNCT
ajlm-1718	222	1	https://doi.org/10.1128/jcm.43.8.4172-4174.2005	https://doi.org/10.1128/jcm.43.8.4172-4174.2005	PROPN
ajlm-1718	222	2	minjolle	minjolle	NOUN
ajlm-1718	222	3	s	s	PART
ajlm-1718	222	4	,	,	PUNCT
ajlm-1718	222	5	michelet	michelet	NOUN
ajlm-1718	222	6	c	c	NOUN
ajlm-1718	222	7	,	,	PUNCT
ajlm-1718	222	8	jusselin	jusselin	PROPN
ajlm-1718	222	9	i	i	PROPN
ajlm-1718	222	10	,	,	PUNCT
ajlm-1718	222	11	joannes	joannes	PROPN
ajlm-1718	222	12	m	m	PROPN
ajlm-1718	222	13	,	,	PUNCT
ajlm-1718	222	14	cartier	cartier	PROPN
ajlm-1718	222	15	f	f	NOUN
ajlm-1718	222	16	,	,	PUNCT
ajlm-1718	222	17	colimon	colimon	PROPN
ajlm-1718	222	18	r.	r.	NOUN
ajlm-1718	222	19	amplification	amplification	NOUN
ajlm-1718	222	20	of	of	ADP
ajlm-1718	222	21	the	the	DET
ajlm-1718	222	22	six	six	NUM
ajlm-1718	222	23	major	major	ADJ
ajlm-1718	222	24	human	human	ADJ
ajlm-1718	222	25	herpesviruses	herpesviruse	NOUN
ajlm-1718	222	26	from	from	ADP
ajlm-1718	222	27	cerebrospinal	cerebrospinal	ADJ
ajlm-1718	222	28	fluid	fluid	NOUN
ajlm-1718	222	29	by	by	ADP
ajlm-1718	222	30	a	a	DET
ajlm-1718	222	31	single	single	ADJ
ajlm-1718	222	32	pcr	pcr	NOUN
ajlm-1718	222	33	.	.	PUNCT
ajlm-1718	223	1	j	j	PROPN
ajlm-1718	223	2	clin	clin	PROPN
ajlm-1718	223	3	microbiol	microbiol	PROPN
ajlm-1718	223	4	.	.	PUNCT
ajlm-1718	224	1	1999;37(4):950–953	1999;37(4):950–953	X
ajlm-1718	224	2	.	.	PUNCT
ajlm-1718	224	3	https://doi.org/10.1128/jcm.37.4.950-953.1999	https://doi.org/10.1128/jcm.37.4.950-953.1999	PROPN
ajlm-1718	224	4	tang	tang	PROPN
ajlm-1718	224	5	yw	yw	PROPN
ajlm-1718	224	6	,	,	PUNCT
ajlm-1718	224	7	espy	espy	VERB
ajlm-1718	224	8	mj	mj	PROPN
ajlm-1718	224	9	,	,	PUNCT
ajlm-1718	224	10	persing	perse	VERB
ajlm-1718	224	11	dh	dh	PROPN
ajlm-1718	224	12	,	,	PUNCT
ajlm-1718	224	13	smith	smith	PROPN
ajlm-1718	225	1	tf	tf	INTJ
ajlm-1718	225	2	.	.	PUNCT
ajlm-1718	226	1	molecular	molecular	ADJ
ajlm-1718	226	2	evidence	evidence	NOUN
ajlm-1718	226	3	and	and	CCONJ
ajlm-1718	226	4	clinical	clinical	ADJ
ajlm-1718	226	5	significance	significance	NOUN
ajlm-1718	226	6	of	of	ADP
ajlm-1718	226	7	herpesvirus	herpesvirus	NOUN
ajlm-1718	226	8	coinfection	coinfection	NOUN
ajlm-1718	226	9	in	in	ADP
ajlm-1718	226	10	the	the	DET
ajlm-1718	226	11	central	central	ADJ
ajlm-1718	226	12	nervous	nervous	ADJ
ajlm-1718	226	13	system	system	NOUN
ajlm-1718	226	14	.	.	PUNCT
ajlm-1718	227	1	j	j	PROPN
ajlm-1718	227	2	clin	clin	PROPN
ajlm-1718	227	3	microbiol	microbiol	PROPN
ajlm-1718	227	4	.	.	PUNCT
ajlm-1718	228	1	1997;35(11):2869–2872	1997;35(11):2869–2872	NUM
ajlm-1718	228	2	.	.	PUNCT
ajlm-1718	229	1	https://doi.org/10.1128/jcm.35.11.2869-2872.1997	https://doi.org/10.1128/jcm.35.11.2869-2872.1997	PROPN
ajlm-1718	229	2	yoshikawa	yoshikawa	PROPN
ajlm-1718	229	3	t	t	PROPN
ajlm-1718	229	4	,	,	PUNCT
ajlm-1718	229	5	suga	suga	PROPN
ajlm-1718	229	6	s	s	PROPN
ajlm-1718	229	7	,	,	PUNCT
ajlm-1718	229	8	asano	asano	PROPN
ajlm-1718	229	9	y	y	PROPN
ajlm-1718	229	10	,	,	PUNCT
ajlm-1718	229	11	yazaki	yazaki	PROPN
ajlm-1718	229	12	t	t	PROPN
ajlm-1718	229	13	,	,	PUNCT
ajlm-1718	229	14	kodama	kodama	PROPN
ajlm-1718	229	15	h	h	PROPN
ajlm-1718	229	16	,	,	PUNCT
ajlm-1718	229	17	ozaki	ozaki	PROPN
ajlm-1718	229	18	t.	t.	NOUN
ajlm-1718	229	19	distribution	distribution	NOUN
ajlm-1718	229	20	of	of	ADP
ajlm-1718	229	21	antibodies	antibody	NOUN
ajlm-1718	229	22	to	to	ADP
ajlm-1718	229	23	a	a	DET
ajlm-1718	229	24	causative	causative	ADJ
ajlm-1718	229	25	agent	agent	NOUN
ajlm-1718	229	26	of	of	ADP
ajlm-1718	229	27	exanthem	exanthem	PROPN
ajlm-1718	229	28	subitum	subitum	NOUN
ajlm-1718	229	29	(	(	PUNCT
ajlm-1718	229	30	human	human	NOUN
ajlm-1718	229	31	herpesvirus-6	herpesvirus-6	NOUN
ajlm-1718	229	32	)	)	PUNCT
ajlm-1718	229	33	in	in	ADP
ajlm-1718	229	34	healthy	healthy	ADJ
ajlm-1718	229	35	individuals	individual	NOUN
ajlm-1718	229	36	.	.	PUNCT
ajlm-1718	230	1	pediatrics	pediatric	NOUN
ajlm-1718	230	2	.	.	PUNCT
ajlm-1718	231	1	1989;84(4):675–677	1989;84(4):675–677	NUM
ajlm-1718	231	2	.	.	PUNCT
ajlm-1718	232	1	https://doi.org/10.1542/peds.84.4.675	https://doi.org/10.1542/peds.84.4.675	PROPN
ajlm-1718	232	2	ward	ward	PROPN
ajlm-1718	232	3	kn	kn	PROPN
ajlm-1718	232	4	,	,	PUNCT
ajlm-1718	232	5	gray	gray	PROPN
ajlm-1718	232	6	jj	jj	PROPN
ajlm-1718	232	7	,	,	PUNCT
ajlm-1718	232	8	fotheringham	fotheringham	PROPN
ajlm-1718	232	9	mw	mw	PROPN
ajlm-1718	232	10	,	,	PUNCT
ajlm-1718	232	11	sheldon	sheldon	PROPN
ajlm-1718	232	12	mj	mj	PROPN
ajlm-1718	232	13	.	.	PUNCT
ajlm-1718	233	1	igg	igg	PROPN
ajlm-1718	233	2	antibodies	antibodie	VERB
ajlm-1718	233	3	to	to	ADP
ajlm-1718	233	4	human	human	NOUN
ajlm-1718	233	5	herpesvirus-6	herpesvirus-6	NOUN
ajlm-1718	233	6	in	in	ADP
ajlm-1718	233	7	young	young	ADJ
ajlm-1718	233	8	children	child	NOUN
ajlm-1718	233	9	:	:	PUNCT
ajlm-1718	233	10	changes	change	NOUN
ajlm-1718	233	11	in	in	ADP
ajlm-1718	233	12	avidity	avidity	NOUN
ajlm-1718	233	13	of	of	ADP
ajlm-1718	233	14	antibody	antibody	NOUN
ajlm-1718	233	15	correlate	correlate	VERB
ajlm-1718	233	16	with	with	ADP
ajlm-1718	233	17	time	time	NOUN
ajlm-1718	233	18	after	after	ADP
ajlm-1718	233	19	infection	infection	NOUN
ajlm-1718	233	20	.	.	PUNCT
ajlm-1718	234	1	j	j	PROPN
ajlm-1718	234	2	med	med	PROPN
ajlm-1718	234	3	virol	virol	NOUN
ajlm-1718	234	4	.	.	PUNCT
ajlm-1718	235	1	1993;39(2):131–138	1993;39(2):131–138	NUM
ajlm-1718	235	2	.	.	PUNCT
ajlm-1718	236	1	https://doi.org/10.1002/jmv.1890390209	https://doi.org/10.1002/jmv.1890390209	ADJ
ajlm-1718	236	2	schvoerer	schvoerer	NOUN
ajlm-1718	236	3	e	e	NOUN
ajlm-1718	236	4	,	,	PUNCT
ajlm-1718	236	5	fréchin	fréchin	PROPN
ajlm-1718	236	6	v	v	PROPN
ajlm-1718	236	7	,	,	PUNCT
ajlm-1718	236	8	fritsch	fritsch	PROPN
ajlm-1718	236	9	s	s	PROPN
ajlm-1718	236	10	,	,	PUNCT
ajlm-1718	236	11	et	et	PROPN
ajlm-1718	236	12	al	al	PROPN
ajlm-1718	236	13	.	.	PROPN
ajlm-1718	236	14	atypical	atypical	ADJ
ajlm-1718	236	15	symptoms	symptom	NOUN
ajlm-1718	236	16	in	in	ADP
ajlm-1718	236	17	patients	patient	NOUN
ajlm-1718	236	18	with	with	ADP
ajlm-1718	236	19	herpesvirus	herpesvirus	NOUN
ajlm-1718	236	20	dna	dna	NOUN
ajlm-1718	236	21	detected	detect	VERB
ajlm-1718	236	22	by	by	ADP
ajlm-1718	236	23	pcr	pcr	PROPN
ajlm-1718	236	24	in	in	ADP
ajlm-1718	236	25	cerebrospinal	cerebrospinal	ADJ
ajlm-1718	236	26	fluid	fluid	NOUN
ajlm-1718	236	27	.	.	PUNCT
ajlm-1718	237	1	j	j	PROPN
ajlm-1718	237	2	clin	clin	PROPN
ajlm-1718	237	3	virol	virol	PROPN
ajlm-1718	237	4	.	.	PUNCT
ajlm-1718	238	1	2006;35(4):458–462	2006;35(4):458–462	NUM
ajlm-1718	238	2	.	.	PUNCT
ajlm-1718	239	1	https://doi.org/10.1016/j.jcv.2005.11.005	https://doi.org/10.1016/j.jcv.2005.11.005	PROPN
ajlm-1718	239	2	collot	collot	NOUN
ajlm-1718	239	3	s	s	PROPN
ajlm-1718	239	4	,	,	PUNCT
ajlm-1718	239	5	petit	petit	PROPN
ajlm-1718	239	6	b	b	PROPN
ajlm-1718	239	7	,	,	PUNCT
ajlm-1718	239	8	bordessoule	bordessoule	NOUN
ajlm-1718	239	9	d	d	PROPN
ajlm-1718	239	10	,	,	PUNCT
ajlm-1718	239	11	et	et	PROPN
ajlm-1718	239	12	al	al	PROPN
ajlm-1718	239	13	.	.	PUNCT
ajlm-1718	240	1	real	real	ADJ
ajlm-1718	240	2	-	-	PUNCT
ajlm-1718	240	3	time	time	NOUN
ajlm-1718	240	4	pcr	pcr	NOUN
ajlm-1718	240	5	for	for	ADP
ajlm-1718	240	6	quantification	quantification	NOUN
ajlm-1718	240	7	of	of	ADP
ajlm-1718	240	8	human	human	ADJ
ajlm-1718	240	9	herpesvirus	herpesvirus	NOUN
ajlm-1718	240	10	6	6	NUM
ajlm-1718	240	11	dna	dna	NOUN
ajlm-1718	240	12	from	from	ADP
ajlm-1718	240	13	lymph	lymph	NOUN
ajlm-1718	240	14	nodes	node	NOUN
ajlm-1718	240	15	and	and	CCONJ
ajlm-1718	240	16	saliva	saliva	NOUN
ajlm-1718	240	17	.	.	PUNCT
ajlm-1718	241	1	j	j	PROPN
ajlm-1718	241	2	clin	clin	PROPN
ajlm-1718	241	3	microbiol	microbiol	PROPN
ajlm-1718	241	4	.	.	PUNCT
ajlm-1718	242	1	2002;40(7):2445–2451	2002;40(7):2445–2451	PROPN
ajlm-1718	242	2	.	.	PUNCT
ajlm-1718	243	1	https://doi.org/10.1128/jcm.40.7.2445-2451.2002	https://doi.org/10.1128/jcm.40.7.2445-2451.2002	PROPN